# EDGAR Filing Document

**Accession Number:** 0000107140
**File Stem:** 0001628280-26-045111
**Filing Date:** 2026-6
**Character Count:** 499323
**Document Hash:** 10163508b5a9d70a534f844fe0168451
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-045111.hdr.sgml**: 20260624

**ACCESSION NUMBER**: 0001628280-26-045111

**CONFORMED SUBMISSION TYPE**: 10-K

**PUBLIC DOCUMENT COUNT**: 172

**CONFORMED PERIOD OF REPORT**: 20260430

**FILED AS OF DATE**: 20260624

**DATE AS OF CHANGE**: 20260624

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JOHN WILEY & SONS, INC.
- **CENTRAL INDEX KEY:** 0000107140
- **STANDARD INDUSTRIAL CLASSIFICATION:** BOOKS: PUBLISHING OR PUBLISHING AND PRINTING [2731]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 135593032
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11507
- **FILM NUMBER:** 261115335

**BUSINESS ADDRESS:**
- **STREET 1:** 111 RIVER STREET
- **CITY:** HOBOKEN
- **STATE:** NJ
- **ZIP:** 07030
- **BUSINESS PHONE:** 2017486000

**MAIL ADDRESS:**
- **STREET 1:** 111 RIVER STREET
- **CITY:** HOBOKEN
- **STATE:** NJ
- **ZIP:** 07030

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WILEY JOHN & SONS, INC.
- **DATE OF NAME CHANGE:** 20070820

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WILEY JOHN & SONS INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? jwa-20260430

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

**FORM 10-K**

(Mark One)

⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: April 30, 2026

OR

□ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission file number 001-11507

**JOHN WILEY & SONS, INC.**

(Exact name of Registrant as specified in its charter)

---

| | |
|:---|:---|
| New York | 13-5593032 |
| State or other jurisdiction of incorporation or organization | I.R.S. Employer Identification No. |
| 111 River Street, Hoboken, New Jersey | 07030 |
| Address of principal executive offices | Zip Code |

---

(201) 748-6000 <br> Registrant's telephone number including area code

---

| | | |
|:---|:---|:---|
| Securities registered pursuant to Section 12(b) of the Act:<br>Title of each class | Trading Symbol | Name of each exchange on which registered |
| Class A Common Stock, par value $1.00 per share | WLY | New York Stock Exchange |
| Class B Common Stock, par value $1.00 per share | WLYB | New York Stock Exchange |

---

 Securities registered pursuant to Section 12(g) of the Act: <br> None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ⌧ No □

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes □ No ⌧

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No □

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧ No □

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | |
|:---|:---|
| Large accelerated filer ⌧ | Accelerated filer □ |
| Non-accelerated filer □ | Smaller reporting company □ |
| | Emerging growth company □ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ⌧

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. □

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes □ No ⌧

The aggregate market value of the voting stock held by non-affiliates of the registrant, computed by reference to the closing price as of the last business day of the registrant's most recently completed second fiscal quarter, October 31, 2025, was approximately $1,498 million. The registrant has no non-voting common stock.

The number of shares outstanding of the registrant's Class A and Class B Common Stock as of May 31, 2026 was 42,001,047 and 8,759,308 respectively.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant's definitive proxy statement for use in connection with its annual meeting of stockholders scheduled to be held on September 24, 2026, are incorporated by reference into Part III of this Annual Report on Form 10-K.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**JOHN WILEY & SONS, INC. AND SUBSIDIARIES**

**FORM 10-K**

**FOR THE FISCAL YEAR ENDED APRIL 30, 2026**

**INDEX**

---

| | | |
|:---|:---|:---|
| **<u>[PART I](#i4999d179a1ee4db3afe68151d34a8db6_13)</u>** | | **PAGE** |
| <u>[ITEM 1.](#i4999d179a1ee4db3afe68151d34a8db6_16)</u> | [Business](#i4999d179a1ee4db3afe68151d34a8db6_16) | [5](#i4999d179a1ee4db3afe68151d34a8db6_16) |
| <u>[ITEM 1A.](#i4999d179a1ee4db3afe68151d34a8db6_22)</u> | [Risk Factors](#i4999d179a1ee4db3afe68151d34a8db6_22) | [13](#i4999d179a1ee4db3afe68151d34a8db6_22) |
| <u>[ITEM 1B.](#i4999d179a1ee4db3afe68151d34a8db6_25)</u> | [Unresolved Staff Comments](#i4999d179a1ee4db3afe68151d34a8db6_25) | [23](#i4999d179a1ee4db3afe68151d34a8db6_25) |
| <u>[ITEM 1C.](#ib031fc37a77d48668f901fa65eb2283b_5366)</u> | Cybersecurity | [23](#i4999d179a1ee4db3afe68151d34a8db6_25) |
| <u>[ITEM 2.](#i4999d179a1ee4db3afe68151d34a8db6_31)</u> | [Properties](#i4999d179a1ee4db3afe68151d34a8db6_31) | [25](#i4999d179a1ee4db3afe68151d34a8db6_31) |
| <u>[ITEM 3.](#i4999d179a1ee4db3afe68151d34a8db6_34)</u> | [Legal Proceedings](#i4999d179a1ee4db3afe68151d34a8db6_34) | [25](#i4999d179a1ee4db3afe68151d34a8db6_34) |
| <u>[ITEM 4.](#i4999d179a1ee4db3afe68151d34a8db6_37)</u> | [Mine Safety Disclosures](#i4999d179a1ee4db3afe68151d34a8db6_37) | [25](#i4999d179a1ee4db3afe68151d34a8db6_37) |
| **<u>[PART II](#i4999d179a1ee4db3afe68151d34a8db6_40)</u>** | | |
| <u>[ITEM 5.](#i4999d179a1ee4db3afe68151d34a8db6_43)</u> | [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](#i4999d179a1ee4db3afe68151d34a8db6_43) | [26](#i4999d179a1ee4db3afe68151d34a8db6_43) |
| <u>[ITEM 6.](#i4999d179a1ee4db3afe68151d34a8db6_46)</u> | [\[Reserved\]](#i4999d179a1ee4db3afe68151d34a8db6_46) | [27](#i4999d179a1ee4db3afe68151d34a8db6_46) |
| <u>[ITEM 7.](#i4999d179a1ee4db3afe68151d34a8db6_49)</u> | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#i4999d179a1ee4db3afe68151d34a8db6_49) | [28](#i4999d179a1ee4db3afe68151d34a8db6_49) |
| <u>[ITEM 7A.](#i4999d179a1ee4db3afe68151d34a8db6_73)</u> | [Quantitative and Qualitative Disclosures About Market Risk](#i4999d179a1ee4db3afe68151d34a8db6_73) | [48](#i4999d179a1ee4db3afe68151d34a8db6_73) |
| <u>[ITEM 8.](#i4999d179a1ee4db3afe68151d34a8db6_76)</u> | [Financial Statements and Supplementary Data](#i4999d179a1ee4db3afe68151d34a8db6_76) | [49](#i4999d179a1ee4db3afe68151d34a8db6_76) |
| <u>[ITEM 9.](#i4999d179a1ee4db3afe68151d34a8db6_169)</u> | [Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](#i4999d179a1ee4db3afe68151d34a8db6_169) | [105](#i4999d179a1ee4db3afe68151d34a8db6_169) |
| <u>[ITEM 9A.](#i4999d179a1ee4db3afe68151d34a8db6_172)</u> | [Controls and Procedures](#i4999d179a1ee4db3afe68151d34a8db6_172) | [105](#i4999d179a1ee4db3afe68151d34a8db6_172) |
| <u>[ITEM 9B.](#i4999d179a1ee4db3afe68151d34a8db6_175)</u> | [Other Information](#i4999d179a1ee4db3afe68151d34a8db6_175) | [105](#i4999d179a1ee4db3afe68151d34a8db6_175) |
| <u>[ITEM 9C.](#i4999d179a1ee4db3afe68151d34a8db6_178)</u> | [Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#i4999d179a1ee4db3afe68151d34a8db6_178) | [105](#i4999d179a1ee4db3afe68151d34a8db6_178) |
| **<u>[PART III](#i4999d179a1ee4db3afe68151d34a8db6_181)</u>** | | |
| <u>[ITEM 10.](#i4999d179a1ee4db3afe68151d34a8db6_184)</u> | [Directors, Executive Officers and Corporate Governance](#i4999d179a1ee4db3afe68151d34a8db6_184) | [106](#i4999d179a1ee4db3afe68151d34a8db6_184) |
| <u>[ITEM 11.](#i4999d179a1ee4db3afe68151d34a8db6_187)</u> | [Executive Compensation](#i4999d179a1ee4db3afe68151d34a8db6_187) | [110](#i4999d179a1ee4db3afe68151d34a8db6_187) |
| <u>[ITEM 12.](#i4999d179a1ee4db3afe68151d34a8db6_190)</u> | [Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](#i4999d179a1ee4db3afe68151d34a8db6_190) | [110](#i4999d179a1ee4db3afe68151d34a8db6_190) |
| <u>[ITEM 13.](#i4999d179a1ee4db3afe68151d34a8db6_193)</u> | [Certain Relationships and Related Transactions, and Director Independence](#i4999d179a1ee4db3afe68151d34a8db6_193) | [111](#i4999d179a1ee4db3afe68151d34a8db6_193) |
| <u>[ITEM 14.](#i4999d179a1ee4db3afe68151d34a8db6_196)</u> | [Principal Accountant Fees and Services](#i4999d179a1ee4db3afe68151d34a8db6_196) | [111](#i4999d179a1ee4db3afe68151d34a8db6_196) |
| **<u>[PART IV](#i4999d179a1ee4db3afe68151d34a8db6_199)</u>** | | |
| <u>[ITEM 15.](#i4999d179a1ee4db3afe68151d34a8db6_202)</u> | [Exhibits and Financial Statement Schedules](#i4999d179a1ee4db3afe68151d34a8db6_202) | [111](#i4999d179a1ee4db3afe68151d34a8db6_202) |
| <u>[ITEM 16.](#i4999d179a1ee4db3afe68151d34a8db6_205)</u> | [Form 10-K Summary](#i4999d179a1ee4db3afe68151d34a8db6_205) | [116](#i4999d179a1ee4db3afe68151d34a8db6_205) |
| **<u>[SIGNATURES](#i4999d179a1ee4db3afe68151d34a8db6_211)</u>** | | [117](#i4999d179a1ee4db3afe68151d34a8db6_211) |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Cautionary Notice Regarding Forward-Looking Statements "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:**

This report contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 concerning our business, consolidated financial condition, and results of operations. The Securities and Exchange Commission (SEC) encourages companies to disclose forward-looking information so that investors can better understand a company's prospects and make informed investment decisions. Forward-looking statements are subject to risks and uncertainties, many of which are outside our control, which could cause actual results to differ materially from these statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements can be identified by such words as "anticipates," "believes," "plan," "assumes," "could," "should," "estimates," "expects," "intends," "potential," "seek," "predict," "may," "will," and similar references to future periods. All statements other than statements of historical facts included in this report regarding our strategies, prospects, financial condition, operations, costs, plans, and objectives are forward-looking statements. Examples of forward-looking statements include, among others, anticipated restructuring charges and savings, operations, performance, and financial condition. Reliance should not be placed on forward-looking statements, as actual results may differ materially from those described in any forward-looking statements. Any such forward-looking statements are based upon many assumptions and estimates that are inherently subject to uncertainties and contingencies, many of which are beyond our control, and are subject to change based on many important factors. Such factors include, but are not limited to (i) the level of investment by Wiley in new technologies and products; (ii) subscriber renewal rates for our journals; (iii) the financial stability and liquidity of journal subscription agents; (iv) the consolidation of book wholesalers and retail accounts; (v) the market position and financial stability of key retailers; (vi) the seasonal nature of our educational business and the impact of the used book market; (vii) worldwide economic and political conditions; (viii) our ability to protect our copyrights and other intellectual property worldwide; (ix) our ability to successfully integrate acquired operations and realize expected synergies and opportunities; (x) the ability to realize operating savings over time and in fiscal year 2027 in connection with our multiyear Global Restructuring Program and completed dispositions; (xi) cyber risk and the failure to maintain the integrity of our operational or security systems or infrastructure, or those of third parties with which we do business; (xii) as a result of acquisitions, we have and may record a significant amount of goodwill and other identifiable intangible assets and we may never realize the full carrying value of these assets; (xiii) our ability to leverage artificial intelligence technologies in our products and services, including generative artificial intelligence, large language models, machine learning, and other artificial intelligence tools; and (xiv) other factors detailed from time to time in our filings with the SEC. We undertake no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

Please refer to Part I, Item 1A, "Risk Factors," of our Annual Report on Form 10-K for important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

**Non-GAAP Financial Measures:**

We present financial information that conforms to Generally Accepted Accounting Principles in the United States of America (US GAAP). We also present financial information that does not conform to US GAAP, which we refer to as non-GAAP.

In this report, we may present the following non-GAAP performance measures:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted Earnings Per Share (Adjusted EPS);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Free Cash Flow less Product Development Spending;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted Revenue;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted Operating Income and margin;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted Income Before Taxes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted Income Tax Provision;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted Effective Tax Rate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• EBITDA (earnings before interest, taxes, depreciation and amortization), Adjusted EBITDA and margin; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Results on a constant currency basis.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

Management uses these non-GAAP performance measures as supplemental indicators of our operating performance and financial position as well as for internal reporting and forecasting purposes, when publicly providing our outlook, to evaluate our performance and calculate incentive compensation. We present these non-GAAP performance measures in addition to US GAAP financial results because we believe that these non-GAAP performance measures provide useful information to certain investors and financial analysts for operational trends and comparisons over time. The use of these non-GAAP performance measures may also provide a consistent basis to evaluate operating profitability and performance trends by excluding items that we do not consider to be controllable activities for this purpose.

The performance metric used by our chief operating decision maker to evaluate performance of our reportable segments is Adjusted Operating Income. We present both Adjusted Operating Income and Adjusted EBITDA for each of our reportable segments as we believe Adjusted EBITDA provides additional useful information to certain investors and financial analysts for operational trends and comparisons over time. It removes the impact of depreciation and amortization expense, as well as presents a consistent basis to evaluate operating profitability and compare our financial performance to that of our peer companies and competitors.

For example:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EPS, Adjusted Revenue, Adjusted Operating Income and margin, Adjusted Income Before Taxes, Adjusted Income Tax Provision, Adjusted Effective Tax Rate, EBITDA, and Adjusted EBITDA and margin provide a more comparable basis to analyze operating results and earnings and are measures commonly used by shareholders to measure our performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Free Cash Flow less Product Development Spending helps assess our ability, over the long term, to create value for our shareholders as it represents cash available to repay debt, pay common stock dividends, and fund share repurchases and acquisitions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Results on a constant currency basis remove distortion from the effects of foreign currency movements to provide better comparability of our business trends from period to period. We measure our performance excluding the impact of foreign currency (or at constant currency), which means that we apply the same foreign currency exchange rates for the current and equivalent prior period.

In addition, we have historically provided these or similar non-GAAP performance measures and understand that some investors and financial analysts find this information helpful in analyzing our operating margins and net income, and in comparing our financial performance to that of our peer companies and competitors. Based on interactions with investors, we also believe that our non-GAAP performance measures are regarded as useful to our investors as supplemental to our US GAAP financial results, and that there is no confusion regarding the adjustments or our operating performance to our investors due to the comprehensive nature of our disclosures.

Non-GAAP performance measures do not have standardized meanings prescribed by US GAAP and therefore may not be comparable to the calculation of similar measures used by other companies and should not be viewed as alternatives to measures of financial results under US GAAP. The adjusted metrics have limitations as analytical tools, and should not be considered in isolation from, or as a substitute for, US GAAP information. It does not purport to represent any similarly titled US GAAP information and is not an indicator of our performance under US GAAP. Non-GAAP financial metrics that we present may not be comparable with similarly titled measures used by others. Investors are cautioned against placing undue reliance on these non-GAAP measures.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**PART I**

**Item 1. Business**

The Company, founded in 1807, was incorporated in the state of New York on January 15, 1904. Throughout this report, when we refer to "Wiley," the "Company," "we," "our," or "us," we are referring to John Wiley & Sons, Inc. and all of our subsidiaries, except where the context indicates otherwise.

Please refer to Part II, Item 8, "Financial Statements and Supplementary Data," for financial information about the Company and its subsidiaries, which is incorporated herein by reference. Also, when we cross reference to a "Note," we are referring to our "Notes to Consolidated Financial Statements," in Part II, Item 8, "Financial Statements and Supplementary Data" unless the context indicates otherwise.

Wiley is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. The Company's content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including institutions, societies, corporations, researchers, students, instructors, and other professionals. Wiley is a predominantly digital company with 85% of revenue for the year ended April 30, 2026 generated by digital products and services. For the year ended April 30, 2026, 48% of revenue is recurring which includes revenue that is contractually obligated or set to recur with a high degree of certainty.

We report financial information for the following reportable segments, as well as a Corporate category, which includes certain costs that are not allocated to the reportable segments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Research** includes the reporting lines of Research Publishing and Research Solutions

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Learning** includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments.

Wiley also reported a Held for Sale or Sold segment in the years ended April 30, 2025 and 2024, which primarily included non-core businesses which were classified as held-for-sale until the date of sale, as well as other businesses which were sold.

Our operations are primarily located in the United States (US) and the United Kingdom (UK), with smaller offices in Germany, India, and Jordan. In the year ended April 30, 2026, approximately 49% of our consolidated revenue was from outside the US.

Wiley's business strategies are tightly aligned with consistent long-term growth trends, including (1) ever-increasing global research and development (R&D) investment and researcher productivity gains from artificial intelligence (AI), leading to growth in scientific research output and the number of institutions and researchers worldwide, and (2) the ever-increasing need for authoritative content to fuel AI models and applications. These strategies include expanding our publishing program and journal portfolio to meet the global demand for peer-reviewed research, driving additional value in our subscription-based models for universities and corporations, volume-based models for open access, content licensing opportunities for applications in AI and data analytics, and content platform and service offerings for corporations and societies. AI and data analytics is our emerging growth engine, leveraging our proprietary content, data, and partnership ecosystem for corporate models and applications. Learning strategies include selectively scaling high-value digital content, courseware, and assessments to meet targeted opportunities in education and professional development.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**<u>Business Segments</u>**

**Research:**

Research's mission is to support researchers, professionals, and learners in the discovery and use of research knowledge to help them achieve their goals. Research provides over 1,900 scientific, technical, medical, and scholarly journals, as well as related content and services in areas of physical sciences and engineering, health sciences, social sciences and humanities, and life sciences. Research customers include academic, corporate, government, and public libraries, funders of research, researchers, scientists, clinicians, engineers and technologists, scholarly and professional societies, and students and professors. Research products are sold and distributed globally through multiple channels, including direct to research libraries and library consortia via multi-year agreements, through independent subscription agents, and direct to researchers and professional society members, and other customers. For fiscal year 2026, approximately 96% of Research revenue is generated by digital and online products, and services. Publishing centers include Australia, China, Germany, India, the UK, and the US. Research revenue accounted for approximately 67% of our consolidated revenue in the year ended April 30, 2026, with a 33.2% Adjusted EBITDA margin. See Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the section "Segment Operating Results" of this Annual Report on Form 10-K for further details and for the reconciliation of Adjusted Operating Income to Adjusted EBITDA.

Research revenue by product type includes Research Publishing and Research Solutions. The graphs below present revenue by product type for the years ended April 30, 2026 and 2025:

![5075](jwa-20260430_g1.jpg)

2026

![5082](jwa-20260430_g2.jpg)

2025

Key growth strategies for the Research segment include publishing more peer-reviewed research and expanding our journal portfolio to meet global demand, thereby increasing the value of our Journal Subscriptions (pay to read), Transformational Agreements (pay to read and publish), developing open access journals and driving volume-based revenue streams (pay to publish), focusing on high-growth and emerging research markets, licensing our content for innovation in the corporate R&D value chain, and developing new digital products and information services to meet the needs of researchers, authors, societies, and corporate customers.

Research Publishing

Research Publishing generates the majority of its revenue from contracts with its customers in the following revenue streams:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Journal Subscriptions (pay to read) and Transformational Agreements (pay to read and publish) under multi-year arrangements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Open Access (pay to publish)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Licensing and ancillary products

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Journal Subscriptions and Transformational Agreements*

As of April 30, 2026, we published over 1,900 academic research journals. We sell Journal Subscriptions directly to thousands of research institutions worldwide through our sales representatives, indirectly through independent subscription agents, through marketing campaigns, and through memberships in professional societies for those journals that are sponsored by societies. Journal Subscriptions are primarily licensed through contracts for digital content available online through our *Wiley Online Library* platform. Contracts are negotiated by us directly with customers or their subscription agents. Subscription periods typically cover calendar years. Payment for subscription revenue is generally collected in advance.

Transformational Agreements (read and publish) are a subscription-based model that blends Journal Subscriptions and Open Access offerings. For a single fee, a national or regional consortium of libraries pays in advance and receives full read access to our journal portfolio and the ability to publish under an open access arrangement (articles made freely available and authors maintain copyright). Like Journal Subscriptions, Transformational Agreements involve recurring revenue under multi-year arrangements.

Long-term publishing alliances play a major role in Research Publishing's success. Approximately 46% of Journal Subscriptions revenue is derived from publication rights that are owned by professional societies and other publishing partners such as research institutions or foundations, and are published by us pursuant to long-term contracts or owned jointly with such entities*.* These alliances, with many of them being decades-long in duration, bring mutual benefit: The partners gain Wiley's publishing, marketing, sales, and distribution expertise, while Wiley benefits from being affiliated with prestigious organizations and their members. Societies that sponsor or own such journals generally receive a royalty and/or other financial consideration. We may procure editorial services from such societies on a prenegotiated fee basis. We also enter into agreements with outside independent editors of journals that define their editorial duties and the fees and expenses for their services. Contributors of articles to our journal portfolio transfer publication rights to us or a professional society, as applicable. We publish the journals of many prestigious societies, including the American Cancer Society, the American Heart Association, the American Anthropological Association, the American Geophysical Union, and the German Chemical Society.

*Wiley Online Library,* our digital content platform for researchers, provides the user with intuitive navigation, enhanced discoverability, expanded functionality, and a range of personalization options. Access to abstracts is free and full content is accessible through licensing agreements or as individual article purchases. Our online publishing platforms provide revenue growth opportunities through new applications and business models, online advertising, deeper market penetration, and individual sales and pay-per-view options. Also note that portions of our content are provided free or at nominal cost to developing nations through partnerships with certain nonprofit organizations.

The annual Clarivate Analytics' Journal Citation Reports (JCR) are one of the most widely used sources of citation metrics used to analyze the performance of peer-reviewed journals. The most prominent of these metrics, the Impact Factor, is based on the frequency with which an average article is cited in the JCR report year. Alongside other metrics, this makes it an important tool for evaluating a journal's impact on ongoing research.

Wiley's performance in the 2025 release of the JCR remains strong, maintaining its top 3 position in terms of citations received. Wiley has 8% of titles, 8% of articles, and 10% of citations.

A total of 1,740 Wiley journals were included in the reports. Wiley journals ranked #1 in 17 categories across 17 of its titles and achieved 269 top-10 category rankings.

*Open Access*

Under the Open Access business model, accepted research articles once published are immediately free to access online. Open Access offers authors choices in how to share and disseminate their work, and it serves the needs of researchers who may be required by their research funder to make articles freely accessible without embargo. APCs are typically paid by the individual author or by the author's funder, and payments are often mediated by the author's institution. We provide specific workflows and infrastructure to authors, funders, and institutions to support the requirements of Open Access.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

We offer two Open Access publishing models. The first of these is *Hybrid Open Access* where authors can publish in the majority of our paid subscription journals. The second offering is *Gold Open Access,* where authors can publish in open access-only journals. All Open Access articles are subject to the same rigorous peer-review process applied to our subscription-based journals. As with our subscription portfolio, a number of the *Gold Open Access Journals* are published under contract for, or in partnership with, prestigious societies, including the American Geophysical Union, the American Heart Association, and the British Ecological Society. The Open Access portfolio spans life, physical, medical, and social sciences and includes a choice of high impact journals and broad-scope titles that offer a responsive, author-centered service.

*Licensing and ancillary products*

Licensing and ancillary products includes the licensing of publishing rights, the licensing of content for AI including training large language models (LLM) to improve accuracy and impact, commercial models such as point of medical care applications, and corporate inference models to drive R&D productivity and impact. Wiley engages with international publishers and receives licensing revenue from reproductions, translations, and other digital uses of our content. Through the *Article Select* and *PayPerView* programs, we provide fee-based access to non-subscribed journal articles, content, book chapters, and major reference work articles. The Research Publishing business is also a provider of content and services in evidence-based medicine (EBM). Through our alliance with The Cochrane Collaboration, we publish *The Cochrane Library*, a premier source of high-quality independent evidence to inform healthcare decision-making. Backfile licenses provide access to a historical collection of Wiley journals, generally for a one-time fee.

Research Solutions

Research Solutions generates revenue through content platforms and services that enable corporations and societies to attract and retain customers.

Research Solutions includes advertising (journals and newsletters), sales, and marketing services (knowledge hubs for pharmaceutical companies). Our recruitment platform offers full-service career site management for pharmaceutical companies and other R&D centric corporations. Spectral database licenses grant access to scientific research-based data on microscopy, spectroscopy, bioanalysis, and separation science. Our projects business offers services related to content creation and distribution, an educational platform for health professionals, and digital events and webinars for corporations in health and physical sciences.

We also provide platform and workflow solutions for societies and publishers, including production and content hosting, submissions and peer review support, and editorial and copy editing services. Atypon® is a publishing platform that hosts content on behalf of approximately 2,000 publishers and societies. In fiscal year 2026, we began providing licensing as a service to other publishers to generate AI-related revenue. Wiley provides the expertise and relationships and combines its content with partner content for LLM or corporate use, paying us a royalty.

Research Exchange (ReX) is Wiley's proprietary end-to-end manuscript submission and peer review platform, designed to streamline the publishing workflow for authors, editors, and reviewers. The platform leverages AI to automate metadata extraction at submission, identify potential integrity issues prior to peer review, and optimize reviewer matching across Wiley's journal portfolio.

**Learning:**

Our Learning segment includes Academic and Professional, whose products and services include scientific, professional, and education print and digital books, digital courseware to support students and instructors, and assessment services for businesses and professionals. Primary categories served include business and leadership, technology, behavioral health, engineering/architecture, science, and professional education. Products are sold to and through brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, distributor networks, and government agencies.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

Publishing centers include Australia, Germany, India, the UK, and the US. Learning accounted for approximately 33% of our consolidated revenue in the year ended April 30, 2026, with a 38.0% Adjusted EBITDA margin. See Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the section "Segment Operating Results" of this Annual Report on Form 10-K for further details and for the reconciliation of Adjusted Operating Income to Adjusted EBITDA. For fiscal year 2026, approximately 62% of Learning revenue is from digital and online products and services.

Learning revenue by product type includes Academic and Professional. The graphs below present revenue by product type for the years ended April 30, 2026 and 2025:

![15762](jwa-20260430_g3.jpg)

2026

![15769](jwa-20260430_g4.jpg)

2025

Key strategies for the Learning business include selectively scaling high-value digital content, courseware, and assessments where the Company is seeking content libraries for new licensing opportunities.

Book manuscripts and materials are sourced from authors around the world, utilizing the efforts of an internal editorial staff, external editorial support, and advisory boards. Most materials originate by the authors themselves or as the result of suggestions or solicitations by editors. We enter into agreements that state the terms and conditions under which the materials will be published, the author name in which the copyright will be registered, the basis for any royalties, and other matters. Author compensation models include royalties, which vary depending on the nature of the product and work-for-hire. We may make advance royalty payments against future royalties to authors of certain publications. Royalty advances are reviewed for recoverability and a reserve for loss is maintained, if appropriate.

We continue to add new titles, revise existing titles, and discontinue the sale of others in the normal course of our business. We also create adaptations of original content for specific markets based on customer demand. Our general practice is to revise our textbooks every 3 to 5 years, as warranted, and to revise other titles as appropriate. Subscription-based products are updated on a more frequent basis.

Wiley does not own any printing facilities. We generally contract independent printers and binderies globally for their services, using a variety of suppliers and materials to support our range of needs. As of April 30, 2026, we had one global warehousing and distribution facility remaining, which is in the UK. We have an agreement to outsource our US-based book distribution operations to Cengage Learning, with the continued aim of improving efficiency in our distribution activities and moving to a more variable cost model.

Book sales for Learning are generally made on a returnable basis with certain restrictions. We provide for estimated future returns on sales made during the year based on historical return experience and current market trends.

Academic

Academic generates the majority of its revenue from contracts with its customers in the following revenue streams:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Print and Digital Publishing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Digital Courseware

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Licensing and ancillary products

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Print and Digital Publishing*

Education textbooks, related supplementary material, and digital products are sold primarily to bookstores and online retailers serving educational institutions (primarily colleges and universities) and direct-to-students. We employ sales representatives who call on faculty responsible for adopting books to be used in courses, and on the bookstores that serve such institutions and their students. The textbook business is seasonal, with the majority of textbook sales occurring during the July-through-October and December-through-February periods. There are various channels to drive accessibility for print and digital materials within the higher education market, including used, rental, and inclusive access whereby the cost of digital course content is added to a student's tuition and fees. Scientific, technical, and medical (STM) reference books are sold and distributed globally in digital and print formats through multiple channels, including research libraries and library consortia, independent subscription agents, direct sales to professional society members, bookstores, online booksellers, and other customers.

Book content is available online through *Wiley Online Library*, *WileyPLUS*<sup>TM</sup>, *zyBooks®, alta®*™, and other proprietary platforms. Digital books are delivered to intermediaries and aggregators, including Amazon, Apple, and Google, for sale to individuals, libraries, or distinct communities in various industry-standard or custom formats. Education and STM publishing alliance partners include IEEE, American Institute of Chemical Engineers, and many others. The ability to join Wiley's product development, sales, marketing, distribution, and technology with a partner's content, technology, and/or brand name has contributed to our success.

*Digital Courseware*

We offer online learning solutions, including *WileyPLUS*, an online education platform that is integrated with a digital textbook. The interactive *zyBooks* platform for STEM disciplines, namely computer science, maximizes learner engagement and retention through demonstration and hands-on learning experiences using question sets, animations, tools, and embedded labs.

*Licensing and ancillary products* 

We engage in co-publishing titles with international publishers and receive licensing revenue from photocopies, reproductions, translations, and digital uses of our content. We also license our Learning content for AI, including training LLM to improve accuracy and impact.

Professional

Professional generates the majority of its revenue from contracts with its customers in the following revenue streams:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Professional Publishing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Assessments

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Licensing and ancillary products

*Professional Publishing* 

Professional books, which include business and finance, technology, and other professional categories are sold to brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, and government agencies. We employ sales representatives who call upon independent bookstores, national and regional chain bookstores, wholesalers, and corporations globally. Sales of professional books also result from direct marketing outreach, conferences, and other industry-relevant outreach. Key franchises and brands in the Professional category include Dummies®, Sybex, The Jon Gordon Companies, and *Disciplined Entrepreneurship* by Bill Aulet. Professional organizations also use our custom professional publications for marketing outreach. This outreach includes customized books written for a specific customer and includes custom cover art, such as imprints, messages, and slogans.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Assessments*

Our assessments offerings include soft-skills training solutions delivered to organizational clients and their employees through online digital delivery platforms, either directly or through an authorized distributor network of independent consultants, trainers, and coaches. Wiley's branded assessment solutions include Everything DiSC®, The Five Behaviors® based on Patrick Lencioni's perennial bestseller *The Five Dysfunctions of a Team*, and Leadership Practices Inventory® from Kouzes and Posner's bestselling *The Leadership Challenge*, as well as PXT Select®™, a pre-hire selection tool. Our solutions help organizations hire and develop effective managers, leaders, and teams.

*Licensing and ancillary products* 

Licensing and distribution services are made available to other publishers under agency arrangements. Wiley also realizes advertising revenue from branded websites (e.g., Dummies.com) and online applications. We also license our content for AI, including training LLM to improve accuracy and impact.

**<u>Human Capital</u>**

As of April 30, 2026, we employed approximately 4,500 colleagues worldwide.

We view our colleagues as one of our most significant assets and investments to deliver on our mission and to champion and advocate for our customers who want to make impacts in their fields, their workplaces, and their lives, through the advancement of scientific discovery, innovation, and learning. Our success depends on our ability to develop, attract, reward, and retain a diverse population of talented, qualified, and highly skilled colleagues at all levels of our organization and across our global workforce. This includes programs, policies, and initiatives that promote inclusion and belonging; talent acquisition; ongoing employee learning and development; competitive compensation and benefits; health and well-being; and emphasis on employee satisfaction and engagement.

Our culture differentiates us as an organization, and our core values define how we work together. We ask colleagues to embody our three behaviors—Obsess Over Impact, Challenge, Then Commit, and Drive What's Next—and assess their performance against these in addition to what they achieve against their goals. These values define who we are as a company and what we stand for.

**Health & Well-Being**

We support colleague well-being through a suite of global programs, including paid parental leave, mental health resources, and a global giving platform, spanning physical, emotional, social, career, and financial well-being.

Our Global Work Model provides colleagues with digitally enabled remote work balanced with purposeful in-person connection and collaboration.

**Careers and Engagement**

Executing Wiley's transformation into an AI-forward research intelligence company requires a workforce with the capabilities, leadership, and culture to deliver. We invest in development across the career lifecycle through curated learning resources, targeted career conversations, leadership development programs, and expanded access to coaching, including an AI-enabled coaching tool. Combined with our annual succession planning process, colleagues in our pipeline experience career progression at more than double the rate of the broader colleague population.

We measure colleague engagement twice annually and continue to expand access to AI tools to support colleague productivity and drive meaningful time savings across the organization. We remain committed to pay transparency, providing salary range visibility and publishing our global equitable pay study annually.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Environment**

At Wiley, environmental sustainability is an integral part of our operations and corporate strategy. We continue to build on our progress to further reduce greenhouse gas emissions, strengthen partnerships that advance environmental action, and promote responsible stewardship throughout our value chain. We are committed to aligning our practices and reporting to relevant environmental regulations and evolving standards to ensure our actions support broader climate and sustainability goals.

Our climate strategy prioritizes achieving net-zero emissions by 2040. We have established science-based targets, validated by the Science Based Targets initiative (SBTi), to drive emissions reductions across Scopes 1 (direct emissions), 2 (indirect emissions from purchased utilities), and 3 (other indirect emissions within our value chain). We continue to transition our owned and leased offices and distribution centers toward renewable energy sources, while utilizing Energy Attribute Certificates (EACs) for locations not yet able to access renewable energy directly. Additionally, we are consolidating our office footprint and prioritizing responsible energy management across our operations. These commitments reflect our conviction that ambitious, science-aligned action is both a business imperative and a responsibility to the broader global transition to net zero.

In parallel, we are advancing sustainable publishing and digital innovation to minimize environmental impact. We are promoting digital adoption, optimizing resource use, and enhancing supply chain engagement to uphold responsible standards. We continue to publish content that supports the United Nations (UN) Sustainable Development Goals and reduce print production through initiatives such as print-on-demand, zero-inventory distribution models, and increased digital offerings. Our efforts are guided by our publicly available Environmental Policy and Paper Selection and Use Policy. Wiley is also a signatory to the UN Global Compact, reflecting our broader commitment to responsible business practices across environmental, social, and governance dimensions.

Wiley remains committed to building on the progress we have made, evolving our strategy to meet the challenges ahead, and making a positive impact on environmental sustainability.

**<u>Financial Information About Business Segments</u>**

The information set forth in Part II, Item 8, "Financial Statements and Supplementary Data" in <u>[Note 3](#i07367b72690a4395824ae69fddb9e9fe_18015)</u>, "Revenue Recognition, Contracts with Customers," and <u>[Note 20](#i5c161295392b452192e95513acc36dba_2292)</u>, "Segment Information," of the Notes to Consolidated Financial Statements and Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" of this Annual Report on Form 10-K are incorporated herein by reference.

**<u>Available Information</u>**

Our investor site is *investors.wiley.com.* Our internet address is *wiley.com*. We make available, free of charge, on or through our *investors.wiley.com* website, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports that we file or furnish pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, as soon as reasonably practicable after we electronically file these materials with, or furnish them to, the SEC. The information contained on, or that may be accessed through our website is not incorporated by reference into, and is not a part of, this Annual Report on Form 10-K.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Item 1A. Risk Factors**

Introduction

The risks described below should be carefully considered before making an investment decision. You should carefully consider all the information set forth in this Annual Report on Form 10-K, including the following risk factors, before deciding to invest in any of our securities. This Annual Report on Form 10-K also contains, or may incorporate by reference, forward-looking statements that involve risks and uncertainties. See the "Cautionary Notice Regarding Forward-Looking Statements," immediately preceding Part I of this Annual Report on Form 10-K. The risks below are not the only risk factors we face. Additional risks not currently known to us or that we presently deem insignificant could impact our consolidated financial position and results of operations. Our businesses, consolidated financial position, and results of operations could be materially adversely affected by any of these risks. The trading price of our securities could decline due to any of these risks, and investors may lose all or part of their investment.

**<u>Strategic Risks</u>**

***Our business may be adversely impacted if we cannot protect our intellectual property.***

Our business depends on our intellectual property, including our valuable trademarks and copyrighted content. A substantial portion of our publications are protected by copyright, held either in our name, in the name of the author of the work, or in the name of a sponsoring professional society. Such copyrights protect our exclusive right to publish the work in many countries abroad for specified periods, in most cases the author's life plus 70 years. We believe the protection and monetization of our proprietary trademarks and copyrighted content, as well as other intellectual property, is critical to our continued success and our competitive position. Our ability to do so is subject to the inherent limitation in protections available under intellectual property laws in the US and other applicable jurisdictions. Unauthorized parties could unlawfully misappropriate our brand, content, technology, and other intellectual property and may continue to do so, and the measures we have taken to protect and enforce our proprietary rights may not be sufficient to fully address or prevent all third-party infringement.

While advancements in technology, including artificial intelligence (collectively, AI Technologies), present meaningful opportunities for our business, they also introduce new challenges in protecting our intellectual property. Detection of unauthorized use of our intellectual property and enforcement of our intellectual property rights have become more challenging due to the increasing volume and sophistication of attempts at unauthorized use. As our business and the presence and impact of bad actors become more global in scope, we may not be able to protect our proprietary rights in a cost-effective manner in other jurisdictions. In addition, intellectual property protection may not be available in every country in which our products and services are distributed or made available through the internet.

If we are unable to protect and enforce our intellectual property rights, we may not succeed in realizing the full value of our assets, our business and profitability may be adversely impacted, and our brand may be tarnished by misuse of our intellectual property.

***We may not be able to realize the expected benefits of our growth strategies, as described in Item 1. Business, which could adversely impact our consolidated financial position and results of operations****.*

We may not be able to adequately drive publishing output and journal expansion to meet the global demand for peer-reviewed research, nor expand related licensing, platform, and service offerings for institutions, corporations, and societies.

***Technological developments in AI could disrupt the markets in which we operate and subject us to increased competition, cannibalization, legal and regulatory risks, and compliance costs.***

Technological developments in AI, including machine learning technology, large language models, and AI Technologies and their current and potential future applications, are rapidly evolving. The full extent of current or future risks related thereto is not possible to predict. AI Technologies could significantly disrupt the markets in which we operate and subject us to increased competition, legal and regulatory risks, which could have a material adverse effect on our business, financial condition, and results of operations. In addition, the sale of new products leveraging AI Technologies may result in the cannibalization of sales for existing products, which may harm our results of operations.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

We intend to seek to avail ourselves of the potential benefits, insights, and efficiencies that are available through the use of AI Technologies, which presents a number of potential risks that cannot be fully mitigated. If the content, analyses, or recommendations that AI Technologies assist in producing are, or are alleged to be, deficient, inaccurate, biased, or otherwise problematic, our reputation may be adversely affected. In addition, the introduction of generative AI tools into our business may negatively impact our workplace culture and ability to attract and retain employees if generative AI tools are viewed as displacing workers. Generative AI also presents emerging legal and ethical issues, and terms governing the use of generative AI are subject to change. Accordingly, our use of, or perceptions of the way that we use, generative AI could adversely affect our business, brand, financial condition, or results of operations. There is also a risk that AI Technologies may be misused or misappropriated by our employees and/or third parties engaged.

Further, we may not be able to control how third-party AI Technologies that we choose to use are developed or maintained, or how data we input is used or disclosed, even where we have sought contractual protections with respect to these matters. The misuse or misappropriation of our data could have an adverse impact on our reputation and could subject us to legal and regulatory investigations and/or actions.

Regulations related to AI Technologies may also impose on us certain obligations and costs related to monitoring and compliance. In the US, multiple federal agencies, including the Federal Trade Commission, the Department of Justice, the Consumer Financial Protection Bureau, and the Equal Employment Opportunity Commission, have expressed interest in monitoring the development and use of automated systems and enforcing their respective laws and regulations in the context of AI. While the current administration has taken a deregulatory approach to AI, including revoking the prior administration's 2023 executive order establishing federal AI safety and security policies and oversight requirements, the regulatory environment remains dynamic and subject to change. In addition to the US regulatory framework, the EU has enacted comprehensive regulation applicable to certain AI systems and the data used to train, test, and deploy them. The regulation is being implemented on a phased basis, with the majority of obligations applicable from August 2026 and certain provisions for high-risk AI systems phased in through 2027 and 2028. It imposes, or is expected to impose, significant requirements on both providers and deployers of AI systems. Implementation guidance and compliance obligations continue to be refined.

***Reductions in or restrictions on federal research funding and changes to US higher education policy may adversely affect our business.***

Our operations and revenue are partially dependent on funding for research and spending by publicly funded institutions, including public libraries, colleges, and universities. Federally supported research has faced disruption through a combination of proposed budget reductions, administrative actions affecting grant funding and agency operations, and ongoing legal challenges, the cumulative impact of which cannot be fully determined at this time. While Congress has not to date enacted the most significant proposed reductions in agency appropriations, reflecting continued bipartisan recognition of the essential role that federal research funding plays in US economic growth and global competitiveness, the effects of federal actions continue to evolve and generate uncertainty.

Wiley is a global business and enjoys healthy geographic revenue distribution and funding diversity worldwide. The current funding environment remains fluid, with ongoing legal challenges, congressional appropriations debates, and administrative actions that continue to evolve. We cannot predict the ultimate scope of these developments, the extent to which they may influence funding policies in other countries, or their full impact on our customers or our business, but such actions may have a significant and negative effect on our US market.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Divestitures could adversely affect our business and financial results and may introduce significant risks and uncertainties.***

We continually evaluate the performance and strategic fit of all of our businesses and may sell businesses or product lines. We completed the divestiture of our non-core education businesses that no longer aligned with our strategic direction or growth targets, as previously disclosed. While these divestitures have been finalized, certain financial arrangements associated with these transactions, including Sellers Notes and earnout provisions, continue to present potential risks and uncertainties that could adversely affect our business, consolidated financial position, and consolidated results of operations. These post-divestiture financial arrangements require ongoing monitoring and management attention to ensure compliance with agreement terms and to mitigate potential adverse impacts on our financial position. If the buyers of our divested businesses experience operational or financial difficulties, our ability to collect on Sellers Notes or realize anticipated earnout payments could be impaired. <u>[See Note 4](#i07300a4eeb7a47b3860e2ee1f39a3e3f_10911)</u>, "Acquisition and Divestitures" for further details.

***A reduction in enrollment at colleges and universities could adversely affect the demand for our Academic products.***

Enrollment in US colleges and universities can be adversely affected by many factors, including changes in government and private student loan and grant programs, uncertainty about current and future economic conditions, increases in tuition, general decreases in family income and net worth, and low unemployment due to an active job market. In addition, enrollment levels at colleges and universities outside the US are influenced by global and local economic factors, local political conditions, and other factors that make predicting foreign enrollment levels difficult. Reductions in expected levels of enrollment at colleges and universities within the US could adversely affect demand for our higher education offerings, which could adversely impact our consolidated financial position and results of operations.

***If we are unable to retain key talent and other colleagues, our consolidated financial condition or results of operations may be adversely affected.***

The Company and industry are highly dependent on the loyal engagement of key leaders and colleagues. Loss of talent due to inadequate skills and career path development or maintaining competitive salaries and benefits could have a significant impact on Company performance.

We are highly dependent on the continued services of key talent who have in-depth market and business knowledge and/or key relationships with business partners. The loss of the services of key talent for any reason and our inability to replace them with suitable candidates quickly or at all, as well as any negative market perception resulting from such loss, could have a material adverse effect on our business, consolidated financial position, and results of operations.

We have a significant investment in our colleagues around the world. We offer competitive salaries and benefits in order to attract and retain the highly skilled workforce needed to sustain and develop new products and services required for growth. Employment costs are affected by competitive market conditions for qualified individuals and factors such as healthcare and retirement benefit costs.

***The competitive pressures we face in our business, as well as our ability to retain our business relationships with our authors and professional societies, could adversely affect our consolidated financial position and results of operations.***

The contribution of authors and their professional societies is one of the more important elements of the highly competitive publishing business. Success and continued growth depend greatly on developing new products and the means to deliver them in an environment of rapid technological change. Attracting new authors and professional societies while retaining our existing business relationships is critical to our success. If we are unable to retain our existing business relationships with authors and professional societies, this could have an adverse impact on our consolidated financial position and results of operations.

***The demand for digital and lower cost books could impact our sales volumes and pricing in an adverse way.***

The trend towards digital content has created contraction in the print book retail market which increases the risk of bankruptcy for certain retail customers, potentially leading to the disruption of short-term product supply to consumers, as well as potential bad debt write-offs.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

As the market has shifted to digital products, customer expectations for lower-priced products have increased due to customer awareness of reductions in production costs and the availability of free or low-cost digital content and products. Increased customer demand for lower prices could reduce our revenue.

Due to growing student demand for less expensive textbooks, many college bookstores, online retailers, and other entities, offer used or rental textbooks to students at lower prices than new textbooks. The Internet has made the used and rental textbook markets more efficient and has significantly increased student access to used and rental textbooks.

**<u>Information Technology Systems and Cybersecurity Risks</u>**

***Our Company is highly dependent on information technology systems and their business management and customer-facing capabilities, which are critical for the long-term competitive sustainability of the business. If we fail to innovate in response to rapidly evolving technological and market developments, our competitive position may be negatively impacted.***

We must continue to invest in technology and other innovations to adapt and add value to our products and services to remain competitive. This is particularly true in the current environment, where investment in new technology is ongoing and there are rapid changes in the products competitors are offering, the products our customers are seeking, and our sales and distribution channels. In some cases, investments will take the form of internal development; in others, they may take the form of an acquisition. There are uncertainties whenever developing or acquiring new products and services, and it is often possible that such new products and services may not be launched, or, if launched, may not be profitable or as profitable as existing products and services. If we are unable to introduce new technologies, products, and services, our ability to be profitable may be adversely affected.

We cannot predict the effect of technological changes on our business. Failure to keep pace with these technological developments or otherwise bring to market products that reflect these technologies could have a material adverse impact on our overall business and results of operations. We may not be successful in anticipating or responding to these developments on a timely and cost-effective basis. Additionally, the effort to gain technological expertise and develop new technologies in our business requires us to incur significant expenses. If we cannot offer new technologies as quickly as our competitors, or if our competitors develop more cost-effective technologies or product offerings, we could experience a material adverse effect on our operating results, growth, and financial condition.

***We may be susceptible to information technology risks that may adversely impact our business, consolidated financial position, and results of operations.***

Information technology is a key part of our business strategy and operations. As a business strategy, Wiley's technology enables us to provide customers with new and enhanced products and services and is critical to our success in migrating from print to digital business models. Information technology is also a fundamental component of all our business processes, collecting and reporting business data, and communicating internally and externally with customers, suppliers, employees, and others. We face technological risks associated with digital products and service delivery in our businesses, including with respect to information technology capability, reliability, security, enterprise resource planning, system implementations, and upgrades. Across our businesses, we hold personal data, including that of employees and customers. Failures of our information technology systems and products (including operational failure, natural disaster, computer virus, or cyberattacks) could interrupt the availability of our digital products and services, result in corruption or loss of data or breach in security, and result in liability or reputational damage to our brands and/or adversely impact our consolidated financial position and results of operations.

Management has designed and implemented policies, processes, and controls to mitigate risks of information technology failure and to provide security from unauthorized access to our systems. In addition, we have disaster recovery plans in place to maintain business continuity for our key financial systems. While key financial systems have backup and tested disaster recovery systems, other applications and services have limited backup and recovery procedures which may delay or prevent recovery in case of disaster. The size and complexity of our information technology and information security systems, and those of our third-party vendors with whom we contract, make such systems potentially vulnerable to cyberattacks common to most industries from inadvertent or intentional actions by employees, vendors, or malicious third parties. While we have taken steps to address these risks, there can be no assurance that a system failure, disruption, or data security breach would not adversely affect our business and could have an adverse impact on our consolidated financial position and results of operations.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

We are continually improving and upgrading our computer systems and software. We have recently initiated a multiyear enterprise modernization program which includes various projects including the consolidation and transformation of our Research publishing infrastructure, and the future implementation of an updated global enterprise resource planning (ERP) system to integrate and upgrade our operational and financial systems and processes. Implementation of this program and the related projects involves risks and uncertainties.

The risks associated with the transformation of our Research publishing infrastructure could include not realizing our projected business benefits of growing article submissions, reducing the time to publication, facilitating growth in open access with a modern open access payment infrastructure, and reducing the cost per article.

Any disruptions, delays, or deficiencies in the design or implementation of a new ERP system could result in increased costs, disruptions in operations, or delays in the collection of cash from our customers, as well as having an adverse effect on our ability to timely report our financial results, all of which could materially adversely affect our business, consolidated financial position, and results of operations. While we have contingency support available, any major disruptions, while unlikely, may require a longer remediation time. This could impact our ability to process and fulfill orders for those businesses. We currently use a legacy platform with limited support for order management of the global Learning business. Any defects and disruptions in the legacy systems which cannot be addressed in a timely manner could impact our ability to process orders and reconcile financial statements. These legacy platforms are being evaluated as part of the recently initiated enterprise modernization program noted above.

***Cyber risk and the failure to maintain the integrity of our operational or security systems or infrastructure, or those of third parties with which we do business, could have a material adverse effect on our business, consolidated financial condition, and results of operations.***

The cybersecurity risks we face range from cyberattacks common to most industries, such as the development and deployment of malicious software to gain access to our networks and attempt to steal confidential information, launch distributed denial of service attacks, or attempt other coordinated disruptions, to more advanced threats that target us because of our prominence in the global research and advisory field. Our employees work remotely, at least some of the time, which magnifies the importance of the integrity of our remote access security measures.

Like many multinational corporations, we, and some third parties upon which we rely, have experienced cyberattacks on our computer systems and networks in the past and may experience them in the future, likely with more frequency and sophistication and involving a broader range of devices and modes of attack, all of which will increase the difficulty of detecting and successfully defending against them. To date, none have resulted in any material adverse impact on our business, operations, products, services, or customers. Wiley has invested heavily in cybersecurity tools and resources to keep our systems safe. We have implemented various security controls to meet our security obligations, while also defending against constantly evolving security threats. Our security controls help to secure our information systems, including our computer systems, intranet, proprietary websites, email, and other telecommunications and data networks, and we scrutinize the security of outsourced website(s) and service providers prior to retaining their services. However, the security measures implemented by us or by our outside service providers may not be effective, and our systems (and those of our outside service providers) may be vulnerable to theft, loss, damage, and interruption from a number of potential sources and events, including unauthorized access or security breaches, cyberattacks, computer viruses, power loss, or other disruptive events.

The security compliance landscape continues to evolve, requiring us to stay apprised of changes in cybersecurity, privacy laws and regulations, such as the following, but not limited to the European Union General Data Protection Regulation (GDPR), the California Consumer Privacy Act (CCPA), the Brazilian General Data Protection Law (LGPD), and the Chinese Cybersecurity, Data Security and Personal Information Protection laws (PIPL). The UK ceased to be an EU Member State on January 31, 2020, but enacted the UK data protection law. It is unclear how UK data protection laws will continue to develop; however, contractual clauses have been established regulating data transfers to and from the UK. Some countries also are considering or have enacted legislation requiring local storage and processing of data that could increase the cost and complexity of delivering our services.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

In addition to new and proposed data protection laws, we also stay apprised and adopt certain security standards required by our clients, such as International Organization for Standardization (ISO), National Institute of Standards and Technology (NIST), and Center for Internet Security (CIS). Recent well-publicized security breaches at other companies have led to enhanced government and regulatory scrutiny of the measures taken by companies to protect against cyberattacks and may in the future result in heightened cybersecurity requirements, including additional regulatory expectations for oversight of vendors and service providers.

A cyberattack could cause delays in initiating or completing sales, impede delivery of our products and services to our clients, disrupt other critical client-facing or business processes, or dislocate our critical internal functions. Additionally, any material breaches or other technology-related catastrophe, or media reports of perceived security vulnerabilities to our systems or those of our third parties, even if no breach has been attempted or has occurred, could cause us to experience reputational harm, loss of customers and revenue, fines, regulatory actions and scrutiny, sanctions or other statutory penalties, litigation, liability for failure to safeguard our customers information, or financial losses.

For more information regarding our process for identifying, assessing and managing material risks from cybersecurity threats, refer to <u>[Item 1C. Cybersecurity.](#ib031fc37a77d48668f901fa65eb2283b_5370)</u>

**<u>Operational Risks</u>**

***We may not realize the anticipated cost savings and benefits from, or our business may be disrupted by, our continuous improvement efforts.***

We will continue to explore opportunities to develop new business models and enhance the efficiency of our cost and organizational structure. The rapid pace and scope of change increases the risk that not all our strategic initiatives will deliver the expected benefits within the anticipated timeframes. In addition, these efforts may disrupt our business activities, which could adversely affect our consolidated financial position and results of operations.

We continue to restructure and realign our cost base with current and anticipated future market conditions, including our Global Restructuring Program. Significant risks associated with these actions that may impair our ability to achieve the anticipated cost savings or that may disrupt our business, include delays in the implementation of anticipated workforce reductions in highly regulated locations outside of the US, decreases in employee morale, the failure to meet operational targets due to the loss of key employees, and disruptions of third parties to whom we have outsourced certain business functions. In addition, our ability to achieve the anticipated cost savings and other benefits from these actions within the expected timeframe is subject to many estimates and assumptions. These estimates and assumptions are subject to significant economic, competitive, and other uncertainties, some of which are beyond our control. If these estimates and assumptions are incorrect, if we experience delays, or if other unforeseen events occur, our business and consolidated financial position and results of operations could be adversely affected.

***We may not realize the anticipated cost savings and processing efficiencies associated with the outsourcing of certain business processes.***

We have outsourced certain business functions, principally in technology, content management, printing, warehousing, fulfillment, distribution, collections and returns processing, and certain other transactional processing functions, to third-party service providers to achieve cost savings and efficiencies. If these third-party service providers do not perform effectively, we may not be able to achieve the anticipated cost savings, and depending on the function involved, we may experience business disruption or processing inefficiencies, all with potential adverse effects on our consolidated financial position and results of operations.

***Challenges and uncertainties associated with operating in certain global markets have a higher risk due to political instability, economic volatility, crime, terrorism, corruption, social and ethnic unrest, and other factors, which may adversely impact our consolidated financial position and results of operations.***

We sell our products to customers in certain sanctioned and previously sanctioned developing markets in accordance with such restrictions. While sales in these markets are not material to our consolidated financial position and results of operations, adverse developments related to the risks associated with these markets may cause actual results to differ from historical and forecasted future consolidated operating results.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

We have certain global operations related to software development and technology architecture, digital content production, and system testing services. Due to the political instability within certain regions, there is the potential for future government embargoes and sanctions, which could disrupt our operations in these areas. While we have developed business continuity plans to address these issues, further adverse developments in these regions could have a material impact on our consolidated financial position and results of operations.

In our Research segment, approximately 31% of the articles we published in calendar year 2025 included China-based authors. This compares to the industry percentage which is approximately 34% of articles published in calendar year 2025 which included China-based authors. Any restrictions on exporting intellectual property could adversely affect our business and consolidated financial position and results of operations.

***In our journal publishing business, we have a trade concentration and credit risk related to subscription agents, and in our book business the industry has a concentration of customers in national, regional, and online book resellers. Changes in the financial position and liquidity of our subscription agents and customers could adversely impact our consolidated financial position and results of operations.***

In the journal publishing business, some subscriptions are sourced through journal subscription agents who, acting as agents for library customers, facilitate ordering by consolidating the subscription orders/billings of each subscriber with various publishers. Cash is generally collected in advance from subscribers by the subscription agents and is principally remitted to us between the months of December and April. Although currently we have minimal credit risk exposure to these agents, future calendar-year subscription receipts from these agents are highly dependent on their financial condition and liquidity.

Subscription agents account for approximately 19% of total annual consolidated revenue, and no one agent accounts for more than 10% of total annual consolidated revenue.

Our book business is not dependent upon a single customer; however, the industry is concentrated in national, regional, and online book resellers. Although no book customer accounts for more than 6% of total consolidated revenue and 7% of accounts receivable, net at April 30, 2026, the top 10 book customers account for approximately 12% of total consolidated revenue and approximately 20% of accounts receivable, net at April 30, 2026.

***In our Research business, a lack of integrity in our published research could adversely impact our consolidated financial position and results of operations.***

We publish research authored by individuals outside our Company. The integrity of that research could be compromised due to the manipulation, misrepresentation, and misconduct by those individuals or other outsiders involved in the publishing process. This activity could adversely impact our open access publishing and article output by causing us to potentially pause publication, retract articles, or halt publication of a journal, which could adversely impact our business and consolidated financial position and results of operations.

**<u>Financial Risks</u>**

***Volatility in the financial markets and a related global economic downturn could impact our ability to access global credit markets and meet our future financing needs.***

Disruptions in credit markets or to our banking partners may negatively affect our access to credit or overall liquidity. We maintain levels of debt that we consider prudent based on our cash flows, interest coverage ratio and ratio of net debt to EBITDA. A disruption in the credit markets could increase our future borrowing costs and impair our ability to access capital and credit markets on terms commercially acceptable to us, which could adversely affect our liquidity and capital resources or significantly increase our cost of capital.

We continue to believe that we can meet our financing needs for the foreseeable future. We typically generate significant operating cash flow from ongoing operations, continue to maintain available cash and other financial assets, retain access to the capital markets, and have available committed lines of credit through our syndicated credit agreement. As market conditions change, we will continue to monitor our liquidity position. However, there can be no assurance that our liquidity or our consolidated financial position and results of operations will not be adversely affected by possible future changes in global financial markets and global economic conditions.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Fluctuations in foreign currency exchange rates and interest rates could materially impact our consolidated financial condition and results of operations.***

Non-US revenues, as well as our substantial non-US net assets, expose our consolidated results to volatility from changes in foreign currency exchange rates. The percentage of consolidated revenue for the year ended April 30, 2026, recognized in the following currencies (on an equivalent US dollar basis) were approximately: 51% US dollar, 29% British pound sterling, 12% euro, and 8% other currencies. In addition, our floating interest rate loans and borrowings are subject to risk from changes in interest rates. We may, from time to time, use derivative instruments to hedge such risks. Notwithstanding our efforts to foresee and mitigate the effects of changes in external financial market or economic conditions, we cannot predict with certainty changes in foreign currency exchange rates and interest rates, inflation, or other related factors affecting our business, consolidated financial position, and results of operations*.*

***We may not be able to mitigate the impact of inflation and cost increases, which could have an adverse impact on our consolidated financial position and results of operations.***

From time to time, we experience cost increases reflecting, in part, general inflationary factors. There is no guarantee that we can increase selling prices or reduce costs to fully mitigate the effect of inflation on our costs, which may adversely impact our consolidated financial position and results of operations.

***As a result of acquisitions, we have and may record a significant amount of goodwill and other identifiable intangible assets, and we may never realize the full carrying value of these assets****.*

As a result of acquisitions, we recorded a significant amount of goodwill and other identifiable intangible assets. At April 30, 2026, we had $1,132.4 million of goodwill and $579.0 million of intangible assets, of which $127.2 million are indefinite-lived intangible assets, on our Consolidated Statements of Financial Position. The intangible assets are principally composed of content and publishing rights, customer relationships, brands and trademarks, and developed technology. Failure to achieve business objectives and financial projections could result in an asset impairment, which would result in a noncash charge to our consolidated results of operations. Goodwill and intangible assets with indefinite lives are tested for impairment on an annual basis and when events or changes in circumstances indicate that impairment may have occurred. Intangible assets with definite lives, which were $451.8 million at April 30, 2026, are tested for impairment only when events or changes in circumstances indicate that an impairment may have occurred. Determining whether an impairment exists can be difficult as a result of increased uncertainty and current market dynamics and requires management to make significant estimates and judgments. A noncash intangible asset impairment charge could have a material adverse effect on our consolidated financial position and results of operations. <u>[See Note 11](#i1c5b5abc6bc24bc48f5fae79ca9c6582_12469)</u>, "Goodwill and Intangible Assets" for further information related to goodwill and intangible assets, and the impairment charges recorded in the year ended April 30, 2024.

**<u>Legal, Regulatory, and Compliance Risks</u>**

***Changes in laws, tariffs, and regulations, including regulations related to open access, could adversely impact our consolidated financial position and results of operations.***

We maintain operations in Asia, Australia, Canada, Europe, South America, the Middle East, and the US. The conduct of our business, including the sourcing of content, distribution, sales, marketing, and advertising, is subject to various laws and regulations administered by governments around the world. Changes in laws, regulations, or government policies, including tax regulations and accounting standards, may adversely affect our future consolidated financial position and results of operations.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The scientific research publishing industry generates much of its revenue from paid customer subscriptions to online and print journal content. There is interest within government, academic, and library communities for such journal content to be made available for free immediately or following a period of embargo after publication, referred to as open access. For instance, certain governments and privately held funding bodies have implemented mandates that require journal articles derived from government-funded research to be made available to the public at no cost immediately or after an embargo period. Open access can be achieved in two ways: Green, which enables authors to publish articles in subscription-based journals and self–archive the author accepted version of the article for free public use immediately or after any embargo period; and Gold, which enables authors to publish their articles in journals that provide immediate free access to the final version of the article on the publisher's website, and elsewhere under permissive licensing terms, following payment or waiver of an APC. These mandates have the potential to put pressure on subscription-based publications. If such regulations are widely implemented, our consolidated financial position and results of operations could be adversely affected.

To date, many of the governments and national research councils that have taken a position on open access have favored the Green model and have generally specified embargo periods of twelve months. The publishing community generally takes the view that this period should be sufficient to protect subscription revenues, provided that publishers' platforms offer sufficient added value to the article. Governments in Europe have been more supportive of the Gold model, which thus far is generating incremental revenue for publishers with active open access programs. Many institutions have signed on to the business model which combines the purchasing of subscription content with the purchase of open access publishing for affiliated authors. This development removes an element of risk by fixing revenues from that market, provided that the terms, price, and rate of transition negotiated are acceptable.

***Increases in income tax rates, changes in income tax laws or regulations, or unfavorable resolutions of tax matters could have a material adverse impact on our financial results.***

We are subject to tax laws in the jurisdictions of the US and numerous other jurisdictions in which we conduct business. Wiley's results of operations could be adversely affected by a change in the consolidated effective tax rate as a result of a change in a number of factors including the mix of earnings in countries with differing statutory tax rates, the result of audits of previously filed tax returns, the cost of repatriation, or changes in tax laws and regulations and the interpretations thereof in the jurisdictions where we operate.

Many jurisdictions have enacted legislation based on the Organization for Economic Co-operation and Development (OECD) Pillar Two framework, which establishes a global minimum tax rate of 15% on a country-by-country basis for large multinational enterprises. Numerous countries, including European Union member states, have implemented these rules with effect from 2024, and additional jurisdictions continue to adopt or refine their implementing legislation.

In January 2026, the OECD released a Side-by-Side (SbS) Safe Harbor, which allows US-parented multinational groups to elect an exemption from two of Pillar Two's principal charging provisions — the Income Inclusion Rule (IIR) and the Undertaxed Profits Rule (UTPR). As a US-parented company, we expect to be eligible to elect this safe harbor for fiscal year 2027. Notwithstanding, Qualified Domestic Minimum Top-Up Taxes (QDMTTs) enacted by jurisdictions in which we operate remain applicable, the safe harbor does not apply retroactively to fiscal years 2025 and 2026, and the timing of domestic legislative adoption across implementing jurisdictions remains uncertain.

This increasingly complex and evolving global tax environment has in the past and could continue to increase tax uncertainty and compliance costs, and we cannot predict the full impact of future changes to the framework on our provision for income taxes and financial performance.

In addition, we are subject to potential taxes in jurisdictions where we have sales, even though we do not have a physical presence, and these potential taxes could have an impact on our consolidated financial position and results of operations. Economic and political pressures to increase tax revenues in jurisdictions in which we operate, or the adoption of new or reformed tax legislation or regulation, has made and could continue to make resolving tax disputes more difficult. Although we believe our tax estimates are reasonable, the final resolution of tax audits and any related litigation can materially differ from our historical income tax provisions and accruals, resulting in an adverse effect on our financial performance.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***A disruption or loss of data sources could limit our collection and use of certain kinds of information, which could adversely impact our communication with our customers.***

Several of our businesses rely extensively upon content and data from external sources. Data is obtained from public records, governmental authorities, customers, and other information companies, including competitors. Legal regulations, such as the EU's GDPR, relating to Internet communications, privacy and data protection, e-commerce, information governance, and use of public records, are becoming more prevalent worldwide. The disruption or loss of data sources, either because of changes in the law or because data suppliers decide not to supply them, may impose limits on our collection and use of certain kinds of information about individuals and our ability to communicate such information effectively with our customers. In addition, GDPR imposes a strict data protection compliance regime with severe penalties of up to 4% of worldwide revenue or €20 million, whichever is greater.

***If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.***

We are subject to the reporting requirements of the Securities Exchange Act of 1934, the Sarbanes-Oxley Act (Sarbanes-Oxley Act), and the rules and regulations of the New York Stock Exchange. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are required to perform system and process evaluations and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting in our Annual Report on Form 10-K, as required by Section 404 of the Sarbanes-Oxley Act. This may require us to incur substantial additional professional fees and internal costs to further expand our accounting and finance functions and expend significant management efforts.

We may in the future discover material weaknesses in our system of internal financial and accounting controls and procedures that could result in a material misstatement of our financial statements. In addition, our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to errors or fraud will not occur, or that all control issues and instances of fraud will be detected.

If we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner, or if we are unable to maintain proper and effective internal controls, we may not be able to produce timely and accurate financial statements. If that were to happen, the market price of our stock could decline, and we could be subject to sanctions or investigations by the SEC or other regulatory authorities.

**<u>General Risks</u>**

***Global economic, market, public health, and geopolitical conditions or other events could negatively impact our consolidated financial positions and results of operations.***

We are exposed to risks and uncertainties caused by factors beyond our control, including global economic, public health, and geopolitical conditions. These include economic weakness, softness in consumer and corporate spending, uncertainty and volatility, including the potential for a recession; a competitive labor market and evolving workforce expectations; inflation, rising interest rates; public health crisis, including pandemics; financial stability of the banking industry, and political and sociopolitical uncertainties and conflicts. The potential escalation of trade tensions between the US and China could slow down China's economy, which could impact Research Publishing, and increase risks related to exchange rate fluctuations. These factors may result in declines and/or volatility in our results or stock price. Our general business strategy may be adversely affected by any such economic downturn, volatile business environment, or continued unpredictable and unstable market conditions. Our business could also be impacted by volatility caused by geopolitical events, such as the conflict in Ukraine and instability in the Middle East. In addition, the actual or perceived effects of a disease outbreak, epidemic, pandemic, or similar widespread public health concern, could also materially and adversely affect our results. The future impact that global economic, public health, and geopolitical conditions will have on our business operations and financial results is uncertain and will depend on numerous evolving factors and developments that we are not able to reliably predict or mitigate. It is also possible that these conditions may impact other risks discussed in this section.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Changes in US and foreign government administrative policy, including the imposition of or increases in tariffs and changes to existing trade agreements, and other changes to macroeconomic conditions could have a material adverse effect on global economic conditions and our business, results of operations, and financial condition.***

Changes in US and foreign government administrative policy, including the imposition of or increases in tariffs and changes to existing trade agreements, and other changes to macroeconomic conditions could have a material adverse effect on global economic conditions and our business, results of operations, and financial condition.

As a predominantly digital content and services business, our direct exposure to goods tariffs is limited. However, these and any further tariff actions and trade restrictions could depress economic activity, constrain the budgets of our institutional customers, and restrict our access to suppliers or customers and, in turn, have a material adverse effect on the business and financial condition of such suppliers and customers or other counterparties we do business with, which in turn would negatively impact our consolidated financial position and results of operations.

***The trading price of the shares of our common stock may fluctuate materially, and investors of our common stock could incur substantial losses.***

Our stock price may fluctuate materially. The stock market in general has experienced significant volatility that has often been unrelated to the operating performance of companies. As a result of this volatility, investors may not be able to sell their common stock at or above the price paid for the shares. The market price for our common stock may be influenced by many factors, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Actual or anticipated changes in our consolidated operating results;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Variances between actual consolidated operating results and the expectations of securities analysts, investors, and the financial community;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in financial estimates by us or by any securities analysts who might cover our stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Conditions or trends in our industry, the stock market, or the economy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The level of demand for our stock, the stock market price, and volume fluctuations of comparable companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Announcements by us or our competitors of new product or service offerings, significant acquisitions, strategic partnerships, or divestitures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Announcements of investigations or regulatory scrutiny of our operations or lawsuits filed against us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Capital commitments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Investors' general perception of the Company and our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Recruitment or departure of key personnel; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sales of our common stock, including sales by our directors and officers or specific stockholders.

***Adverse publicity could negatively impact our reputation, which could adversely affect our consolidated financial position and results of operations.***

Our professional customers worldwide rely upon many of our publications to perform their jobs. It is imperative that we consistently demonstrate our ability to maintain the integrity of the information included in our publications. Adverse publicity, whether valid or not, may reduce demand for our publications and adversely affect our consolidated financial position and results of operations.

**Item 1B. Unresolved Staff Comments**

None.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Item 1C. Cybersecurity** 

**Risk Management and Strategy** 

Wiley is committed to maintaining robust cybersecurity practices to safeguard our operations, data, and stakeholders' interests. We monitor our cybersecurity landscape and adapt our strategies and governance practices to mitigate risks in this rapidly evolving area.

Wiley adopted the National Institute of Standards and Technology Cybersecurity Framework (NIST-CSF) as a guide for its cybersecurity program to establish and maintain a continuous improvement process for identifying, assessing, and managing cyber risks and cyber-related threats. Informed by the NIST-CSF, we maintain a cybersecurity risk management program that is designed to identify, assess, manage, and mitigate cybersecurity risks and provides a framework for handling cybersecurity threats and incidents, including threats and incidents associated with the use of services provided by third-party service providers. To secure our technology environment, our organization leverages the latest software and security capabilities with a defense-in-depth and layered strategy. We deploy endpoint detection and response, network anomaly detection, and multi-factor authentication across most of our environment. We engage with various third-party consultants as well as utilize various threat intelligence services to assist in our oversight and to identify risks. We require employees with access to our information systems, including all corporate employees and consultants, to undertake annual data protection and cybersecurity training and ongoing phishing simulation exercises. In addition, Wiley's controls are also monitored and tested on a continuous basis by an external third-party to assess the effectiveness of our cyber program.

Based on the information we have as of the date of this Annual Report on Form 10-K, we do not believe that any cybersecurity incident experienced by the Company has materially affected or is reasonably likely to materially affect Wiley, including our business strategy, results of operations, or financial condition. For additional information about cybersecurity risks, see Item 1A. "Risk Factors."

**Governance** 

Our Board is responsible for the overall oversight of our enterprise risk management. The Board receives regular updates on the key risks to the organization on a quarterly basis. The Board has delegated oversight of cybersecurity risks to the Audit Committee. The Audit Committee receives quarterly and yearly cybersecurity updates from the Company's Senior Director of Information Security and Compliance, which includes updates on the Company's cybersecurity policies and strategies, cyber risks and threats, the status of projects designed to continuously improve the Company's information security systems, assessments of the Company's security program, employee training and awareness programs, emerging threat landscape, and engagement with external cybersecurity experts and advisors, as needed.

**Management's Role** 

Management is responsible for day-to-day risk management activities, including identifying and assessing cybersecurity risks, establishing processes to ensure that potential cybersecurity risk exposures are monitored, implementing appropriate mitigation or remediation measures, and maintaining cybersecurity programs. Risk mitigation strategies and key performance indicators are defined, and tracked, as part of the quarterly internal reporting. The information security team consists of subject matter experts in the fields of security operations, governance risk and compliance, application security, e-commerce fraud, identity and access management, vulnerability management, security engineering, and security architecture. The security operations center (SOC) operates on a 24x7x365 basis. Our Senior Director of Information Security and Compliance is part of the senior management team and regularly updates the Audit Committee on the Company's cybersecurity program, including cybersecurity risks, incidents, and mitigation strategies.

The information security team is led by the Senior Director of Information Security and Compliance who has 30 years of experience in software and cybersecurity. The information security team has established processes and procedures that guide and enable continuous monitoring, detection, prevention, mitigation, and remediation of cybersecurity incidents. These processes are carried out using various security platforms tools, capabilities, and strategies including tests of our information security program, tabletop exercises, penetration and vulnerability testing, and other exercises to evaluate the effectiveness of our information security program and improve our security measures and planning. Incident response teams within the SOC utilize procedures that identify escalation paths when security events are identified. Incident priorities dictate escalation of events and how they are reported from an incident commander up to the executive leadership team within Wiley as well as to the Board.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

Despite our efforts, we cannot eliminate all risks from cybersecurity threats or provide assurances that we have not experienced an undetected cybersecurity incident. The threat landscape is constantly changing and will continue to as new technologies, such as AI, evolve.

**Item 2. Properties**

We occupy office, warehouse, and distribution facilities in various parts of the world, as listed below (excluding those locations with less than 10,000 square feet of floor area, none of which are considered material property).

All of the current buildings and the equipment owned or leased are believed to be in good operating condition and are suitable for the conduct of our business.

---

| | | | |
|:---|:---|:---|:---|
| **Location** | **Purpose** | **Owned or Leased** | **Approx. Sq. Ft.** |
| **United States:** | | | |
| New Jersey | Corporate Headquarters | Leased | 247000 |
| Indiana | Office | Leased | 42000 |
| North Carolina | Office | Leased | 12000 |
| **International:** |  |  |  |
| England | Distribution Centers | Leased | 298000 |
|  | Offices | Leased | 64000 |
| Germany | Office | Owned | 104000 |
|  | Office | Leased | 14000 |
| India | Distribution Centers | Leased | 20000 |
|  | Office | Leased | 25000 |
| China | Offices | Leased | 40000 |
| Jordan | Office | Leased | 24000 |
| Brazil | Office | Leased | 12000 |
| Greece | Office | Leased | 11000 |

---

**Item 3. Legal Proceedings**

The information set forth in Part II, Item 8, "Financial Statements and Supplementary Data" in <u>[Note 16](#i766be0afdcdd4734a931157e1a37c8d7_1366)</u>, "Commitment and Contingencies," of the Notes to Consolidated Financial Statements is incorporated herein by reference.

We are involved in routine litigation in the ordinary course of our business. In the opinion of management, the ultimate resolution of all pending litigation will not have a material effect upon our consolidated financial position or results of operations.

**Item 4. Mine Safety Disclosures**

Not applicable.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**PART II**

**Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities**

Our Class A and Class B shares are listed on the New York Stock Exchange under the symbols WLY and WLYB, respectively.

On a quarterly basis, the Board of Directors considers the payment of cash dividends based upon its review of earnings, our financial position, and other relevant factors. As of May 31, 2026, the approximate number of holders of our Class A and Class B Common Stock were 635 and 40, respectively, based on the holders of record.

In fiscal year 2020, our Board of Directors authorized a share repurchase program of up to $200 million of Class A or B Common Stock, which was fully utilized as of April 30, 2026. In the first quarter of fiscal year 2026, our Board of Directors authorized an additional share repurchase program of up to $250 million of Class A or B Common Stock.

During the fourth quarter of fiscal year 2026, we made the following purchases of Class A and Class B Common Stock under the publicly announced stock repurchase program.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Total Number<br>of Shares<br>Purchased** | **Average**<br>**Price Paid**<br>**Per Share**<sup>(1)</sup> | **Total Number<br>of Shares Purchased<br>as Part of a Publicly<br>Announced Program** | **Maximum Number<br>of Shares that May<br>Be Purchased<br>Under the Program** | **Maximum Dollar<br>Value of Shares<br>that May Yet Be Purchased<br>Under Additional Plans<br> or Programs<br>(Dollars in Millions)** |
| February 2026 | 367693 | $29.66 | 367693 |  | $226.4 |
| March 2026 | 275919 | 35.71 | 275919 |  | 216.6 |
| April 2026 | 227896 | 40.12 | 227896 |  | 207.4 |
| **Total** | 871508 | $34.31 | 871508 |  | $207.4 |

---

(1) Average price per share excludes excise taxes payable on share repurchases.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Performance Graph**

The below graph provides an indicator of the cumulative total return to shareholders of the Company's Class A Common Stock as compared with the cumulative total return on the Russell 2000, the Dow Jones Publishing Index, and the S&P SmallCap 600, for the period from April 30, 2021 to April 30, 2026. The Company has elected to use the Russell 2000 Index and the S&P SmallCap 600 index as its broad equity market indices because it is currently included in these indices. Cumulative total return assumes $100.00 invested on April 30, 2021, and reinvestment of dividends throughout the period.

![1613](jwa-20260430_g5.jpg)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **April 30, 2021** | **April 30, 2022** | **April 30, 2023** | **April 30, 2024** | **April 30, 2025** | **April 30, 2026** |
| WLY | $100.00 | $91.63 | $71.90 | $72.95 | $87.46 | $85.22 |
| Russell 2000 | $100.00 | $83.10 | $80.05 | $90.68 | $91.45 | $132.19 |
| Dow Pub | $100.00 | $88.89 | $84.09 | $104.36 | $123.31 | $145.56 |
| S&P 600 | $100.00 | $91.40 | $87.82 | $98.76 | $96.81 | $134.50 |

---

**Item 6. [Reserved]**

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations**

The information in our Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read together with our Consolidated Financial Statements and related notes set forth in Part II, Item 8, as well as the discussion included in Part I, Item 1, "Business," "Cautionary Notice Regarding Forward-Looking Statements "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995" and "Non-GAAP Financial Measures," along with Part I, Item 1A, "Risk Factors," of this Annual Report on Form 10-K. All amounts and percentages are approximate due to rounding and all dollars are in thousands, except per share amounts or where otherwise noted. When we cross-reference to a "Note," we are referring to our "Notes to Consolidated Financial Statements," in Part II, Item 8, "Financial Statements and Supplementary Data" unless the context indicates otherwise.

**Overview**

Wiley is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. The Company's content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including institutions, societies, corporations, researchers, students, instructors, and other professionals. Wiley is a predominantly digital company with 85% of its revenue for the year ended April 30, 2026, generated by digital products and services. For the year ended April 30, 2026, 48% of revenue is recurring which includes revenue that is contractually obligated or set to recur with a high degree of certainty.

We report financial information for the following reportable segments, as well as a Corporate category, which includes certain costs that are not allocated to the reportable segments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Research** includes the reporting lines of Research Publishing and Research Solutions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Learning** includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments.

Wiley also reported a Held for Sale or Sold segment in the years ended April 30, 2025 and 2024, which primarily included non-core businesses which were classified as held-for-sale until the date of sale, as well as other businesses which were sold. Through the Research segment, we provide peer-reviewed STM journals, content platforms, and related publishing and audience solutions to academic, corporate, and government customers, academic societies, and individual researchers. The Learning segment provides scientific, professional, and education print and digital books to researchers, professionals, and students, digital courseware for instructors and students, and assessment services to businesses and professionals.

Wiley's business strategies are tightly aligned with consistent long-term growth trends, including (1) ever-increasing global R&D investment and researcher productivity gains from AI, leading to growth in scientific research output and the number of institutions and researchers worldwide, and (2) the ever-increasing need for authoritative content to fuel AI models and applications. These strategies include expanding our publishing program and journal portfolio to meet the global demand for peer-reviewed research, driving additional value in our subscription-based models for universities and corporations, volume-based models for open access, content licensing opportunities for applications in AI and data analytics, and content platform and service offerings for corporations and societies. AI and data analytics is our emerging growth engine, leveraging our proprietary content, data, and partnership ecosystem for corporate models and applications. Learning strategies include selectively scaling high-value digital content, courseware, and assessments to meet targeted opportunities in education and professional development.

On June 1, 2026, subsequent to the end of fiscal year 2026, we acquired Emerald Publishing for £337.5 million (approximately $452 million), funded with available cash and proceeds from our revolving credit facility. Emerald Publishing is a research publisher headquartered in Leeds, England, with a portfolio of over 480 peer-reviewed journals, 8,000 books, and 3,000 business cases across disciplines with particular emphasis on economics, business, finance, engineering, and the social sciences. The acquisition was made to extend our scale in our Research business and to strengthen our proprietary content advantage in AI. <u>[See Note 21](#i4999d179a1ee4db3afe68151d34a8db6_541)</u>, "Subsequent Event" for further details.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**<u>Consolidated Results of Operations</u>**

**FISCAL YEAR 2026 AS COMPARED TO FISCAL YEAR 2025 SUMMARY RESULTS**

**SUMMARY**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **US GAAP Results**: Revenue of $1,676.5 million (consistent with the prior year), Operating income of $276.9 million (+25% compared with the prior year), and Diluted Earnings per Share of $4.16 (+$2.63 compared with the prior year).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Adjusted Results at Constant Currency (excluding Held for Sale or Sold segment results):** Adjusted Revenue of $1,676.5 million (consistent with the prior year), Adjusted Operating Income of $296.2 million (+18%, compared with the prior year), Adjusted EBITDA of $439.6 million (+10% compared with the prior year), and Adjusted EPS of $4.19 (+15% compared with the prior year).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net Cash Provided by Operating Activities of $260.5 million (+$57.9 million compared with the prior year), and Free Cash Flow Less Product Development Spending of $195.3 million (+$69.5 million compared with the prior year).

**Revenue:**

Revenue for the year ended April 30, 2026, decreased $1.1 million, essentially flat compared with the prior year. On a constant currency basis, revenue decreased 1% as compared with the prior year. Excluding the revenues from the Held for Sale or Sold segment, Adjusted Revenue was consistent with the prior year on a constant currency basis.

AI license revenue was $49.1 million in the year ended April 30, 2026 compared to $40 million in the prior year. The AI license revenue in the year ended April 30, 2026 includes $19.4 million of revenue related to content which Wiley has licensed from other publishers. The period to period comparability of AI license revenue can fluctuate due to timing and the nature of the underlying content.

***Adjusted Revenue***

Below is a reconciliation of our consolidated US GAAP Revenue, net to Non-GAAP Adjusted Revenue, net:

---

| | | |
|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** |
| | **2026** | **2025** |
| **US GAAP Revenue, net** | $1676528 | $1677609 |
| Less: Held for Sale or Sold segment |  | (17382) |
| **Non-GAAP Adjusted Revenue, net** | $1676528 | $1660227 |

---

See the "Segment Operating Results" below for additional details on each segment's revenue and Adjusted EBITDA performance**.**

**Cost of Sales:**

Cost of sales for the year ended April 30, 2026, of $431.5 million, increased $0.1 million, and was consistent with the prior year. On a constant currency basis, cost of sales decreased 1% as compared with the prior year. This was primarily due to lower inventory costs primarily in Learning and, to a lesser extent, the prior year including employee costs primarily related to the Wiley Edge business which was sold on May 31, 2024. These factors were partially offset by higher royalty costs.

Excluding the cost of sales from the Held for Sale or Sold segment, cost of sales increased 1% on a constant currency basis primarily due to higher royalty costs which includes higher royalty on AI license revenue from content licensed from other publishers, partially offset by lower inventory costs primarily in Learning.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Operating and Administrative Expenses:**

Operating and administrative expenses for the year ended April 30, 2026, of $895.9 million decreased $51.5 million, or 5%, as compared with the prior year. On a constant currency basis, operating and administrative expenses decreased 7% as compared with the prior year primarily due to restructuring and cost savings initiatives resulting in lower employee costs and, to a lesser extent, lower professional fees.

On a constant currency basis, operating and administrative expenses excluding expenses from the Held for Sale or Sold segment decreased 6% as compared with the prior year. This decline was primarily due to restructuring and cost savings initiatives resulting in lower employee costs and, to a lesser extent, lower professional fees.

**Restructuring and Related Charges:**

We recorded restructuring and related charges in the years ended April 30, 2026 and 2025 of $19.2 million and $25.6 million, respectively. These charges are reflected in the Restructuring and related charges in the Consolidated Statements of Income (Loss). These amounts include a credit of $(0.1) million and $(3.8) million for the years ended April 30, 2026 and 2025, respectively, related to the Business Optimization Program, a prior restructuring initiative.

***Global Restructuring Program***

Beginning in fiscal year 2023, the Company initiated the Global Restructuring Program which was expanded in fiscal year 2024 to include those actions that will focus Wiley on its leading global position in the development and application of new knowledge and drive greater profitability, growth, and cash flow. We will focus on our strongest and most profitable businesses and large market opportunities in Research and Learning, as well as streamline our organization and rightsize our cost structure to reflect these portfolio actions. Under this program, we reduced our real estate square footage occupancy by approximately 35%.

In the fourth quarter of fiscal year 2025, the program was further extended due to the completion of our divestitures with a focus on optimizing our cost structure, with particular emphasis on aligning our technology costs and other corporate expenses. As a result of these initiatives, this expanded program will include severance related charges, facility-related costs associated with certain properties, and other activities.

Excluding actions related to the Held for Sale or Sold segment, we anticipate to yield annualized cost savings of approximately $120 million, with approximately $110 million of that realized this fiscal year from actions taken starting in fiscal year 2024.

For the years ended April 30, 2026 and 2025, we recorded pretax restructuring charges of $19.3 million and $29.4 million, respectively, related to this program.

In the first quarter of fiscal year 2027, the program was further expanded to include additional portfolio and cost optimization actions. As a result of these initiatives, we expect to incur additional restructuring charges in future periods, which includes severance, consulting, and facility-related costs associated with certain properties.

<u>[See Note 7](#i349fc9c6047d49dbbed2272840f209d9_6505)</u>, "Restructuring and Related Charges" for more details on these charges.

For the impact of our restructuring program on diluted earnings per share, see the section below, "Diluted Earnings per Share (EPS)."

**Amortization of Intangible Assets:**

Amortization of intangible assets was $53.1 million for the year ended April 30, 2026, an increase of $1.2 million, or 2% as compared with the prior year. On a constant currency basis, amortization of intangible assets was consistent with the prior year primarily due to the completion of amortization of certain acquired intangible assets, offset by amortization expense related to acquired definite lived intangible assets, including those acquired as part of an acquisition.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Operating Income, Adjusted Operating Income (OI) and Adjusted EBITDA:**

Operating income for the year ended April 30, 2026, of $276.9 million increased $55.5 million, or 25% as compared with the prior year. On a constant currency basis, operating income increased 25% as compared with the prior year. The increase was primarily due to lower operating and administrative expenses, partially offset by a decrease in revenue.

Adjusted OI and Adjusted EBITDA on a constant currency basis for the year ended April 30, 2026 increased 18% and 10%, respectively, as compared with the prior year. The increase in Adjusted OI and Adjusted EBITDA was primarily due to lower operating and administrative expenses, partially offset by higher cost of sales.

***Adjusted OI***

Below is a reconciliation of our consolidated US GAAP Operating Income to Non-GAAP Adjusted OI:

---

| | | |
|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** |
| | **2026** | **2025** |
| **US GAAP Operating Income** | $276859 | $221409 |
| Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and related charges | 19203 | 25561 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Held for Sale or Sold segment Adjusted Operating Loss |  | 3578 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal settlement | 108 |  |
| **Non-GAAP Adjusted OI** | $296170 | $250548 |

---

***Adjusted EBITDA***

Below is a reconciliation of our consolidated US GAAP Net Income to Non-GAAP EBITDA and Adjusted EBITDA:

---

| | | |
|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** |
| | **2026** | **2025** |
| **Net Income** | $221617 | $84161 |
| Interest expense | 43848 | 52547 |
| (Benefit) provision for income taxes | (6531) | 58717 |
| Depreciation and amortization | 143477 | 147126 |
| **Non-GAAP EBITDA** | 402411 | 342551 |
| Restructuring and related charges | 19203 | 25561 |
| Net foreign exchange transaction losses | 6564 | 8142 |
| Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | 4828 | 23340 |
| Other expense (income), net | 6533 | (5498) |
| Held for Sale or Sold segment Adjusted EBITDA |  | 3578 |
| Legal settlement | 108 |  |
| **Non-GAAP Adjusted EBITDA** | $439647 | $397674 |

---

**Interest Expense:**

Interest expense for the year ended April 30, 2026, was $43.8 million compared with the prior year of $52.5 million. This decrease was primarily due to a lower weighted average effective interest rate and a decrease in the total debt outstanding.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Foreign Exchange Transaction Losses:**

Foreign exchange transaction losses were $(6.6) million for the year ended April 30, 2026, and were primarily due to losses on our foreign currency denominated third-party receivable and payable balances and, to a lesser extent, losses on our intercompany accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

Foreign exchange transaction losses were $(8.1) million for the year ended April 30, 2025, and were primarily due to losses on our intercompany accounts receivable and payable balances and, to a lesser extent, losses on our foreign currency denominated third-party receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar. In the year ended April 30, 2025, we wrote off an additional net gain of $1.4 million in cumulative translation adjustments from our Russian entity which was formally liquidated in the fourth quarter of fiscal year 2025.

**Net Loss on Sale of Businesses, Assets, and Impairment Charges Related to Assets Held-for-Sale:**

For the years ended April 30, 2026 and 2025, we recorded pretax loss on sale of businesses, assets, and impairment charges related to assets held-for-sale as follows:

---

| | | |
|:---|:---|:---|
| | **Year Ended** <br>**April 30,** | **Year Ended** <br>**April 30,** |
| | **2026** | **2025** |
| CrossKnowledge | $(2309) | $4119 |
| University Services | (934) | (12578) |
| Wiley Edge | (422) | (14852) |
| Other disposition activity | (1163) | (29) |
| Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | $(4828) | $(23340) |

---

These charges are reflected in Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale on our Consolidated Statements of Income (Loss). <u>[See Note 4](#i07300a4eeb7a47b3860e2ee1f39a3e3f_10911)</u>, "Acquisition and Divestitures" for more details on these divestitures.

**Other (Expense) Income, Net:**

Other (expense), net was $(6.5) million for the year ended April 30, 2026 compared with the prior year Other income, net of $5.5 million, a decrease of $12.0 million. This change was primarily due to foregone interest income due to the sale of the University Services Seller Note on June 5, 2025 and, to a lesser extent, an increase in pension expense for our defined benefit plans.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**(Benefit) Provision for Income Taxes:**

Below is a reconciliation of our US GAAP Income Before Taxes to Non-GAAP Adjusted Income Before Taxes:

---

| | | |
|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** |
| | **2026** | **2025** |
| **US GAAP Income Before Taxes** | $215086 | $142878 |
| Pretax Impact of Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and related charges | 19203 | 25561 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 2881 | 5590 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of acquired intangible assets | 53050 | 51864 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | 4828 | 23340 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Held for Sale or Sold segment Adjusted Loss Before Taxes |  | 3578 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal settlement | 108 |  |
| **Non-GAAP Adjusted Income Before Taxes** | $295156 | $252811 |

---

Below is a reconciliation of our US GAAP Income Tax (Benefit) Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

---

| | | |
|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** |
| | **2026** | **2025** |
| **US GAAP Income Tax (Benefit) Provision** | (6531) | 58717 |
| Income Tax Impact of Adjustments<sup>(1)</sup>: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and related charges | 4682 | 5947 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 464 | 1170 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of acquired intangible assets | 11298 | 10231 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | 480 | 2368 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Held for Sale or Sold segment Adjusted Tax Benefit |  | 807 |
| Income Tax Adjustments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impact of withholding tax on Sri Lanka distribution | (982) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impact of valuation allowance on the US GAAP effective tax rate | 58324 | (26008) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impact of change in Germany statutory tax rate on deferred tax balances | 4286 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impact of change in certain US state tax rates in 2025 |  | (117) |
| **Non-GAAP Adjusted Income Tax Provision** | 72021 | 53115 |
| **US GAAP Effective Tax Rate** | (3.0)% | 41.1% |
| **Non-GAAP Adjusted Effective Tax Rate** | 24.4% | 21.0% |

---

(1) For the years ended April 30, 2026 and 2025, substantially all of the tax impact was from deferred taxes.

The Company's effective tax rate for the year ended April 30, 2026, was primarily driven by the impact of the US valuation allowance release, the enactment of tax rate reductions in Germany, and the rates of tax imposed on income earned in foreign jurisdictions.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

In fiscal year 2024, due to losses in the US resulting from impairments, restructuring activities, and the acceleration of amortization expense on capitalized software, we concluded it was more likely than not that a portion of our deferred tax assets would not be realized. As a result, we established a valuation allowance of $53.5 million, which increased to $77.3 million in fiscal year 2025.

During fiscal year 2026, we concluded that it was more likely than not that substantially all US deferred tax assets would be realized based on all available positive and negative evidence, having demonstrated sustained US profitability, which is objective and verifiable, and taking into account anticipated future earnings. As a result, we decreased our valuation allowance by approximately $70.0 million, of which $58.3 million was reflected in our GAAP Income Tax Provision only and $11.7 million in our Non-GAAP Adjusted Income Tax Provision.

The Non-GAAP Adjusted Effective Tax Rate for the year ended April 30, 2026, was 24.4%. The Non-GAAP Adjusted Effective Tax Rate for the year ended April 30, 2025, was 21.0%. The increase in the Non-GAAP Adjusted Effective Tax Rate before these items was primarily due to the mix of earnings by jurisdiction for the year ended April 30, 2026.

**Diluted Earnings Per Share (EPS):**

EPS for the year ended April 30, 2026, was $4.16 per share compared to $1.53 per share in the prior year. This increase was primarily due to higher income before taxes, and a benefit for income taxes in fiscal year 2026 compared with a provision for income taxes in the prior year.

Below is a reconciliation of our US GAAP Earnings Per Share to Non-GAAP Adjusted EPS. The amount of the pretax and the related income tax impact for the adjustments included in the table below are presented in the section above, "(Benefit) Provision for Income Taxes."

---

| | | |
|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** |
| | **2026** | **2025** |
| **US GAAP Earnings Per Share** | $4.16 | $1.53 |
| <u>Adjustments:</u> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and related charges | 0.27 | 0.36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 0.05 | 0.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of acquired intangible assets | 0.79 | 0.76 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | 0.08 | 0.38 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Held for Sale or Sold segment Adjusted Net Loss |  | 0.05 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax adjustments | (1.16) | 0.48 |
| **Non-GAAP Adjusted EPS** | $4.19 | $3.64 |

---

On a constant currency basis, Adjusted EPS increased 15% primarily due to an increase in Adjusted Operating Income, partially offset by an increase in the Adjusted Effective Tax Rate.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**SEGMENT OPERATING RESULTS:**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** | **% Change<br>Favorable<br>(Unfavorable)** | **Constant Currency % Change<br>Favorable<br>(Unfavorable)** |
| **RESEARCH** | **2026** | **2025** | **% Change<br>Favorable<br>(Unfavorable)** | **Constant Currency % Change<br>Favorable<br>(Unfavorable)** |
| **Revenue:** |  |  |  |  |
| Research Publishing | 965767 | 922553 | 5% | 3% |
| Research Solutions | 164175 | 152906 | 7% | 6% |
| &nbsp;&nbsp;&nbsp;**Total Research Revenue** | 1129942 | 1075459 | 5% | 4% |
| Cost of sales | 303702 | 278867 | (9)% | (8)% |
| Direct expenses | 331192 | 336484 | 2% | 4% |
| Allocated Corporate expenses | 167578 | 160959 | (4)% | (3)% |
| Amortization of intangible assets | 44866 | 43569 | (3)% | 0% |
| **Adjusted Operating Income** | 282604 | 255580 | 11% | 10% |
| Depreciation and amortization | 92472 | 89302 | (4)% | (2)% |
| **Adjusted EBITDA** | 375076 | 344882 | 9% | 8% |
| Adjusted EBITDA Margin | 33.2% | 32.1% |  |  |

---

**Revenue:**

Research revenue for the year ended April 30, 2026, increased $54.5 million, or 5%, as compared with the prior year. On a constant currency basis, revenue increased 4% as compared with the prior year.

Research Publishing revenue on a constant currency basis increased 3% primarily due to continued growth in author-funded open access and, to a lesser extent, recurring revenue models which includes subscriptions and transformational agreements. These increases were partially offset by softness in ancillary products. Research Solutions revenue on a constant currency basis increased 6% primarily due to AI licensing as a service revenue which includes content licensed from other publishers, partially offset by a decrease in recruitment and, to a lesser extent, marketing services due to lower corporate customer spending.

Research AI licensing revenue for the year ended April 30, 2026 was $33.1 million as compared to approximately $11 million in the prior year. Open access article output growth was approximately 25% as compared with the prior year.

**Adjusted EBITDA:**

On a constant currency basis, Adjusted EBITDA increased 8% as compared with the prior year. This increase was primarily due to higher revenue and, to a lesser extent, restructuring and cost savings initiatives, partially offset by higher royalty costs.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** | **% Change<br>Favorable<br>(Unfavorable)** | **Constant Currency % Change<br>Favorable<br>(Unfavorable)** |
| **LEARNING** | **2026** | **2025** | **% Change<br>Favorable<br>(Unfavorable)** | **Constant Currency % Change<br>Favorable<br>(Unfavorable)** |
| **Revenue:** |  |  |  |  |
| Academic | 318757 | 333693 | (4)% | (5)% |
| Professional | 227829 | 251075 | (9)% | (10)% |
| &nbsp;&nbsp;&nbsp;**Total Learning Revenue** | 546586 | 584768 | (7)% | (7)% |
| Cost of sales | 127807 | 144758 | 12% | 13% |
| Direct expenses | 136301 | 142204 | 4% | 5% |
| Allocated Corporate expenses | 107909 | 114703 | 6% | 7% |
| Amortization of intangible assets | 8184 | 8253 | 1% | 1% |
| **Adjusted Operating Income** | 166385 | 174850 | (5)% | (5)% |
| Depreciation and amortization | 41148 | 43900 | 6% | 7% |
| **Adjusted EBITDA** | 207533 | 218750 | (5)% | (6)% |
| Adjusted EBITDA Margin | 38.0% | 37.4% |  |  |

---

**Revenue:**

Learning revenue for the year ended April 30, 2026, decreased $38.2 million, or 7%, as compared with the prior year. On a constant currency basis, revenue decreased 7% as compared with the prior year.

Academic revenue on a constant currency basis decreased 5% primarily due to a decline in print book sales and, to a lesser extent, licensing revenue including AI, partially offset by higher digital content growth. Professional revenue on a constant currency basis decreased 10% primarily due to a decline in print and digital sales through retail channels and, to a lesser extent, a decrease in licensing revenue including AI.

Learning AI licensing revenue for the year end April 30, 2026 was $16.0 million compared to approximately $29 million in the prior year.

**Adjusted EBITDA:**

On a constant currency basis, Adjusted EBITDA decreased 6% as compared with the prior year. This decrease was primarily due to lower revenue, partially offset by lower inventory costs, royalty costs, and restructuring and cost savings initiatives.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** | **% Change**<br>**Favorable**<br>**(Unfavorable)**  | **Constant Currency** <br>**% Change**<br>**Favorable**<br>**(Unfavorable)**  |
| **HELD FOR SALE OR SOLD** | **2026** | **2025** | **2025** | **% Change**<br>**Favorable**<br>**(Unfavorable)**  | **Constant Currency** <br>**% Change**<br>**Favorable**<br>**(Unfavorable)**  |
| &nbsp;&nbsp;&nbsp;**Total Held for Sale or Sold Revenue** | $| $| 17382 | # | # |
| Cost of sales |  | 7755 | 7755 | # | # |
| Direct expenses |  | 10365 | 10365 | # | # |
| Allocated Corporate expenses |  | 2840 | 2840 | # | # |
| Amortization of intangible assets |  |  |  | # | # |
| **Adjusted Operating Loss** |  | (3578) | (3578) | # | # |
| Depreciation and amortization |  |  |  | # | # |
| **Adjusted EBITDA** | $| $| (3578) | # | # |
| Adjusted EBITDA Margin | 0.0% | (20.6)% | (20.6)% |  |  |

---

# Not meaningful

**Revenue:**

Held for Sale or Sold revenue for the year ended April 30, 2026, decreased $17.4 million as compared with the prior year due to the sale of Wiley Edge on May 31, 2024, with the exception of its India operations which sold on August 31, 2024, and CrossKnowledge on August 31, 2024.

**Adjusted EBITDA:**

On a constant currency basis, Adjusted EBITDA was zero for the year ended April 30, 2026 compared to a loss of $3.6 million in the prior year due to the sale of the Wiley Edge and CrossKnowledge businesses.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** | **% Change**<br>**Favorable**<br>**(Unfavorable)**  | **Constant Currency** <br>**% Change**<br>**Favorable**<br>**(Unfavorable)**  |
| **CORPORATE EXPENSES** | **2026** | **2025** | **% Change**<br>**Favorable**<br>**(Unfavorable)**  | **Constant Currency** <br>**% Change**<br>**Favorable**<br>**(Unfavorable)**  |
| Unallocated Corporate expenses | $152819 | $179882 | 15% | 16% |
| **Adjusted Unallocated Corporate Expenses** | (152819) | (179882) | 15% | 16% |
| Depreciation and amortization | 9857 | 13924 | 29% | 30% |
| **Adjusted EBITDA** | $(142962) | $(165958) | 14% | 15% |

---

On a constant currency basis, adjusted corporate expenses of $143.0 million on an Adjusted EBITDA basis decreased 15% as compared with the prior year. This was primarily due to restructuring and cost savings initiatives resulting in lower employment costs, and professional fees.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**FISCAL YEAR 2025 AS COMPARED TO FISCAL YEAR 2024 SUMMARY RESULTS**

Discussions of our results of operations for the year ended April 30, 2025 compared to April 30, 2024 have been omitted under this item, but may be found in Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended April 30, 2025, which was filed with the SEC on June 25, 2025.

**<u>LIQUIDITY AND CAPITAL RESOURCES:</u>**

Principal Sources of Liquidity

We believe that our operating cash flow, together with our revolving credit facilities and other available debt financing, will be adequate to meet our operating, investing, and financing needs in the next twelve months. Operating cash flow provides the primary source of cash to fund operating needs and capital expenditures. Excess operating cash is used to fund shareholder dividends and share repurchases. Other discretionary uses of cash flow include investments and acquisitions to complement and grow our portfolio of businesses. As necessary, we may supplement operating cash flow with debt to fund these activities. The overall cash position of the Company reflects our durable business results and a global cash management strategy that considers liquidity management, economic factors, and tax considerations. Our cash and cash equivalents are maintained at a number of financial institutions. To mitigate the risk of uninsured balances, we select financial institutions based on their credit ratings and financial strength, and we perform ongoing evaluations of these institutions to limit our concentration risk exposure to any financial institution.

As of April 30, 2026, we had cash and cash equivalents of $75.6 million, of which approximately 96% was located outside the US. Maintenance of these cash and cash equivalent balances outside the US does not have a material impact on the liquidity or capital resources of our operations. We intend to repatriate earnings from our non-US subsidiaries, and to the extent we repatriate these funds to the US, we may be required to pay taxes in various US state and local jurisdictions and withholding or similar taxes in applicable non-US jurisdictions in the periods in which such repatriation occurs. Accordingly, as of April 30, 2026, we have recorded a deferred tax liability of approximately $2.2 million related to the estimated taxes that would be incurred upon repatriating certain non-US earnings to the US.

On November 30, 2022, we entered into the second amendment to the Third Amended and Restated Credit Agreement (collectively, the Amended and Restated CA). <u>[See Note 14](#ibca3b3235d7c467fbc5aca76ca773567_4200)</u>, "Debt and Available Credit Facilities" for more details on the amendment. The Amended and Restated CA provided for senior unsecured credit facilities comprised of the following (i) a five-year revolving credit facility in an aggregate principal amount up to $1.115 billion which matures November 2027, (ii) a five-year term loan A facility consisting of $200 million which matures November 2027, and (iii) $185 million aggregate principal amount revolving credit facility which matured in May 2024. We also may request an increase in the aggregate commitments provided that the total credit exposures of all lenders shall at no time exceed $2 billion, and any such request shall be in minimum increments of $50 million, subject to the approval of the lenders. On May 15, 2026, we entered into the third amendment to the Third Amended and Restated Credit Agreement for the establishment of incremental term commitments in an aggregate principal amount of $300.0 million, increasing the total available lines of credit to $1,590.5 million.

As of April 30, 2026, we had approximately $683.4 million of debt outstanding, net of unamortized issuance costs of $0.3 million, and approximately $606.9 million of unused borrowing capacity under our Amended and Restated CA and other facilities. Our Amended and Restated CA contains certain restrictive covenants related to our consolidated leverage ratio and interest coverage ratio, which we were in compliance with as of April 30, 2026.

**Contractual Obligations and Commercial Commitments**

A summary of contractual obligations and commercial commitments, excluding unrecognized tax benefits further described in <u>[Note 13](#if082921157e54be5bc1d60bc0359f2c8_4648)</u>, "Income Taxes," of the Notes to Consolidated Financial Statements, as of April 30, 2026, is as follows:

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Payments Due by Period<br>(in millions)** | **Payments Due by Period<br>(in millions)** | **Payments Due by Period<br>(in millions)** | **Payments Due by Period<br>(in millions)** | **Payments Due by Period<br>(in millions)** |
| | **Total** | **Within<br>Year 1** | **2–3<br>Years** | **4–5<br>Years** | **After 5<br>Years** |
| Total debt<sup>(1)</sup> | $683.7 | $12.5 | $671.2 | $— | $— |
| Interest on debt<sup>(2)</sup> | 54.8 | 35.5 | 19.3 |  |  |
| Non-cancellable leases | 102.7 | 20.2 | 31.7 | 29.2 | 21.6 |
| Minimum royalty obligations | 350.3 | 98.8 | 131.9 | 69.8 | 49.8 |
| Other operating commitments<sup>(3)</sup> | 278.6 | 95.9 | 132.9 | 49.8 |  |
| Total | $1470.1 | $262.9 | $987.0 | $148.8 | $71.4 |

---

(1) Total debt is exclusive of unamortized issuance costs of $0.3 million .

(2) Interest on debt includes the effect of our interest rate swap agreements and the estimated future interest payments on our unhedged variable rate debt, assuming that the interest rates as of April 30, 2026, remain constant until the maturity of the debt.

(3) Other operating commitments consist primarily of non-cancellable commitments under technology contracts, including cloud hosting, software licensing, and related services agreements.

***Analysis of Historical Cash Flow***

The following table shows the changes in our Consolidated Statements of Cash Flows:

---

| | | |
|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** |
| | **2026** | **2025** |
| Net cash provided by operating activities | $260519 | $202591 |
| Net cash provided by (used in) investing activities | 28105 | (94018) |
| Net cash used in financing activities | (298303) | (125330) |
| Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash | $(581) | $3146 |

---

Cash flow from operations is seasonally a use of cash in the first half of Wiley's fiscal year principally due to the timing of collections for annual Journal Subscriptions and Transformational Agreements, which typically occurs in the beginning of the second half of our fiscal year.

Free cash flow less product development spending helps assess our ability, over the long term, to create value for our shareholders, as it represents cash available to repay debt, pay common dividends, and fund share repurchases, and acquisitions. Below are the details of Free cash flow less product development spending.

**Free Cash Flow Less Product Development Spending:**

---

| | | |
|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** |
| | **2026** | **2025** |
| Net cash provided by operating activities | $260519 | $202591 |
| Less: Additions to technology, property, and equipment | (51166) | (61473) |
| Less: Product development spending | (14012) | (15228) |
| Free cash flow less product development spending | $195341 | $125890 |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Net Cash Provided By Operating Activities***

***2026 Compared to 2025***

The following is a summary of the $57.9 million change in Net cash provided by operating activities for the year ended April 30, 2026, as compared with the year ended April 30, 2025 (amounts in millions).

---

| | |
|:---|:---|
| **Net cash provided by operating activities – Year ended April 30, 2025** | $202.6 |
| Net income adjusted for items to reconcile net income to net cash provided by operating activities, which would include such noncash items as depreciation and amortization, net losses on sale of businesses, assets, and impairment charges related to assets held-for-sale, restructuring charges, and the change in deferred taxes | 38.8 |
| <u>Working capital changes:</u> |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net and contract liabilities | (11.4) |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued royalties | (20.7) |
| &nbsp;&nbsp;&nbsp;Changes in other assets and liabilities | 51.2 |
| **Net cash provided by operating activities – Year ended April 30, 2026** | $260.5 |

---

The unfavorable change in accounts receivable, net and contract liabilities was primarily due to the timing of customer billings and collections.

The unfavorable change in accounts payable and accrued royalties was due to the timing of payments.

The favorable changes in other assets and liabilities noted in the table above was primarily due to lower contributions to defined benefit plans in fiscal year 2026, lower costs related to cloud computing arrangements, lower inventory levels and other changes in working capital. This was partially offset by a larger decline in accrued employee related costs in fiscal year 2026. This decline reflects both lower incentive compensation expense accrued during the year and lower cash payments for prior year annual incentive compensation.

Our negative working capital (current assets less current liabilities) was $359.3 million and $381.0 million as of April 30, 2026, and April 30, 2025, respectively. The primary driver of the negative working capital is the benefit realized from unearned contract liabilities related to subscriptions (which includes Transformational Agreements) for which cash has been collected in advance. The contract liabilities will be recognized as revenue when the products are shipped or made available online to the customers over the term of the subscription. Current liabilities as of April 30, 2026, and as of April 30, 2025 include contract liabilities of $451.4 million and $462.7 million, respectively, primarily related to deferred subscription revenue for which cash was collected in advance. Cash collected in advance for subscriptions is used by us for a number of purposes, including funding operations, capital expenditures, acquisitions, debt repayments, dividend payments, and share repurchases.

***Net Cash Provided By (Used In) Investing Activities***

***2026 Compared to 2025***

Net cash provided by investing activities in the year ended April 30, 2026, was $28.1 million compared to net cash used in investing activities of $94.0 million in the prior year. The change in investing activities was primarily due to the $115.3 million in cash received in fiscal year 2026 as a result of selling the remaining University Services assets in June 2025 and, to a lesser extent, lower additions for technology, property, and equipment of $10.3 million. This was partially offset by higher additions for publication rights of $17.4 million in 2026. <u>[See Note 4](#i07300a4eeb7a47b3860e2ee1f39a3e3f_10911)</u>, "Acquisition and Divestitures" for further details on the sale of the University Services assets.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Net Cash Used In Financing Activities***

***2026 Compared to 2025***

Net cash used in financing activities in the year ended April 30, 2026, was $298.3 million compared to $125.3 million in the year ended April 30, 2025. The change in cash used was primarily due to net debt repayments of $120.3 million in fiscal year 2026 compared with net debt borrowings of $13.5 million in fiscal year 2025, and an increase in cash used for purchases of treasury shares in fiscal year 2026 of $39.7 million.

In the years ended April 30, 2026 and 2025, our quarterly dividend to shareholders was $1.42 and $1.41 per share annualized, respectively.

In fiscal year 2020, our Board of Directors authorized a share repurchase program of up to $200 million of Class A or B Common Stock, which was fully utilized as of April 30, 2026. In the first quarter of fiscal year 2026, our Board of Directors authorized an additional share repurchase program of up to $250 million of Class A or B Common Stock. As of April 30, 2026, $207.4 million of share repurchase authority remained under this authorization.

The following table summarizes the shares repurchased (shares in thousands):

---

| | | |
|:---|:---|:---|
| | **Year Ended<br>April 30,** | **Year Ended<br>April 30,** |
| | **2026** | **2025** |
| Shares repurchased – Class A | 2843 | 1186 |
| Shares repurchased – Class B | 7 | 173 |
| Average price – Class A and Class B | $35.08 | $44.16 |

---

During the years ended April 30, 2026 and 2025, we purchased $100.0 million and $60.0 million, respectively, under these programs.

The total amount purchased and the average price per share excludes excise taxes payable on share repurchases and may differ from the share repurchases reflected in Purchases of treasury shares in our Consolidated Statements of Cash Flows. For the year ended April 30, 2026, the total amount repurchased and the total shares repurchased includes unsettled purchases, and such amount differs from the amount reflected in Purchases of treasury shares in our Unaudited Condensed Consolidated Statements of Cash Flows.

***<u>2025 Compared to 2024</u>***

A discussion of changes in our cash flows for the year ended April 30, 2025, compared to the year ended April 30, 2024, has been omitted under this item, but may be found in Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources" in our Annual Report on Form 10-K for the year ended April 30, 2025, which was filed with the SEC on June 25, 2025.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**RECENTLY ISSUED STATEMENTS OF FINANCIAL ACCOUNTING STANDARDS, ACCOUNTING GUIDANCE, AND DISCLOSURE REQUIREMENTS**

We are subject to numerous recently issued statements of financial accounting standards, accounting guidance, and disclosure requirements. The information set forth in Part II, Item 8, "Financial Statements and Supplementary Data" in <u>[Note 2](#ib89f1fe374d74cbb9d0c7be7b6367e87_28579)</u>, "Summary of Significant Accounting Policies, Recently Issued and Recently Adopted Accounting Standards," of the Notes to Consolidated Financial Statements of this Annual Report on Form 10-K is incorporated by reference and describes these new accounting standards.

**CRITICAL ACCOUNTING POLICIES AND ESTIMATES:**

The preparation of our Consolidated Financial Statements and related disclosures in conformity with US GAAP requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and revenue and expenses during the reporting period. We review these estimates and assumptions periodically using historical experience and other factors and reflect the effects of any revisions on the Consolidated Financial Statements in the period we determine any revisions to be necessary. Actual results could differ from those estimates, which could affect the reported results. In Part II, Item 8, "Financial Statements and Supplementary Data" in <u>[Note 2](#ib89f1fe374d74cbb9d0c7be7b6367e87_28579)</u>, "Summary of Significant Accounting Policies, Recently Issued and Recently Adopted Accounting Standards" of the Notes to Consolidated Financial Statements includes a summary of the significant accounting policies and methods used in preparation of our Consolidated Financial Statements. Set forth below is a discussion of our more critical accounting policies and methods.

*Revenue Recognition:*

In Part II, Item 8, "Financial Statements and Supplementary Data," <u>[see Note 2](#ib89f1fe374d74cbb9d0c7be7b6367e87_28579)</u>, "Summary of Significant Accounting Policies, Recently Issued and Recently Adopted Accounting Standards" in the section "Summary of Significant Accounting Policies", and <u>[see Note 3](#i07367b72690a4395824ae69fddb9e9fe_18015)</u>, "Revenue Recognition, Contracts with Customers," of the Notes to Consolidated Financial Statements for details of our revenue recognition policy.

*Sales Return Reserves:*

In Part II, Item 8, "Financial Statements and Supplementary Data," <u>[see Note 2](#ib89f1fe374d74cbb9d0c7be7b6367e87_28579)</u>, "Summary of Significant Accounting Policies, Recently Issued and Recently Adopted Accounting Standards" in the section "Summary of Significant Accounting Policies" of the Notes to Consolidated Financial Statements for details of our sales return reserves.

A one percent change in the estimated sales return rate could affect net income by approximately $2 million. A change in the pattern or trends in returns could also affect the estimated allowance.

*Allocation of Acquisition Purchase Price to Assets Acquired and Liabilities Assumed*:

In connection with acquisitions, we allocate the cost of the acquisition to the assets acquired and the liabilities assumed based on the estimates of fair value for such items, including intangible assets. The excess of the purchase consideration over the fair value of assets acquired and liabilities assumed is recorded as goodwill. The determination of the acquisition date fair value of the assets acquired, and liabilities assumed, requires us to make significant estimates and assumptions, such as, if applicable, forecasted revenue growth rates and operating cash flows, royalty rates, customer attrition rates, obsolescence rates of developed technology, and discount rates. We may use a third-party valuation consultant to assist in the determination of such estimates.

In Part II, Item 8, "Financial Statements and Supplementary Data," <u>[see Note 4](#i07300a4eeb7a47b3860e2ee1f39a3e3f_10911)</u>, "Acquisition and Divestitures" of the Notes to Consolidated Financial Statements for details of our acquisition.

*Goodwill and Indefinite-lived Intangible Assets:*

Goodwill is reviewed for possible impairment at least annually on a reporting unit level during the fourth quarter of each year. Our annual impairment assessment date is February 1. A review of goodwill may be initiated before or after conducting the annual analysis if events or changes in circumstances indicate the carrying value of goodwill may no longer be recoverable.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

A reporting unit is the operating segment unless, at businesses one level below that operating segment – the "component" level, discrete financial information is prepared and regularly reviewed by management, and the component has economic characteristics that are different from the economic characteristics of the other components of the operating segment, in which case the component is the reporting unit.

As part of the annual impairment test, we may elect to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In a qualitative assessment, we would consider the macroeconomic conditions, including any deterioration of general conditions and industry and market conditions, including any deterioration in the environment where the reporting unit operates, increased competition, changes in the products/services and regulatory and political developments, cost of doing business, overall financial performance, including any declining cash flows and performance in relation to planned revenues and earnings in past periods, other relevant reporting unit specific facts, such as changes in management or key personnel or pending litigation, and events affecting the reporting unit, including changes in the carrying value of net assets.

If the results of our qualitative assessment indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we are required to perform a quantitative assessment to determine the fair value of the reporting unit.

Alternatively, if an optional qualitative goodwill impairment assessment is not performed, we may perform a quantitative assessment. Under the quantitative assessment, we compare the fair value of each reporting unit to its carrying value, including the goodwill allocated to the reporting unit. If the fair value of the reporting unit exceeded its carrying value, there would be no indication of impairment. If the fair value of the reporting unit were less than the carrying value, an impairment charge would be recognized for the difference.

We derive an estimate of fair values for each of our reporting units using a combination of an income approach and a market approach. Absent an indication of fair value from a potential buyer or similar specific transactions, we believe that the use of these methods provides a reasonable estimate of a reporting unit's fair value.

Fair value computed by these methods is arrived at using a number of key assumptions including forecasted revenues and related growth rates, forecasted operating cash flows, the discount rate, and the selection of relevant market multiples of comparable publicly-traded companies with similar characteristics to the reporting unit. There are inherent uncertainties, however, related to these factors and to our judgment in applying them to this analysis. We believe that the combination of these methods provides a reasonable approach to estimate the fair value of our reporting units.

*Income Approach Used to Determine Fair Values*

The income approach is based upon the present value of expected cash flows. Expected cash flows are converted to present value using factors that consider the timing and risk of the future cash flows. The estimate of cash flows used is prepared on an unleveraged debt-free basis. We use a discount rate that reflects a market-derived weighted average cost of capital. We believe that this approach is appropriate because it provides a fair value estimate based upon the reporting unit's expected long-term operating and cash flow performance. The projections are based upon our best estimates of forecasted economic and market conditions over the related period including growth rates, expected changes in forecasted operating cash flows, and cash expenditures. Other estimates and assumptions include terminal value long-term growth rates, provisions for income taxes, future capital expenditures, and changes in future cashless, debt-free working capital. Changes in any of these assumptions could materially impact the estimated fair value of our reporting units. Our forecasts take into account the near and long-term expected business performance, considering the long-term market conditions and business trends within the reporting units. However, changes in these assumptions may impact our ability to recover the allocated goodwill in the future. For further discussion of the factors that could result in a change in our assumptions, see "Risk Factors" in this Annual Report on Form 10-K.

*Market Approach Used to Determine Fair Values*

The market approach estimates the fair value of the reporting unit by applying multiples of operating performance measures to the reporting unit's operating performance (the Guideline Public Company Method). These multiples are derived from comparable publicly-traded companies with similar investment characteristics to the reporting unit, and such comparable data are reviewed and updated as needed annually. We believe that this approach is appropriate because it provides a fair value estimate using multiples from entities with operations and economic characteristics comparable to our reporting units and Wiley.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The key estimates and assumptions that are used to determine fair value under this market approach include current and forward 12-month revenue and EBITDA results, as applicable, and the selection of the relevant multiples to be applied. Under the Guideline Public Company Method, a control premium, or an amount that a buyer is usually willing to pay over the current market price of a publicly-traded company is considered and applied to the calculated equity values to adjust the public trading value upward for a 100% ownership interest, where applicable.

In order to assess the reasonableness of the calculated fair values of our reporting units, we also compare the sum of the reporting units' fair values to our market capitalization and calculate an implied control premium (the excess of the sum of the reporting units' fair values over the market capitalization). We evaluate the control premium by comparing it to control premiums of recent comparable market transactions. If the implied control premium is not reasonable in light of these recent transactions, we will reevaluate our fair value estimates of the reporting units by adjusting the discount rates and/or other assumptions.

If our assumptions and related estimates change in the future, or if we change our reporting unit structure or other events and circumstances change (such as a sustained decrease in the price of our common stock, a decline in current market multiples, a significant adverse change in legal factors or business climates, an adverse action or assessment by a regulator, heightened competition, strategic decisions made in response to economic or competitive conditions, or a more-likely-than-not expectation that a reporting unit or a significant portion of a reporting unit will be sold or disposed of), we may be required to record impairment charges in future periods. Any impairment charges that we may take in the future could be material to our consolidated results of operations and financial condition.

*Fiscal Year 2026 and 2025 Annual Goodwill Impairment Test*

As of February 1, 2026 and 2025, we completed a qualitative assessment for our annual goodwill impairment test for our reporting units within Research and Learning segments. This assessment included consideration of key factors including macroeconomic conditions, industry and market considerations, cost factors, financial performance, and other relevant entity and reporting unit-specific events. Based on our qualitative assessment, we determined it was not more likely than not that the fair value of any reporting unit was less than its carrying amount. As such, it was not necessary to perform a quantitative test. There have been no significant events or circumstances affecting the valuation of goodwill subsequent to the qualitative assessment performed as of February 1, 2026.

*Fiscal Year 2024 Segment Realignment Goodwill Impairment Test*

In the first quarter of fiscal year 2024, we began to operate under a new organizational structure, which resulted in a change in our composition of our reportable segments, which resulted in a change in our reporting units. The Learning reportable segment includes two reporting units, Academic and Professional, and the Held for Sale or Sold reportable segment includes three reporting units, University Services, Wiley Edge, and CrossKnowledge. No changes were made to the Research reportable segment. As a result of this realignment, we were required to test goodwill for impairment immediately before and after the realignment. Since there were no changes to the Research reportable segment, no interim impairment test of the Research reportable segment goodwill was required.

*Goodwill Impairment Before Realignment*

Prior to the realignment, we concluded that the fair value of the Academic Publishing, Talent Development (which includes Wiley Edge) and Professional Learning reporting units were above their carrying values. Therefore, there was no indication of impairment. The carrying value of the University Services reporting unit was above its fair value which resulted in a pretax noncash goodwill impairment of $11.4 million. Such impairment reduced the goodwill of the University Services reporting unit to zero. This charge is reflected in Impairment of goodwill in the Consolidated Statements of Income (Loss).

University Services was adversely impacted by market conditions and headwinds for online degree programs, which lead to a decline in projected enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term which adversely impacted forecasted revenue growth and operating cash flows.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The key assumptions underlying the estimate of the fair value of the University Services reporting unit included the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Future cash flow assumptions – the projections for future cash flows utilized in the model were derived from historical experience and assumptions regarding future growth and profitability of the reporting unit. These projections include forecasted revenues and related growth rates, and forecasted operating cash flows, and are consistent with our operating budget and strategic plan. We applied a compounded annual growth rate of approximately 4.6% for forecasted sales in our projected cash flows through fiscal year 2031. Beyond the forecasted period, a terminal value was determined using a perpetuity growth rate of 3.0% to reflect our estimate of stable and perpetual growth.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Discount rate based on the weighted average cost of capital (WACC) – the WACC is the rate used to discount the reporting unit's estimated future cash flows. The WACC is calculated based on a proportionate weighting of the cost of debt and equity. The cost of equity is based on a capital asset pricing model and includes a company-specific risk premium to capture the perceived risks and uncertainties associated with the reporting unit's projected cash flows. The cost of debt component is calculated based on the after-tax cost of debt of Moody's Baa-rated corporate bonds. The cost of debt and equity is weighted based on the debt to market capitalization ratio of publicly traded companies with similarities to the University Services reporting unit. The WACC applied to the University Services reporting unit was 17%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Valuation Multiples – for the Guideline Public Company Method, we applied relevant current and forward 12-month EBITDA multiples based on an evaluation of multiples of publicly-traded companies with similarities to the University Services reporting unit. The multiples applied ranged from 4.5x to 6.0x EBITDA.

Prior to performing the goodwill impairment test for University Services, we also evaluated the recoverability of long-lived assets of the reporting unit. The carrying value of the long-lived assets that were tested for impairment was approximately $231.0 million. When indicators of impairment are present, we test definite lived and long-lived assets for recoverability by comparing the carrying value of an asset group to an estimate of the future undiscounted cash flows expected to result from the use and eventual disposition of the asset group. We considered the lower-than-expected revenue and forecasted operating cash flows over a sustained period of time, and downward revisions to our cash flow forecasts for this reporting unit to be indicators of impairment for their long-lived assets. Based on the results of the recoverability test, we determined that the undiscounted cash flows of the asset group of the University Services reporting unit exceeded the carrying value. Therefore, there was no impairment.

*Goodwill Impairment After Realignment*

After the realignment, we concluded that the fair value of the Academic, Professional, and Wiley Edge reporting units was above their carrying values. Therefore, there was no indication of impairment. As noted above, the goodwill of the University Services reporting unit was zero and no further testing of goodwill for impairment was required. The carrying value of the CrossKnowledge reporting unit was above its fair value, which resulted in a pretax noncash goodwill impairment of $15.3 million. This charge is reflected in Impairment of goodwill in the Consolidated Statements of Income (Loss).

CrossKnowledge was adversely impacted by a decline in the demand for its offerings, which resulted in lower sales and a decline in average contract value that adversely impacted forecasted revenue growth and operating cash flows.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The key assumptions underlying the estimate of the fair value of the CrossKnowledge reporting unit included the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Future cash flow assumptions – the projections for future cash flows utilized in the model were derived from historical experience and assumptions regarding future growth and profitability of the reporting unit. These projections include forecasted revenues and related growth rates, and forecasted operating cash flows, and are consistent with our operating budget and strategic plan. We applied a compounded annual growth rate of approximately 3.3% for forecasted sales in our projected cash flows through fiscal year 2032. Beyond the forecasted period, a terminal value was determined using a perpetuity growth rate of 2.0% to reflect our estimate of stable and perpetual growth.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Discount rate based on the WACC – the WACC is the rate used to discount the reporting unit's estimated future cash flows. The WACC is calculated based on a proportionate weighting of the cost of debt and equity. The cost of equity is based on a capital asset pricing model and includes a company-specific risk premium to capture the perceived risks and uncertainties associated with the reporting unit's projected cash flows. The cost of debt component is calculated based on the after-tax cost of debt of Moody's Baa-rated corporate bonds. The cost of debt and equity is weighted based on the debt to market capitalization ratio of publicly traded companies with similarities to the CrossKnowledge reporting unit. The WACC applied to the CrossKnowledge reporting unit was 16%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Valuation Multiples – for the Guideline Public Company Method, we applied relevant current and forward 12-month EBITDA multiples based on an evaluation of multiples of publicly-traded companies with similarities to the CrossKnowledge reporting unit. The multiples applied ranged from 6.0x to 7.0x EBITDA.

Prior to performing the goodwill impairment test for CrossKnowledge, we also evaluated the recoverability of long-lived assets of the reporting unit. The carrying value of the long-lived assets that were tested for impairment was approximately $50.2 million. When indicators of impairment are present, we test definite lived and long-lived assets for recoverability by comparing the carrying value of an asset group to an estimate of the future undiscounted cash flows expected to result from the use and eventual disposition of the asset group. We considered the lower-than-expected revenue and forecasted operating cash flows over a sustained period of time, and downward revisions to our cash flow forecasts for this reporting unit to be indicators of impairment for their long-lived assets. Based on the results of the recoverability test, we determined that the undiscounted cash flows of the asset group of the CrossKnowledge reporting unit exceeded the carrying value. Therefore, there was no impairment.

*Wiley Edge Fiscal Year 2024 Interim Impairment Test*

As a result of signing the stock and asset purchase agreement (Edge Agreement) with Inspirit Vulcan Bidco Limited, a private limited company incorporated in England & Wales (Inspirit) and the decrease in the fair value of the business which was impacted by a decline in placements in the third quarter of fiscal year 2024, we tested the goodwill of the Wiley Edge reporting unit for impairment. We estimated the fair value of the reporting unit based on the terms and conditions in the Edge Agreement at that time which reflected a selling price that included $10.0 million in cash, $18.3 million in the form of a loan, a fair value estimate for an earnout, and an estimate for a working capital adjustment.

We concluded that the carrying value of the Wiley Edge reporting unit was above its fair value which resulted in a pretax noncash goodwill impairment of approximately $81.7 million in the three months ended January 31, 2024. Such impairment reduced the goodwill of the Wiley Edge reporting unit to zero. This charge is reflected in Impairment of goodwill in the Consolidated Statements of Income (Loss). The impairment was due to subsequent changes in the fair value resulting from the continued progression of the selling process, indications of changes in the consideration for the business, and a decline in placements in the third quarter of fiscal year 2024, as well as changes in the carrying amounts of the disposal group.

Prior to performing the goodwill impairment test for Wiley Edge, we also evaluated the recoverability of long-lived assets of the reporting unit. The carrying value of the long-lived assets that were tested for impairment was approximately $141.5 million. We considered the changes in the fair value of the consideration for the business due to the continued progression of the selling process to be an indicator of impairment for its long-lived assets. Based on the results of the recoverability test, we determined that the undiscounted cash flows of the asset group of the Wiley Edge reporting unit exceeded the carrying value. Therefore, there was no impairment.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Fiscal Year 2026 and 2025 Annual Indefinite-lived Intangible Impairment Test*

We also review our indefinite-lived intangible assets for impairment annually, which consists of brands and trademarks and certain acquired publishing rights.

For fiscal year 2026 and 2025, we performed a qualitative assessment for our annual indefinite-lived intangible assets impairment test. This assessment included consideration of key factors including macroeconomic conditions, industry and market considerations, cost factors, financial performance, and other relevant entity and reporting unit-specific events. Based on our qualitative assessment, we determined it was not more likely than not that the fair value of any indefinite-lived intangible asset was less than its carrying amount. As such, it was not necessary to perform a quantitative test.

*Intangible Assets with Definite Lives and Other Long-Lived Assets:*

<u>[See Note 2](#ib89f1fe374d74cbb9d0c7be7b6367e87_28579)</u>, "Summary of Significant Accounting Policies, Recently Issued, and Recently Adopted Accounting Standards," in the section "Summary of Significant Accounting Policies" of the Notes to Consolidated Financial Statements for details of definite lived intangible assets and other long-lived assets.

*Retirement Plans:*

We provide defined benefit pension plans for certain employees worldwide. Our Board of Directors approved amendments to the US, Canada, and UK defined benefit plans that froze the future accumulation of benefits effective June 30, 2013, December 31, 2015, and April 30, 2015, respectively. Under the amendments, no new employees will be permitted to enter these plans and no additional benefits for current participants for future services will be accrued after the effective dates of the amendments.

The accounting for benefit plans is highly dependent on assumptions concerning the outcome of future events and circumstances, including discount rates, long-term return rates on pension plan assets, healthcare cost trends, compensation increases, and other factors. In determining such assumptions, we consult with outside actuaries and other advisors.

The discount rates for the US, Canada, and UK pension plans are based on the derivation of a single-equivalent discount rate using a standard spot rate curve and the timing of expected benefit payments as of the balance sheet date. The spot rate curves are based upon portfolios of corporate bonds rated at Aa or above by a respected rating agency. The discount rate for Germany is based on the expected benefit payments for the sample mixed population plan. The expected long-term rates of return on pension plan assets are estimated using forecasted returns for the asset classifications within the asset portfolio, and a composite return assumption range is determined using a weighted average based on each plan's target asset allocation percentage. Salary growth and healthcare cost trend assumptions are based on our historical experience and future outlook. While we believe that the assumptions used in these calculations are reasonable, differences in actual experience or changes in assumptions could materially affect the expense and liabilities related to our defined benefit pension plans. A hypothetical one percent increase in the discount rate would increase net income and decrease the accrued pension liability by approximately $0.9 million and $59.4 million, respectively. A one percent decrease in the discount rate would decrease net income and increase the accrued pension liability by approximately $0.6 million and $68.0 million, respectively. A one percent change in the expected long-term rate of return would affect net income by approximately $3.5 million.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Item 7A. Quantitative and Qualitative Disclosures about Market Risk**

We are exposed to market risk primarily related to interest rates, foreign exchange, and credit risk. It is our policy to monitor these exposures, and to use derivative financial investments from time to time to reduce fluctuations in earnings and cash flows when it is deemed appropriate to do so. We do not use derivative financial instruments for trading or speculative purposes.

Interest Rates:

From time to time, we may use interest rate swaps, collars, or options to manage our exposure to fluctuations in interest rates. It is management's intention that the notional amount of interest rate swaps be less than the variable rate loans outstanding during the life of the derivatives.

The information set forth in <u>[Note 15](#i86fd38c47ecb4620b3fd1cbefd041910_2578)</u>, "Derivative Instruments and Hedging Activities," of the Notes to Consolidated Financial Statements under the caption "Interest Rate Contracts," is incorporated herein by reference.

On an annual basis, a hypothetical 1% change in interest rates for the $383.7 million of unhedged variable rate debt as of April 30, 2026, would affect net income and cash flow by approximately $2.9 million.

Foreign Exchange Rates:

Fluctuations in the currencies of countries where we operate outside the US may have a significant impact on financial results. We are primarily exposed to movements in British pound sterling, euros, Canadian and Australian dollars, and certain currencies in Asia. The statements of financial position of non-US business units are translated into US dollars using period-end exchange rates for assets and liabilities and the Statements of Income (Loss) are translated into US dollars using weighted-average exchange rates for revenues and expenses. The percentage of consolidated revenue for the year ended April 30, 2026, recognized in the following currencies (on an equivalent US dollar basis) were approximately: 51% US dollar, 29% British pound sterling, 12% euro, and 8% other currencies.

Our significant investments in non-US businesses are exposed to foreign currency risk. Adjustments resulting from translating assets and liabilities are reported as a separate component of Total accumulated other comprehensive loss, net of tax within Total shareholders' equity under the caption Foreign currency translation adjustment. During the year ended April 30, 2026, we recorded foreign currency translation gains in Total accumulated other comprehensive loss, net of tax of approximately $15.8 million primarily as a result of the fluctuations of the US dollar relative to the British pound sterling and, to a lesser extent, the euro. During the year ended April 30, 2025, we recorded foreign currency translation gains in Total accumulated other comprehensive loss, net of tax of approximately $69.3 million primarily as a result of the fluctuations of the US dollar relative to the British pound sterling and, to a lesser extent, the euro. During the year ended April 30, 2024, we recorded foreign currency translation (losses) in Total accumulated other comprehensive loss, net of tax of approximately $(7.5) million, primarily as a result of the fluctuations of the US dollar relative to the euro and, to a lesser extent, the British pound sterling.

Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses on the Consolidated Statements of Income (Loss) as incurred. Under certain circumstances, we may enter into derivative financial instruments in the form of foreign currency forward contracts to hedge against specific transactions, including intercompany purchases and loans.

The information set forth in <u>[Note 15](#i86fd38c47ecb4620b3fd1cbefd041910_2578)</u>, "Derivative Instruments and Hedging Activities," of the Notes to Consolidated Financial Statements under the caption "Foreign Currency Contracts," is incorporated herein by reference.

Customer Credit Risk:

In the journal publishing business, some subscriptions are sourced through journal subscription agents who, acting as agents for library customers, facilitate ordering by consolidating the subscription orders/billings of each subscriber with various publishers. Cash is generally collected in advance from subscribers by the subscription agents and is principally remitted to us between the months of December and April. Although currently we have minimal credit risk exposure to these agents, future calendar-year subscription receipts from these agents are highly dependent on their financial condition and liquidity. Subscription agents account for approximately 19% of total annual consolidated revenue, and no one agent accounts for more than 10% of total annual consolidated revenue.

Our book business is not dependent upon a single customer; however, the industry is concentrated in national, regional, and online book resellers. Although no book customer accounts for more than 6% of total consolidated revenue and 7% of accounts receivable, net at April 30, 2026, the top 10 book customers account for approximately 12% of total consolidated revenue and approximately 20% of accounts receivable, net at April 30, 2026.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Item 8. Financial Statements and Supplementary Data**

The following Consolidated Financial Statements and Notes are filed as part of this report.

**John Wiley & Sons, Inc. and Subsidiaries**

---

| | | |
|:---|:---|:---|
| <u>[Report](#i4999d179a1ee4db3afe68151d34a8db6_79)[of Independent Registered Public Accounting Firm](#i4999d179a1ee4db3afe68151d34a8db6_79)</u> (PCAOB ID 238) | <u>[Report](#i4999d179a1ee4db3afe68151d34a8db6_79)[of Independent Registered Public Accounting Firm](#i4999d179a1ee4db3afe68151d34a8db6_79)</u> (PCAOB ID 238) |  |
| [Financial Statements](#i4999d179a1ee4db3afe68151d34a8db6_82) | [Financial Statements](#i4999d179a1ee4db3afe68151d34a8db6_82) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Financial Position](#i5621e0aa3dba4ad6b9f1d1397827b6d1_166)</u> as of April 30, 2026 and 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Financial Position](#i5621e0aa3dba4ad6b9f1d1397827b6d1_166)</u> as of April 30, 2026 and 2025 | [52](#i4999d179a1ee4db3afe68151d34a8db6_85) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Income (Loss)](#i4999d179a1ee4db3afe68151d34a8db6_88)</u> [for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_88)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Income (Loss)](#i4999d179a1ee4db3afe68151d34a8db6_88)</u> [for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_88)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | [53](#i4999d179a1ee4db3afe68151d34a8db6_88) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Comprehensive Income (Loss)](#i4999d179a1ee4db3afe68151d34a8db6_91)</u> [for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_91)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Comprehensive Income (Loss)](#i4999d179a1ee4db3afe68151d34a8db6_91)</u> [for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_91)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | [54](#i4999d179a1ee4db3afe68151d34a8db6_91) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Cash Flows](#i4999d179a1ee4db3afe68151d34a8db6_94)</u>[for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_94)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Cash Flows](#i4999d179a1ee4db3afe68151d34a8db6_94)</u>[for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_94)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | [55](#i4999d179a1ee4db3afe68151d34a8db6_94) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Shareholders' Equity](#i4999d179a1ee4db3afe68151d34a8db6_97)</u>[for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_97)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Shareholders' Equity](#i4999d179a1ee4db3afe68151d34a8db6_97)</u>[for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_97)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | [56](#i4999d179a1ee4db3afe68151d34a8db6_97) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Notes to Consolidated Financial Statements](#i4999d179a1ee4db3afe68151d34a8db6_100) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Notes to Consolidated Financial Statements](#i4999d179a1ee4db3afe68151d34a8db6_100) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 1.](#i4999d179a1ee4db3afe68151d34a8db6_103)</u> | [Description of Business](#i4999d179a1ee4db3afe68151d34a8db6_103) | [57](#i4999d179a1ee4db3afe68151d34a8db6_103) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 2.](#i4999d179a1ee4db3afe68151d34a8db6_106)</u> | [Summary of Significant Accounting Policies, Recently Issued and Recently Adopted Accounting Standards](#i4999d179a1ee4db3afe68151d34a8db6_106) | [57](#i4999d179a1ee4db3afe68151d34a8db6_106) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 3.](#i4999d179a1ee4db3afe68151d34a8db6_109)</u> | [Revenue Recognition, Contracts with Customers](#i4999d179a1ee4db3afe68151d34a8db6_109) | [65](#i4999d179a1ee4db3afe68151d34a8db6_109) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 4.](#i4999d179a1ee4db3afe68151d34a8db6_115)</u> | [Acquisition](#i4999d179a1ee4db3afe68151d34a8db6_115) and Divestitures | [70](#i4999d179a1ee4db3afe68151d34a8db6_115) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 5.](#i4999d179a1ee4db3afe68151d34a8db6_118)</u> | [Reconciliation of Weighted Average Shares Outstanding](#i4999d179a1ee4db3afe68151d34a8db6_118) | [72](#i4999d179a1ee4db3afe68151d34a8db6_118) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 6.](#i4999d179a1ee4db3afe68151d34a8db6_121)</u> | [Accumulated Other Comprehensive Loss](#i4999d179a1ee4db3afe68151d34a8db6_121) | [73](#i4999d179a1ee4db3afe68151d34a8db6_121) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 7.](#i4999d179a1ee4db3afe68151d34a8db6_124)</u> | Restructuring and Related Charges | [74](#i4999d179a1ee4db3afe68151d34a8db6_124) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 8.](#i4999d179a1ee4db3afe68151d34a8db6_127)</u> | [Inventories](#i4999d179a1ee4db3afe68151d34a8db6_127) | [76](#i4999d179a1ee4db3afe68151d34a8db6_127) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 9.](#i4999d179a1ee4db3afe68151d34a8db6_130)</u> | [Product Development Assets](#i4999d179a1ee4db3afe68151d34a8db6_130) | [76](#i4999d179a1ee4db3afe68151d34a8db6_130) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 10.](#i4999d179a1ee4db3afe68151d34a8db6_133)</u> | [Technology, Property, and Equipment](#i4999d179a1ee4db3afe68151d34a8db6_133) | [77](#i4999d179a1ee4db3afe68151d34a8db6_133) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 11.](#i4999d179a1ee4db3afe68151d34a8db6_136)</u> | [Goodwill and Intangible Assets](#i4999d179a1ee4db3afe68151d34a8db6_136) | [78](#i4999d179a1ee4db3afe68151d34a8db6_136) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 12.](#i4999d179a1ee4db3afe68151d34a8db6_139)</u> | [Operating Leases](#i4999d179a1ee4db3afe68151d34a8db6_139) | [81](#i4999d179a1ee4db3afe68151d34a8db6_139) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 13.](#i4999d179a1ee4db3afe68151d34a8db6_142)</u> | [Income Taxes](#i4999d179a1ee4db3afe68151d34a8db6_142) | [82](#i4999d179a1ee4db3afe68151d34a8db6_142) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 14.](#i4999d179a1ee4db3afe68151d34a8db6_145)</u> | [Debt and Available Credit Facilities](#i4999d179a1ee4db3afe68151d34a8db6_145) | [87](#i4999d179a1ee4db3afe68151d34a8db6_145) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 15.](#i4999d179a1ee4db3afe68151d34a8db6_148)</u> | [Derivative Instruments and](#i4999d179a1ee4db3afe68151d34a8db6_148)[He](#i4999d179a1ee4db3afe68151d34a8db6_148)[dging](#i4999d179a1ee4db3afe68151d34a8db6_148)[Activities](#i4999d179a1ee4db3afe68151d34a8db6_148) | [89](#i4999d179a1ee4db3afe68151d34a8db6_148) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 16.](#i4999d179a1ee4db3afe68151d34a8db6_151)</u> | [Commitment and Contingencies](#i4999d179a1ee4db3afe68151d34a8db6_151) | [90](#i4999d179a1ee4db3afe68151d34a8db6_151) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 17.](#i4999d179a1ee4db3afe68151d34a8db6_154)</u> | [Retirement Plans](#i4999d179a1ee4db3afe68151d34a8db6_154) | [91](#i4999d179a1ee4db3afe68151d34a8db6_154) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 18.](#i4999d179a1ee4db3afe68151d34a8db6_157)</u> | [Stock-Based Compensation](#i4999d179a1ee4db3afe68151d34a8db6_157) | [96](#i4999d179a1ee4db3afe68151d34a8db6_157) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 19.](#i4999d179a1ee4db3afe68151d34a8db6_160)</u> | [Capital Stock and Changes in Capital Accounts](#i4999d179a1ee4db3afe68151d34a8db6_160) | [99](#i4999d179a1ee4db3afe68151d34a8db6_160) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 20.](#i4999d179a1ee4db3afe68151d34a8db6_166)</u> | [Segment Information](#i4999d179a1ee4db3afe68151d34a8db6_166) | [101](#i4999d179a1ee4db3afe68151d34a8db6_166) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 2](#i4999d179a1ee4db3afe68151d34a8db6_541)[1](#i4999d179a1ee4db3afe68151d34a8db6_541)[.](#i4999d179a1ee4db3afe68151d34a8db6_541)</u> | [Subsequent Event](#i4999d179a1ee4db3afe68151d34a8db6_541) | [104](#i4999d179a1ee4db3afe68151d34a8db6_541) |
| [Financial Statement Schedule](#i4999d179a1ee4db3afe68151d34a8db6_202) | [Financial Statement Schedule](#i4999d179a1ee4db3afe68151d34a8db6_202) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Schedule II](#i4999d179a1ee4db3afe68151d34a8db6_208)</u>[– Valuation and Qualifying Accounts for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_208)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Schedule II](#i4999d179a1ee4db3afe68151d34a8db6_208)</u>[– Valuation and Qualifying Accounts for the years ended](#i4999d179a1ee4db3afe68151d34a8db6_208)April 30, 2026, 2025[, and](#i4999d179a1ee4db3afe68151d34a8db6_88)2024 | [116](#i4999d179a1ee4db3afe68151d34a8db6_208) |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Report of Independent Registered Public Accounting Firm** 

To the Board of Directors and Shareholders of John Wiley & Sons, Inc.

***Opinions on the Financial Statements and Internal Control over Financial Reporting***

We have audited the accompanying consolidated statements of financial position of John Wiley & Sons, Inc. and its subsidiaries (the "Company") as of April 30, 2026 and 2025, and the related consolidated statements of income (loss), of comprehensive income (loss), of shareholders' equity and of cash flows for each of the three years in the period ended April 30, 2026, including the related notes and financial statement schedule listed in the accompanying index (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of April 30, 2026, based on criteria established in *Internal Control - Integrated Framework* (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of April 30, 2026 and 2025, and the results of its operations and its cash flows for each of the three years in the period ended April 30, 2026 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of April 30, 2026, based on criteria established in *Internal Control - Integrated Framework* (2013) issued by the COSO.

***Basis for Opinions***

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company's consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

***Definition and Limitations of Internal Control over Financial Reporting***

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

***Critical Audit Matters***

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

*Revenue Recognition - Research Subscriptions Revenue*

As described in Note 3 to the consolidated financial statements, the Company recorded $965.8 million of research publishing revenue for the year ended April 30, 2026, of which a majority relates to research subscriptions. The majority of research publishing revenue is recognized over time. Journal subscription contracts are negotiated by the Company directly with customers or their subscription agents. Subscription periods typically cover calendar years. In a typical journal subscription sale, there is a written agreement between the Company and the customer that covers multiple years. However, management typically accounts for these agreements as one-year contracts because the enforceable rights under the agreements are subject to an annual confirmation and negotiation process with the customer. The transaction price consists of fixed consideration. Journal subscription revenue is generally collected in advance when the annual license is granted. Transformational agreements (read and publish) blend journal subscription and open access offerings. Generally, for a single fee, a national or regional consortium of libraries pays for and receives full read access to the Company's journal portfolio and the ability to publish under an open access arrangement.

The principal considerations for our determination that performing procedures relating to revenue recognition for the research subscriptions revenue is a critical audit matter are a high degree of auditor effort in performing procedures and evaluating audit evidence related to the Company's revenue recognition.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the revenue recognition process, including controls over research subscriptions revenue recognized. These procedures also included, among others (i) testing revenue recognized for a sample of research subscription revenue transactions by obtaining and inspecting source documents, such as sales contracts, invoices, and cash receipts and (ii) confirming a sample of outstanding customer invoice balances as of April 30, 2026 and, for confirmations not returned, obtaining and inspecting source documents, such as sales contracts, invoices, and subsequent cash receipts.

/s/ PricewaterhouseCoopers LLP

New York, New York

June 24, 2026

We have served as the Company's auditor since 2023.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**John Wiley & Sons, Inc. and Subsidiaries**

**CONSOLIDATED STATEMENTS OF FINANCIAL POSITION**

**In thousands**

---

| | | |
|:---|:---|:---|
| | **April 30,** | **April 30,** |
| | **2026** | **2025** |
| **Assets:** |  |  |
| &nbsp;&nbsp;Current assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $75622 | $85882 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 244164 | 228410 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 19265 | 22875 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 80614 | 102717 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 419665 | 439884 |
| Technology, property, and equipment, net | 136260 | 162125 |
| Intangible assets, net | 578959 | 595044 |
| Goodwill | 1132392 | 1121505 |
| Operating lease right-of-use assets | 57128 | 66128 |
| Other non-current assets | 267414 | 306780 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2591818 | $2691466 |
| **Liabilities and shareholders' equity:** |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $67199 | $60948 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued royalties | 97791 | 109765 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term portion of long-term debt | 12500 | 10000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities | 451423 | 462693 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued employment costs | 71068 | 93117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term portion of operating lease liabilities | 15954 | 18282 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued liabilities | 63012 | 66051 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 778947 | 820856 |
| Long-term debt | 670897 | 789435 |
| Accrued pension liability | 59527 | 71899 |
| Deferred income tax liabilities | 98972 | 105145 |
| Operating lease liabilities | 69544 | 81482 |
| Other long-term liabilities | 65689 | 70443 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1743576 | 1939260 |
| Commitment and contingencies (<u>[Note 1](#i4999d179a1ee4db3afe68151d34a8db6_151)[6](#i4999d179a1ee4db3afe68151d34a8db6_151)</u>) |  |  |
| Shareholders' equity |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, $1 par value per share: Authorized shares – 2 million, Issued shares - 0 |  |  |
| &nbsp;&nbsp;Class A common stock, $1 par value per share: Authorized shares - 180 million, Issued shares - 70,314 and 70,312 as of April 30, 2026 and 2025, respectively | 70314 | 70312 |
| &nbsp;&nbsp;Class B convertible common stock, $1 par value per share: Authorized shares - 72 million, Issued shares - 12,868 and 12,870 as of April 30, 2026 and 2025, respectively | 12868 | 12870 |
| &nbsp;&nbsp;&nbsp;Additional paid-in-capital | 487178 | 481863 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 1738164 | 1591168 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | (248720) | (264548) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unamortized retirement costs, net of tax | (190326) | (209190) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on interest rate swaps, net of tax | (3172) | (5182) |
| &nbsp;&nbsp;&nbsp;Total accumulated other comprehensive loss, net of tax | (442218) | (478920) |
| &nbsp;&nbsp;Less treasury shares at cost (Class A – 28,219 and 25,687 as of April 30, 2026 and 2025, respectively; Class B – 4,108 and 4,101 as of April 30, 2026 and 2025, respectively) | (1018064) | (925087) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 848242 | 752206 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $2591818 | $2691466 |

---

See accompanying Notes to Consolidated Financial Statements.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**John Wiley & Sons, Inc. and Subsidiaries**

**CONSOLIDATED STATEMENTS OF INCOME (LOSS)**

**Dollars in thousands, except per share information**

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Revenue, net | $1676528 | $1677609 | $1872987 |
| Costs and expenses |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 431509 | 431380 | 579722 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating and administrative expenses | 895907 | 947437 | 1013520 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of goodwill |  |  | 108449 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and related charges | 19203 | 25561 | 63041 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 53050 | 51822 | 55994 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total costs and expenses | 1399669 | 1456200 | 1820726 |
| Operating income | 276859 | 221409 | 52261 |
| Interest expense | (43848) | (52547) | (49003) |
| Net foreign exchange transaction losses | (6564) | (8142) | (2959) |
| Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | (4828) | (23340) | (183389) |
| Other (expense) income, net | (6533) | 5498 | (3957) |
| Income (loss) before taxes | 215086 | 142878 | (187047) |
| (Benefit) provision for income taxes | (6531) | 58717 | 13272 |
| Net income (loss) | $221617 | $84161 | $(200319) |
| Earnings (loss) per share: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $4.22 | $1.56 | $(3.65) |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $4.16 | $1.53 | $(3.65) |
| Weighted average number of common shares outstanding: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 52466 | 54054 | 54945 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 53247 | 54830 | 54945 |

---

See accompanying Notes to Consolidated Financial Statements.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**John Wiley & Sons, Inc. and Subsidiaries**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)**

**Dollars in thousands**

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Net income (loss) | $221617 | $84161 | $(200319) |
| Other comprehensive income (loss): |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | 15828 | 69279 | (7481) |
| &nbsp;&nbsp;Unamortized retirement costs, net of tax (expense) benefit of $(6449), $552, and $(2010), respectively | 18864 | (8268) | 5884 |
| &nbsp;&nbsp;Unrealized gain (loss) on interest rate swaps, net of tax (expense) benefit of $(614), $1,450, and $(663), respectively | 2010 | (11492) | 2060 |
| Total other comprehensive income | 36702 | 49519 | 463 |
| Comprehensive income (loss) | $258319 | $133680 | $(199856) |

---

See accompanying Notes to Consolidated Financial Statements.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**John Wiley & Sons, Inc. and Subsidiaries**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**Dollars in thousands**

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| **Operating activities** |  |  |  |
| Net income (loss) | $221617 | $84161 | $(200319) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Impairment of goodwill |  |  | 108449 |
| &nbsp;&nbsp;&nbsp;Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | 4828 | 23340 | 183389 |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 53050 | 51822 | 55994 |
| &nbsp;&nbsp;&nbsp;Amortization of product development assets | 16058 | 16610 | 22835 |
| &nbsp;&nbsp;&nbsp;Amortization of cloud computing arrangements | 2770 | 1081 | 1210 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization of technology, property, and equipment | 74369 | 78694 | 98160 |
| &nbsp;&nbsp;&nbsp;Restructuring and related charges | 19203 | 25561 | 63041 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation expense | 20608 | 22222 | 24982 |
| &nbsp;&nbsp;&nbsp;Employee retirement plan expense | 31976 | 31987 | 27844 |
| &nbsp;&nbsp;&nbsp;Net foreign exchange transaction losses | 6564 | 8142 | 2959 |
| &nbsp;&nbsp;&nbsp;Other noncash (credits) charges | (54616) | 13896 | (12319) |
| Changes in operating assets and liabilities |  |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | (19878) | 7951 | (22062) |
| &nbsp;&nbsp;&nbsp;Inventories, net | 6719 | (1419) | 5436 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued royalties | (12547) | 8112 | (38460) |
| &nbsp;&nbsp;&nbsp;Contract liabilities | (3576) | (20009) | (1332) |
| &nbsp;&nbsp;&nbsp;Restructuring payments | (17704) | (22333) | (38520) |
| &nbsp;&nbsp;&nbsp;Other accrued liabilities | (26861) | (19929) | 19274 |
| &nbsp;&nbsp;&nbsp;Employee retirement plan contributions | (26243) | (38746) | (36887) |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | (22704) | (22209) | (25852) |
| &nbsp;&nbsp;&nbsp;Other | (13114) | (46343) | (30184) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 260519 | 202591 | 207638 |
| **Investing activities** |  |  |  |
| &nbsp;&nbsp;&nbsp;Product development spending | (14012) | (15228) | (17262) |
| &nbsp;&nbsp;&nbsp;Additions to technology, property and equipment | (51166) | (61473) | (76080) |
| &nbsp;&nbsp;&nbsp;Businesses acquired in purchase transactions, net of cash acquired | (243) | (3602) | (3116) |
| &nbsp;&nbsp;&nbsp;Net cash proceeds (transferred) related to the sale of businesses and assets | 112194 | (7642) | (1771) |
| &nbsp;&nbsp;&nbsp;Acquisitions of publication rights and other | (18668) | (6073) | (8414) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) investing activities | 28105 | (94018) | (106643) |
| **Financing activities** |  |  |  |
| &nbsp;&nbsp;&nbsp;Repayments of long-term debt | (1085548) | (1186371) | (1156939) |
| &nbsp;&nbsp;&nbsp;Borrowings of long-term debt | 965251 | 1199880 | 1184706 |
| &nbsp;&nbsp;&nbsp;Purchases of treasury shares | (100082) | (60421) | (45050) |
| &nbsp;&nbsp;&nbsp;Change in book overdrafts | 4427 | 4650 | (4472) |
| &nbsp;&nbsp;&nbsp;Cash dividends | (74358) | (76101) | (76964) |
| &nbsp;&nbsp;&nbsp;Impact of tax withholding on stock-based compensation and other | (7993) | (6967) | (8502) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (298303) | (125330) | (107221) |
| **Effects of exchange rate changes on cash, cash equivalents, and restricted cash** | (581) | 3146 | (1493) |
| ***Cash reconciliation:*** |  |  |  |
| Cash and cash equivalents | 85882 | 99441 | 106714 |
| Restricted cash included in Prepaid expenses and other current assets | 50 | 102 | 548 |
| &nbsp;&nbsp;&nbsp;**Balance at beginning of year** | 85932 | 99543 | 107262 |
| &nbsp;&nbsp;&nbsp;**Decrease for the year** | (10260) | (13611) | (7719) |
| Cash and cash equivalents | 75622 | 85882 | 99441 |
| Restricted cash included in Prepaid expenses and other current assets | 50 | 50 | 102 |
| &nbsp;&nbsp;&nbsp;**Balance at end of year**<sup>(1)</sup> | $75672 | $85932 | $99543 |
| Cash paid during the year for: |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest | $43073 | $51328 | $47101 |
| &nbsp;&nbsp;&nbsp;Income taxes, net of refunds | $58424 | $53884 | $50834 |

---

(1) The balance as of April 30, 2024, includes held-for-sale cash, cash equivalents and restricted cash.

See accompanying Notes to Consolidated Financial Statements.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**John Wiley & Sons, Inc. and Subsidiaries**

**CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**

**Dollars in thousands**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A common stock** | **Class B common stock** | **Additional<br>paid-in capital** | **Retained<br>earnings** | **Accumulated other comprehensive loss, net of tax** | **Treasury stock** | **Total<br>shareholders' equity** |
| Balance at April 30, 2023 | $70231 | $12951 | $469802 | $1860872 | $(528902) | $(839927) | $1045027 |
| Restricted shares issued under stock-based compensation plans |  |  | (20392) | 1 |  | 20698 | 307 |
| Impact of tax withholding on stock-based compensation and other |  |  |  |  |  | (8502) | (8502) |
| Stock-based compensation expense |  |  | 24996 |  |  |  | 24996 |
| Purchases of treasury shares |  |  |  |  |  | (45050) | (45050) |
| Class A common stock dividends ($1.40 per share) |  |  |  | (64584) |  |  | (64584) |
| Class B common stock dividends ($1.40 per share) |  |  |  | (12622) |  |  | (12622) |
| Common stock class conversions | 28 | (28) |  |  |  |  |  |
| Comprehensive loss, net of tax |  |  |  | (200319) | 463 |  | (199856) |
| Balance at April 30, 2024 | $70259 | $12923 | $474406 | $1583348 | $(528439) | $(872781) | $739716 |
| Restricted shares issued under stock-based compensation plans |  |  | (14792) |  |  | 15082 | 290 |
| Impact of tax withholding on stock-based compensation and other |  |  |  |  |  | (6967) | (6967) |
| Stock-based compensation expense |  |  | 22249 |  |  |  | 22249 |
| Purchases of treasury shares |  |  |  |  |  | (60421) | (60421) |
| Class A common stock dividends ($1.41 per share) |  |  |  | (63758) |  |  | (63758) |
| Class B common stock dividends ($1.41 per share) |  |  |  | (12583) |  |  | (12583) |
| Common stock class conversions | 53 | (53) |  |  |  |  |  |
| Comprehensive income, net of tax |  |  |  | 84161 | 49519 |  | 133680 |
| Balance at April 30, 2025 | $70312 | $12870 | $481863 | $1591168 | $(478920) | $(925087) | $752206 |
| Restricted shares issued under stock-based compensation plans |  |  | (15267) |  |  | 15532 | 265 |
| Impact of tax withholding on stock-based compensation and other |  |  |  |  |  | (7993) | (7993) |
| Stock-based compensation expense |  |  | 20582 |  |  |  | 20582 |
| Purchases of treasury shares |  |  |  |  |  | (100516) | (100516) |
| Class A common stock dividends ($1.42 per share) |  |  |  | (62175) |  |  | (62175) |
| Class B common stock dividends ($1.42 per share) |  |  |  | (12446) |  |  | (12446) |
| Common stock class conversions | 2 | (2) |  |  |  |  |  |
| Comprehensive income, net of tax |  |  |  | 221617 | 36702 |  | 258319 |
| Balance at April 30, 2026 | $70314 | $12868 | $487178 | $1738164 | $(442218) | $(1018064) | $848242 |

---

See accompanying Notes to Consolidated Financial Statements.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**John Wiley & Sons, Inc. and Subsidiaries**

**Notes to Consolidated Financial Statements**

**Note 1 – Description of Business**

The Company, founded in 1807, was incorporated in the state of New York on January 15, 1904. Throughout this report, when we refer to "Wiley," the "Company," "we," "our," or "us," we are referring to John Wiley & Sons, Inc. and all our subsidiaries, except where the context indicates otherwise.

Wiley is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. The Company's content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including institutions, societies, corporations, researchers, students, instructors, and other professionals.

We report financial information in three reportable segments which include Research, Learning, and Held for Sale or Sold, as well as a Corporate expense category. Through the Research segment, we provide peer-reviewed scientific, technical, and medical (STM) journals, content platforms, and related publishing and audience solutions to academic, corporate, and government customers, academic societies, and individual researchers. The Learning segment provides scientific, professional, and education print and digital books to researchers, professionals, and students, digital courseware for instructors and students and assessment services to businesses and professionals. The Held for Sale or Sold segment primarily consists of non-core businesses which were classified as held-for-sale until the date of sale, as well as other businesses which were sold.

**Note 2 – Summary of Significant Accounting Policies, Recently Issued and Recently Adopted Accounting Standards**

***Summary of Significant Accounting Policies***

*Basis of Presentation:*

Our Consolidated Financial Statements include all the accounts of the Company and our subsidiaries. We have eliminated all intercompany transactions and balances in consolidation. All amounts are presented in United States (US) dollars, unless otherwise specified. All amounts are in thousands, except per share amounts, and are approximate due to rounding.

*Reclassifications:*

Certain prior year amounts have been reclassified to conform to the current year's presentation, including the recast of prior period geographic revenue information resulting from a change in our method of attributing revenue by geography. <u>[See Note 20](#i5c161295392b452192e95513acc36dba_2292)</u>, "Segment Information," for additional information.

*Use of Estimates:*

The preparation of our Consolidated Financial Statements and related disclosures in conformity with Generally Accepted Accounting Principles in the United States of America (US GAAP) requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and revenue and expenses during the reporting period. These estimates include, among other items, sales return reserves, allocation of acquisition purchase price to assets acquired and liabilities assumed, assets and liabilities held-for-sale, goodwill and indefinite-lived intangible assets, intangible assets with definite lives and other long-lived assets, and retirement plans. We review these estimates and assumptions periodically using historical experience and other factors and reflect the effects of any revisions on the Consolidated Financial Statements in the period we determine any revisions to be necessary. Actual results could differ from those estimates, which could affect the reported results.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Book Overdrafts:*

Under our cash management system, a book overdraft balance exists for our primary disbursement accounts. This overdraft represents uncleared checks in excess of cash balances in individual bank accounts. Our funds are transferred from other existing bank account balances or from lines of credit as needed to fund checks presented for payment. As of April 30, 2026 and 2025, book overdrafts of $19.2 million and $14.8 million, respectively, were included in Accounts payable on the Consolidated Statements of Financial Position. We elected to classify changes in book overdraft balances as financing activities in the Consolidated Statements of Cash Flows.

*Revenue Recognition:*

Revenue from contracts with customers is recognized using a five-step model consisting of the following: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract based on its stand-alone selling price. We use an observable price to determine the stand-alone selling price for separate performance obligations if available or, when not available, an estimate that maximizes the use of observable inputs and faithfully depicts the selling price of the promised goods or services if we sold those goods or services separately to a similar customer in similar circumstances. Suitable methods for estimating the stand-alone selling price include adjusted market assessment approach, expected cost plus a margin approach, and the residual approach. Any contract discount within the agreement is allocated across all performance obligations unless observable evidence exists that the discount relates to a specific performance obligation or obligations in the contract, and (5) recognize revenue when (or as) we satisfy a performance obligation. Performance obligations are satisfied when we transfer control of a good or service to a customer, which can occur over time or at a point in time. The amount of revenue recognized is based on the consideration to which we expect to be entitled in exchange for those goods or services, including the expected value of variable consideration. The customer's ability and intent to pay the transaction price is assessed in determining whether a contract exists with the customer. If collectability of substantially all the consideration in a contract is not probable, consideration received is not recognized as revenue unless the consideration is nonrefundable, and we no longer have an obligation to transfer additional goods or services to the customer, or collectability becomes probable.

<u>[See Note 3](#i07367b72690a4395824ae69fddb9e9fe_18015)</u>, "Revenue Recognition, Contracts with Customers," for further details of our revenue recognition policy.

*Cash and Cash Equivalents:*

Cash and cash equivalents consist of highly liquid investments with an original maturity of three months or less at the time of purchase and are stated at cost, which approximates market value, because of the short-term maturity of the instruments.

*Allowance for Credit Losses:*

We are exposed to credit losses through our accounts receivable with customers. Accounts receivable, net, is stated at amortized cost net of provision for credit losses. Our methodology to measure the provision for credit losses requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable, such as, delinquency trends, aging behavior of receivables, credit and liquidity indicators for industry groups, customer classes or individual customers, and reasonable and supportable forecasts of the economic and geopolitical conditions that may exist through the contractual life of the asset. Our provision for credit losses is reviewed and revised periodically. Our accounts receivable is evaluated on a pool basis that is based on customer groups with similar risk characteristics. This includes consideration of the following factors to develop these pools: size of the customer, industry, geographical location, historical risk, and types of services or products sold. We write off receivables only when deemed no longer collectible.

We are also exposed to potential credit losses through our notes receivable issued in connection with our divestitures. As of April 30, 2026 and 2025, notes receivable inclusive of interest are $15.2 million and $121.5 million, respectively, and are reflected in Other non-current assets in the Consolidated Statements of Financial Position. We evaluate the collectability of outstanding notes receivable and record an allowance to represent an estimate of future expected credit losses, as applicable. As of April 30, 2026 and 2025, we did not record an allowance on the notes receivable. On June 5, 2025, Wiley entered into an agreement to sell the University Services Seller Note and other assets. The cash consideration was also fully paid in June 2025. <u>[See Note 4](#i4999d179a1ee4db3afe68151d34a8db6_115)</u>, "Acquisition and Divestitures" for more details on the notes receivable issued in connection with our divestitures and the sale.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Sales Return Reserves:*

The process that we use to determine our sales returns and the related reserve provision charged against revenue is based on applying an estimated return rate to current year returnable print book sales. This rate is based upon an analysis of actual historical return experience in the various markets and geographic regions in which we do business. We collect, maintain, and analyze significant amounts of sales returns data for large volumes of homogeneous transactions. This allows us to make reasonable estimates of the amount of future returns. All available data is utilized to identify the returns by market and to which fiscal year the sales returns apply. This enables management to track the returns in detail and identify and react to trends occurring in the marketplace, with the objective of being able to make the most informed judgments possible in setting reserve rates. Associated with the estimated sales return reserves, we also include a related increase to inventory and a reduction to accrued royalties as a result of the expected returns. Print book sales return reserves amounted to a net liability balance of $7.1 million and $9.0 million as of April 30, 2026 and 2025, respectively.

The reserves are reflected in the following accounts of the Consolidated Statements of Financial Position as of April 30:

---

| | | |
|:---|:---|:---|
| | **2026** | **2025** |
| Increase in Inventories, net | $3085 | $4042 |
| Decrease in Accrued royalties | (1661) | (2067) |
| Increase in Contract liabilities | 11825 | 15093 |
| Print book sales return reserve net liability balance | $(7079) | $(8984) |

---

*Inventories:*

Inventories are carried at the lower of cost or net realizable value. US book inventories aggregating $8.3 million and $10.9 million at April 30, 2026 and 2025, respectively, are valued using the last-in, first-out (LIFO) method. All other inventories are valued using the first-in, first-out (FIFO) method.

*Product Development Assets:* 

Product development assets consist of book composition costs and other product development costs and are included in Other non-current assets on the Consolidated Statements of Financial Position. Costs associated with developing a book for publication are expensed until the product is determined to be commercially viable. Book composition costs represent the costs incurred to bring an edited commercial manuscript to publication, which include typesetting, proofreading, design, illustration costs, and digital formatting. Book composition costs are capitalized and are generally amortized on a double-declining basis over their estimated useful lives, ranging from 1 to 3 years. Other product development costs represent the costs incurred in developing software, platforms, and digital content to be sold and licensed to third parties. Other product development costs are capitalized and amortized on a straight-line basis over their estimated useful lives. As of April 30, 2026, the weighted average estimated useful life of other product development costs was approximately 3 years.

*Royalty Advances:*

Royalty advances are capitalized in Other non-current assets on the Consolidated Statements of Financial Position and, upon publication, are expensed as royalties earned based on sales of the published works. Royalty advances are reviewed for recoverability, and a reserve for loss is maintained, if appropriate.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Advertising and Marketing Costs:*

Advertising and marketing costs are expensed as incurred. These costs are reflected primarily in Operating and administrative expenses on the Consolidated Statements of Income (Loss) as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024**<sup>(1)</sup> |
| Advertising and marketing costs | $29250 | $31235 | $61709 |

---

(1) For the year ended April 30, 2024, this includes $28.8 million of advertising and marketing costs reflected in Cost of sales on the Consolidated Statements of Income (Loss), incurred to fulfill performance obligations from contracts with educational institutions. These costs were incurred by the University Services business, which was sold on January 1, 2024 and had been reported in our Held for Sale or Sold segment.

*Technology, Property, and Equipment:*

Technology, property, and equipment is recorded at cost, except for property and equipment that have been impaired, for which we reduce the carrying amount to the estimated fair value at the impairment date. Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.

Technology, property, and equipment is depreciated using the straight-line method based upon the following estimated useful lives: Computer Software – 3 to 10 years; Computer Hardware – 3 to 5 years; Buildings and Leasehold Improvements – the lesser of the estimated useful life of the asset up to 40 years or the duration of the lease; Furniture, Fixtures, and Warehouse Equipment – 5 to 10 years.

Costs incurred for computer software internally developed or obtained for internal use are capitalized during the application development stage and expensed as incurred during the preliminary project and post-implementation stages. Costs incurred during the application development stage include costs of materials, services, payroll, and payroll-related costs for employees who are directly associated with the software project. Maintenance, training, and upgrade costs that do not result in additional functionality are expensed as incurred.

*Cloud Computing Arrangements:*

We incur costs to implement cloud computing arrangements that are hosted by third parties. Costs incurred during the application development stage are capitalized if they consist of internal and external costs directly attributable to developing and configuring the cloud computing software for its intended use. Once a project is substantially complete and ready for its intended use, such costs are amortized using the straight-line method over the term of the cloud computing arrangement in Operating and administrative expenses on the Consolidated Statements of Income (Loss). As of April 30, 2026 and 2025, the unamortized implementation costs related to our cloud computing arrangements were $33.4 million and $24.0 million, respectively, and are reflected in Other non-current assets in our Consolidated Statements of Financial Position. Payments for capitalized implementation costs are included in Net cash provided by operating activities on the Consolidated Statements of Cash Flows.

*Allocation of Acquisition Purchase Price to Assets Acquired and Liabilities Assumed*:

In connection with acquisitions, we allocate the cost of the acquisition to the assets acquired and the liabilities assumed based on the estimates of fair value for such items, including intangible assets and technology acquired. The excess of the purchase consideration over the fair value of assets acquired and liabilities assumed is recorded as goodwill. The determination of the acquisition-date fair value of the assets acquired, and liabilities assumed, requires us to make significant estimates and assumptions, such as forecasted revenue growth rates and operating cash flows, royalty rates, customer attrition rates, obsolescence rates of developed technology, and discount rates. We may use a third-party valuation consultant to assist in the determination of such estimates.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Goodwill and Indefinite-lived Intangible Assets:*

Goodwill represents the excess of the aggregate of the following: (1) consideration transferred, (2) the fair value of any noncontrolling interest in the acquiree, and (3) if the business combination is achieved in stages, the acquisition-date fair value of our previously held equity interest in the acquiree over the net of the acquisition-date amounts of the identifiable assets acquired and the liabilities assumed.

Indefinite-lived intangible assets primarily consist of brands and trademarks, and publishing rights, and are typically characterized by intellectual property with a long and well-established revenue stream resulting from strong and well-established imprint/brand recognition in the market.

We use the acquisition method of accounting for all business combinations and do not amortize goodwill or intangible assets with indefinite useful lives. Goodwill and intangible assets with indefinite useful lives are tested for possible impairment annually during the fourth quarter of each fiscal year, or more frequently if events or changes in circumstances indicate that the asset might be impaired.

<u>[See Note 11](#i1c5b5abc6bc24bc48f5fae79ca9c6582_12469)</u>, "Goodwill and Intangible Assets" for further details of our policy.

*Intangible Assets with Definite Lives and Other Long-Lived Assets:*

Definite-lived intangible assets principally consist of content and publishing rights, customer relationships, developed technology, brands and trademarks, and covenants not to compete agreements, and are amortized over their estimated useful lives. The most significant factors in determining the estimated lives of these intangibles are the history and longevity, combined with the strength and pattern of projected cash flows.

Intangible assets with definite lives as of April 30, 2026 are amortized on a straight-line basis over the following weighted average estimated useful lives: content and publishing rights – 26 years, customer relationships – 16 years, developed technology – 8 years, and brands and trademarks – 17 years.

Assets with definite lives are evaluated for indicators of impairment upon a significant change in the operating or macroeconomic environment. When indicators of impairment are present, we test definite lived and long-lived assets for recoverability by comparing the carrying value of an asset group to an estimate of the future undiscounted cash flows expected to result from the use and eventual disposition of the asset group. In these circumstances, if an evaluation of the projected undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value based on the discounted future cash flows.

*Leases:*

We have operating leases with contractual obligations as a lessee with respect to offices, warehouses and distribution centers, automobiles, and office equipment. We determine if an arrangement is a lease at inception of the contract in accordance with guidance detailed in the lease standard and we perform the lease classification test as of the lease commencement date. Right-of-use (ROU) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term.

The present value of the lease payments is calculated using an incremental borrowing rate, which was determined based on the rate of interest that we would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. We use an unsecured borrowing rate and risk-adjust that rate to approximate a collateralized rate.

We recognize operating lease expense on a straight-line basis over the term of the lease. Lease payments may be fixed or variable. Only lease payments that are fixed, in-substance fixed or depend on a rate or index are included in determining the lease liability. Variable lease payments include payments made to the lessor for taxes, insurance and maintenance of the leased asset and are recognized as operating costs as incurred.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

We apply certain practical expedients allowed by the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 842, "Leases." Leases that are more than one year in duration are capitalized and recorded on our Consolidated Statements of Financial Position. Leases with an initial term of 12 months or less are recognized as short term lease operating costs on a straight-line basis over the term. We have also elected to account for the lease and non-lease components as a single component. Some of our leases offer an option to extend the term of such leases. We utilize the reasonably certain threshold criteria in determining which options we will exercise.

*Employee Benefit Plans:*

We provide various defined benefit plans to our employees. We use actuarial assumptions to calculate pension and benefit costs as well as pension assets and liabilities included in the consolidated financial statements. <u>[See Note 17](#ide19e66b47d645e79fca4e1d39593ec4_9347)</u>, "Retirement Plans" for further details of our policy.

*Income Taxes:*

Income taxes are recorded using the asset and liability method. Under this method, deferred income taxes are recognized for temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred taxes are measured using rates the Company expects to apply to taxable income in years in which those temporary differences are expected to reverse. The financial effect of changes in tax laws or rates is accounted for in the period of enactment. Future tax benefits are recognized to the extent that the realization of such benefits is more likely than not. Valuation allowances are established when management determines that it is more likely than not that some or all of a deferred tax asset will not be realized.

From time to time, the Company engages in transactions in which the tax consequences may be subject to uncertainty. Judgment is required in assessing and estimating the tax consequences of these transactions. The Company prepares and files tax returns based on its interpretation of tax laws and regulations. In the normal course of business, the Company's tax returns are subject to examination by various taxing authorities. Such examinations may result in future tax and interest assessments by these taxing authorities.

In determining the Company's tax provision for financial reporting purposes, the Company establishes a reserve for uncertain tax positions, unless such positions are determined to be more likely than not of being sustained upon examination based on their technical merits, including the resolution of any appeals or litigation processes. The Company includes interest and, where appropriate, penalties as a component of income tax expense. There is judgment involved in determining whether positions taken on the Company's tax returns are more likely than not of being sustained, which involve the use of estimates and assumptions with respect to the potential outcome of positions taken on tax returns that may be reviewed by tax authorities.

*Derivative Financial Instruments:*

From time to time, we enter into foreign exchange forward and interest rate swap contracts as a hedge against foreign currency asset and liability commitments, changes in interest rates, and anticipated transaction exposures, including intercompany purchases. All derivatives are recognized as assets or liabilities and measured at fair value. Derivatives that are not determined to be effective hedges are adjusted to fair value with a corresponding adjustment to earnings. We do not use financial instruments for trading or speculative purposes.

Derivative instruments that are designated as cash flow hedges have changes in their fair value recorded initially within Accumulated other comprehensive loss on the Consolidated Statements of Financial Position. As interest expense is recognized based on the variable rate loan agreements, the corresponding deferred gain or loss on the interest rate swaps is reclassified from Accumulated Other Comprehensive Loss to Interest Expense on the Consolidated Statements of Income (Loss). The interest settlement payments associated with the interest rate swap agreements are classified as cash flows from operating activities in the Consolidated Statements of Cash Flows.

For derivative instruments executed with the same counterparty under a master netting arrangement, we do not offset fair value amounts of interest rate swaps in liability positions with the ones in asset positions in the Consolidated Statements of Financial Position.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Foreign Currency Gains/Losses:*

We maintain operations in many non-US locations. Assets and liabilities are translated into US dollars using end-of-period exchange rates and revenues, and expenses are translated into US dollars using weighted average rates. Our significant investments in non-US businesses are exposed to foreign currency risk. Foreign currency translation adjustments are reported as a separate component of Accumulated Other Comprehensive Loss within Shareholders' Equity. Foreign currency transaction gains or losses are recognized on the Consolidated Statements of Income (Loss) as incurred.

*Stock-Based Compensation:*

We recognize stock-based compensation expense based on the fair value of the stock-based awards on the grant date, reduced by an estimate for future forfeited awards. As such, stock-based compensation expense is only recognized for those awards that are expected to ultimately vest. The fair value of stock-based awards is recognized in net income generally on a straight-line basis over the requisite service period. Stock-based compensation expense associated with performance-based stock awards is based on actual financial results for targets established up to three years in advance, or less. The cumulative effect on current and prior periods of a change in the estimated number of performance share awards, or estimated forfeiture rate, is recognized as an adjustment to earnings in the period of the revision. Judgment was also required in estimating the number of stock-based awards that may be forfeited. If actual results differ significantly from estimates, our stock-based compensation expense and Consolidated Statements of Income (Loss) could be impacted. We accelerate expense on performance-based awards using a graded vesting schedule for employees who meet retirement eligibility requirements prior to the end of the award's service period.

The grant date fair value for stock options is estimated using the Black-Scholes option-pricing model. The determination of the assumptions used in the Black-Scholes model include the expected life of an option, the expected volatility of our common stock over the estimated life of the option, a risk-free interest rate, and the expected dividend yield.

*Fair Value Measurement:*

The carrying value of financial assets and liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value at the end of every reporting period. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs.

In accordance with FASB ASC 820, "Fair Value Measurements and Disclosures" (ASC Topic 820), assets and liabilities subject to fair value measurement disclosures are classified according to the three-level fair value hierarchy with respect to the inputs used to determine fair value. The level in which an asset or liability is disclosed within the fair value hierarchy is based on the lowest level input that is significant to the related fair value measurement in its entirety. The levels of input are defined as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1:&nbsp;&nbsp;&nbsp;&nbsp;Quoted prices unadjusted for identical assets or liabilities in an active market.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2:&nbsp;&nbsp;&nbsp;&nbsp;Quoted prices for similar assets or liabilities in an active market, quoted prices for identical similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3:&nbsp;&nbsp;&nbsp;&nbsp;Unobservable inputs that reflect the entity's own assumptions which market participants would use in pricing the asset or liability.

***Recently Adopted Accounting Standards***

Improvements to Income Tax Disclosures

In December 2023, the FASB issued Accounting Standards Update (ASU) 2023-09, "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures." This ASU enhances the transparency and comparability of income tax disclosures by requiring consistent categories and greater disaggregation of information related to income tax rate reconciliations and the jurisdictions in which income taxes are paid. A public entity should apply the amendments in this ASU on a prospective basis with the option to apply the standard retrospectively. We elected to adopt ASU 2023-09 on a prospective basis for the year ended April 30, 2026. <u>[See Note 13](#if082921157e54be5bc1d60bc0359f2c8_4648)</u>, "Income Taxes" for further details. The adoption expanded our disclosures but did not have a material impact on our consolidated financial statements.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Recently Issued Accounting Standards***

Codification Improvements

In December 2025, the FASB issued ASU 2025-12 "Codification Improvements," to make various technical corrections, clarifications, and other minor improvements to existing US GAAP. The amendments are intended to improve the clarity and consistency of existing guidance and are not expected to significantly change current accounting practice. This ASU is effective for us on May 1, 2027 and interim periods within the fiscal year. Early adoption is permitted. We are required to apply the amendments to ASC Topic 260, "Earnings Per Share" retrospectively. All other amendments may be applied prospectively or retrospectively. We are currently assessing the impact of the disclosure requirements on our consolidated financial statements.

Interim Reporting Narrow-Scope Improvements

In December 2025, the FASB issued ASU 2025-11 "Interim Reporting (Topic 270): Narrow-Scope Improvements" to amend the guidance in "Interim Reporting" (Topic 270). This ASU provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. This ASU is effective for us on May 1, 2028 and interim periods within the fiscal year. Early adoption is permitted. We may elect to apply the ASU using a prospective or retrospective transition method. We are currently assessing the impact of the disclosure requirements on our consolidated financial statements.

Hedge Accounting Improvements

In November 2025, the FASB issued ASU 2025-09, "Derivatives and Hedging (Topic 815): Hedge Accounting Improvements." This ASU makes targeted amendments to expand the application of hedge accounting to a greater number of highly effective economic hedges in five areas: i) similar risk assessment for cash flow hedges; ii) hedging forecasted interest payments on choose-your-rate debt instruments; iii) cash flow hedges of nonfinancial forecasted transactions; iv) net written options as hedging instruments; and v) foreign-currency-denominated debt instrument as hedging instrument and hedged item (dual hedge). The ASU is intended to better reflect the economics of risk management activities and to reduce complexity in applying hedge accounting. This ASU is effective for us on May 1, 2027 and interim periods within the fiscal year. Early adoption is permitted. This ASU is applied prospectively for all hedging relationships as of the date of adoption. The impact will be based on future economic hedges after we adopt the standard.

Targeted Improvements to the Accounting for Internal-Use Software

In September 2025, the FASB issued ASU 2025-06, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." This ASU removes the references to software development stages and requires capitalization of software costs when management has committed to the software project and it is probable that the software will be completed and perform its intended use. This ASU is effective for us on May 1, 2028 and interim reporting periods within the fiscal year. Early adoption is permitted. We may elect to apply the ASU using a prospective, modified based on the status of the project and whether software costs were capitalized before the date of adoption, or retrospective transition method. We are currently evaluating the impact this ASU will have on our consolidated financial statements.

Measurement of Credit Losses for Accounts Receivable and Contract Assets

In July 2025, the FASB issued ASU 2025-05, "Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses for Accounts Receivable and Contract Assets." In developing reasonable and supportable forecasts as part of estimating expected credit losses on current accounts receivable and/or current contract assets, we may elect a practical expedient in accordance with this new ASU that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset.

This ASU is effective for us on May 1, 2026 and interim periods within the fiscal year. This ASU is applied prospectively if the practical expedient is elected. We have elected to adopt the practical expedient effective May 1, 2026. The adoption of this ASU is not expected to have a material impact on our consolidated financial statements.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), Disaggregation of Income Statement Expenses." In January 2025, the FASB clarified the effective date of this guidance with the issuance of ASU 2025-01, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date." This ASU requires disclosure about specific types of expenses included in expense captions, including purchases of inventory, employee compensation, depreciation, amortization, and depletion. This ASU is effective for our annual disclosures starting fiscal year 2028 and interim periods starting in fiscal year 2029. Early adoption is permitted. A public entity should apply the amendments in this ASU on a prospective basis with the option to apply the standard retrospectively. We are currently assessing the impact of the disclosure requirements on our consolidated financial statements.

**Note 3** — **Revenue Recognition, Contracts with Customers**

***Disaggregation of Revenue***

The following tables present our revenue from contracts with customers disaggregated by segment and product type.

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| **Research:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research Publishing | $965767 | $922553 | $892784 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research Solutions | 164175 | 152906 | 149921 |
| **Total Research** | 1129942 | 1075459 | 1042705 |
| **Learning:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Academic | 318757 | 333693 | 323541 |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional | 227829 | 251075 | 251198 |
| **Total Learning** | 546586 | 584768 | 574739 |
| **Held for Sale or Sold** |  | 17382 | 255543 |
| **Total Revenue** | $1676528 | $1677609 | $1872987 |

---

The following information describes our disaggregation of revenue by segment and product type. Overall, the majority of our revenue is recognized over time.

**Research** 

Total Research revenue was $1,129.9 million in the year ended April 30, 2026. Research products are sold and distributed globally through multiple channels. The majority of revenue generated from Research products is recognized over time.

We disaggregated revenue by Research Publishing and Research Solutions to reflect the different types of products and services provided.

<u>Research Publishing Products</u>

Research Publishing products provide scientific, technical, medical, and scholarly journals, as well as related content and services, to academic, corporate, and government libraries, learned societies, and individual researchers and other professionals. Research Publishing revenue was $965.8 million in the year ended April 30, 2026, and the majority is recognized over time.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

In the year ended April 30, 2026, Research Publishing products generated approximately 88% of its revenue from contracts with its customers from Journal Subscriptions (pay to read) and Transformational Agreements (read and publish) under multiyear arrangements, and Open Access (pay to publish). The remaining revenue is from Licensing and ancillary products.

*Journal Subscriptions and Transformational Models*

Journal Subscription contracts are negotiated by us directly with customers or their subscription agents. Subscription periods typically cover calendar years. In a typical Journal Subscription sale, there is a written agreement between us and our customer that covers multiple years. However, we typically account for these agreements as one-year contracts because our enforceable rights under the agreements are subject to an annual confirmation and negotiation process with the customer.

In Journal Subscriptions, there are generally two performance obligations: a functional intellectual property license with a stand-ready obligation to provide access to new content for one year, which includes online hosting of the content (collectively referred to as Read) which is recognized over time, and a functional intellectual property perpetual license for access to historical journal content (Perpetual License) which is recognized at the point in time when access to the historical content is initially granted. The transaction price consists of fixed consideration. Journal Subscription revenue is generally collected in advance when the annual license is granted.

The total transaction price is allocated to each performance obligation based on its relative stand-alone selling price. We allocate revenue to the stand-ready obligation to provide access to new content for one year based on its observable stand-alone selling price to provide the right of access to additional intellectual property. The allocation of revenue to the perpetual licenses for access to historical journal content is done using the expected cost plus a margin approach, as applicable.

Transformational Agreements (read and publish) blend Journal Subscription and Open Access offerings. Generally, for a single fee, a national or regional consortium of libraries pays for and receives full read access to our journal portfolio and the ability to publish under an open access arrangement. Transformational Agreements include multiple performance obligations and depending upon the model, can include a combination of Read which is recognized over time; a Perpetual License which is recognized at a point in time; and a publishing right that allows for articles to be published in hybrid and/or gold open access journals, which is recognized point in time or over time depending upon the model. The total transaction price is generally fixed and allocated to each performance obligation based on its relative stand-alone selling price using a combination of observable and estimated stand-alone selling prices. Estimated stand-alone selling prices include the expected cost plus a margin approach, and a residual approach.

*Open Access*

Under the open access business model, there is generally one performance obligation whereby accepted research articles are published and all open articles are immediately free to access online. The transaction price is fixed based on payment of an article publication charge (APC). Revenue is recognized at a point in time which is upon publication which is when Wiley's obligation is complete.

*Licensing and Ancillary Products* 

Within licensing, the revenue derived from these contracts primarily consist of advance payments, including minimum guarantees and sales- or usage-based royalty agreements. Our intellectual property is considered to be functional intellectual property. Due to the stand-ready obligation to provide updates during the subscription period, which is generally an annual period, revenue for the minimum guarantee is recognized on a straight-line basis over the term of the agreement. For our sales- or usage-based royalty agreements, we recognize revenue in the period of usage based on the amounts earned. We record revenue under these arrangements for the amounts due and not yet reported to us based on estimates of the sales or usage of these customers and pursuant to the terms of the contracts. We also have certain licenses whereby we receive a non-refundable minimum guarantee in advance (recorded over time as described above) against a volume-based royalty throughout the term of the agreement. When the cumulative consideration exceeds the minimum guarantee, it is recognized as the subsequent sales or usage occurs. We also license content for artificial intelligence (AI) generally at a fixed transaction price, with revenue recognized at a point in time or a combination of point in time and over time.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

<u>Research Solutions Products and Services</u>

Research Solutions revenue was $164.2 million in the year ended April 30, 2026, and the majority is recognized over time.

In the year ended April 30, 2026, Research Solutions products and services generated approximately 48% of their revenue from contracts with customers that include corporate solutions such as managed services which includes advertising, and full sales and marketing services for publishers and societies; recruitment platform and services; spectral databases; and projects which includes content creation and distribution, digital events, and webinars.

The remainder of the revenue within Research Solutions from contracts with customers includes platform and workflow solutions for societies and publishers, which includes production and content hosting, submissions and peer review support, editorial, and copy-editing services. We also license content, including for AI which includes content licensed from other publishers. Included within platforms is our Atypon® publishing platform for societies and publishers which includes a single performance obligation for the implementation and hosting of subscription services. The transaction price is fixed, which may include price escalators that are fixed increases per year. Revenue is recognized upon the initiation of the subscription period and recognized on a straight-line basis over the time of the contractual period. The duration of these contracts is generally multiyear ranging from 2 to 5 years.

**Learning**

Total Learning revenue was $546.6 million in the year ended April 30, 2026. We disaggregated revenue by Academic and Professional to reflect the different types of products and services provided.

<u>Academic</u>

Academic products revenue was $318.8 million in the year ended April 30, 2026. Products and services include scientific, professional, and education print and digital books, and digital courseware to libraries, corporations, students, professionals, and researchers. Products are developed for worldwide distribution through multiple channels, including chain and online booksellers, libraries, colleges and universities, corporations, direct to consumer, websites, distributor networks and other online applications.

In the year ended April 30, 2026, Academic products generated approximately 54% of their revenue from contracts with their customers for print and digital publishing, which is recognized at a point in time. Digital Courseware products generate approximately 35% of their revenue from contracts with their customers which is recognized over time. The remainder of their revenues were from Licensing, and ancillary products which have a mix of revenue recognized at a point in time and over time.

*Print and Digital Publishing* 

Our performance obligations as they relate to print and digital publishing are primarily book products delivered in both print and digital form which could include single or multiple performance obligations based on the number of print or digital books purchased. Each is represented by an International Standard Book Number (ISBN), with each ISBN representing a performance obligation. Each ISBN has an observable stand-alone selling price as Wiley sells the books separately. This revenue stream also includes variable consideration as it relates to returns for both print and digital books. Revenue is recognized at the point when control of the product transfers, which for print is upon shipment or for digital when fulfillment of the products has been rendered.

*Digital Courseware Products*

Courseware customers purchase access codes to utilize the product. Revenue is recognized over time in the period from when the access codes are activated over the applicable semester term to which such product relates.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

*Licensing and Ancillary Products* 

Revenue derived from our licensing contracts is primarily comprised of advance payments and sales- or usage-based royalties. Revenue for advance payments is recognized at the point in time that the functional intellectual property license is granted. For sales- or usage-based royalties, we record revenue under these arrangements for the amounts due and not yet reported to us based on estimates of the sales or usage of these customers and pursuant to the terms of the contracts. We also have certain licenses whereby we receive a non-refundable minimum guarantee (recognized at a point in time as described above) against a volume-based royalty throughout the term of the agreement. We recognize volume-based royalty income only when cumulative consideration exceeds the minimum guarantee and the subsequent sales or usage occurs. We also license content for AI which includes training large language models (LLM) at a fixed transaction price and the revenue is recognized at a point in time.

<u>Professional</u>

Professional products revenue was $227.8 million in the year ended April 30, 2026. Professional provides learning, development, publishing, and assessment services for businesses and professionals. Our professional publishing produces books, which includes business and finance, technology, professional development for educators, test preparation books and other professional categories, as well as the *For Dummies*® brand. Products are sold to brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, and government agencies.

In the year ended April 30, 2026, Professional products generated approximately 53% of their revenue from contracts with their customers for professional publishing, which is recognized at a point in time. Our assessments offering in the year ended April 30, 2026 generates approximately 32% of their revenue from contracts with its customers, which has a mix of revenue recognized at a point in time and over time. The remainder of Professional revenues were from Licensing and ancillary revenue streams, which has a mix of revenue recognized at a point in time and over time.

*Professional Publishing* 

Professional publishing has the same performance obligations as Academic print and digital publishing which is described above. Revenue is recognized at the point when control of the product transfers, which for print is upon shipment or for digital when fulfillment of the products has been rendered.

*Assessments*

Our assessments offering includes high-demand soft-skills training solutions that are delivered to organizational clients through online digital delivery platforms, either directly or through an authorized distributor network of independent consultants, trainers, and coaches. Our assessments product offering includes multiple performance obligations which includes annual memberships which are recognized over time, and the assessments and related products or services which are recognized at a point in time. We allocate revenue based on observable stand-alone selling prices of each performance obligation.

*Licensing and Ancillary Products*

See the description of Licensing and Ancillary Products in the Academic section above, which also applies to the Professional reporting line.

**Held for Sale or Sold**

The Held for Sale or Sold segment had no operating results for the year ended April 30, 2026, as all businesses within this segment were sold prior to this fiscal year. These businesses included Wiley Edge, sold on May 31, 2024, except for its India operations which sold on August 31, 2024, CrossKnowledge, sold on August 31, 2024, and University Services and Tuition Manager, which were sold in fiscal year 2024.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Accounts Receivable, Net and Contract Liability Balances***

When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded. Contract liabilities are recognized as revenue when, or as, control of the products or services are transferred to the customer and all revenue recognition criteria have been met.

The following table provides information about accounts receivable, net and contract liabilities from contracts with customers.

---

| | | | |
|:---|:---|:---|:---|
| | **April 30, 2026** | **April 30, 2025** | **(Decrease)/<br>Increase** |
| Balances from contracts with customers: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | $244164 | $228410 | $15754 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities <sup>(1)</sup> | 451423 | 462693 | (11270) |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities (included in Other long-term liabilities) | $17230 | $16725 | $505 |

---

(1) The sales return reserve recorded in Contract liabilities is $11.8 million and $15.1 million as of April 30, 2026 and April 30, 2025, respectively. <u>[See Note 2](#ib89f1fe374d74cbb9d0c7be7b6367e87_28579)</u>, "Summary of Significant Accounting Policies, Recently Issued, and Recently Adopted Accounting Standards" for further details of the sales return reserve.

For the years ended April 30, 2026 and 2025, we recognized as revenue substantially all of the current contract liability balance at April 30, 2025 and 2024, respectively.

The decrease in contract liabilities, excluding the sales return reserve, was primarily driven by revenue earned on journal subscription agreements, transformational agreements, and open access, partially offset by renewals of journal subscription agreements, transformational agreements, and open access.

***Remaining Performance Obligations included in Contract Liability***

As of April 30, 2026, the aggregate amount of the transaction price allocated to the remaining performance obligations is approximately $468.6 million, which includes the sales return reserve of $11.8 million. Excluding the sales return reserve, we expect that approximately $439.6 million will be recognized in the next twelve months with the remaining $17.2 million to be recognized thereafter.

***Assets Recognized for the Costs to Fulfill a Contract***

Costs to fulfill a contract are directly related to a contract that will be used to satisfy a performance obligation in the future and are expected to be recovered. These costs are amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. These types of costs are incurred in Research Solutions services which includes customer specific implementation costs per the terms of the contract.

Our assets associated with incremental costs to fulfill a contract were $1.3 million and $2.2 million at April 30, 2026 and 2025, respectively, and are included within Other non-current assets on our Consolidated Statements of Financial Position.

We recorded amortization expense related to these assets within Cost of sales on the Consolidated Statements of Income (Loss) as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Amortization expense | $1324 | $1385 | $4527 |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

In the year ended April 30, 2024, amortization expense for costs to fulfill includes the amortization related to the University Services business which was sold on January 1, 2024.

Sales and value-added taxes are excluded from revenues. Shipping and handling costs, which are primarily incurred within the Learning segment, occur before the transfer of control of the related goods. Therefore, in accordance with the revenue standard, it is not considered a promised service to the customer and would be considered a cost to fulfill our promise to transfer the goods. Costs incurred for third-party shipping and handling are primarily reflected in Operating and administrative expenses on the Consolidated Statements of Income (Loss) and were incurred as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Shipping and handling costs | $23122 | $23644 | $25853 |

---

**Note 4 – Acquisition and Divestitures** 

***Acquisition***

On February 3, 2025, we completed the acquisition of an immaterial business included in our Learning segment. The allocation of the total consideration transferred to the assets acquired, including intangible assets and goodwill, and the liabilities assumed was finalized during the three months ended April 30, 2026.

Pro forma financial information related to this acquisition has not been provided as it is not material to our consolidated results of operations.

***Divestitures***

We recorded net pretax loss on sale of businesses, assets, and impairment charges related to assets held-for-sale as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| CrossKnowledge | $(2309) | $4119 | $(55440) |
| University Services | (934) | (12578) | (107048) |
| Wiley Edge | (422) | (14852) | (19401) |
| Other disposition activity | (1163) | (29) | (1500) |
| Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | $(4828) | $(23340) | $(183389) |

---

These charges are reflected in Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale on our Consolidated Statements of Income (Loss).

CrossKnowledge

On August 31, 2024, we completed the sale of CrossKnowledge, which was included in our Held for Sale or Sold segment.

In the year ended April 30, 2026, we recognized a loss of $2.3 million related to the sale of this business. Included in the selling price for CrossKnowledge was contingent consideration in the form of an earnout. We estimate the fair value of the CrossKnowledge earnout, which had a fair value of $1.8 million at the time of sale, to be zero as of April 30, 2026, based upon the business outlook which reflects adverse changes in market conditions. In addition, in the year ended April 30, 2026, we recorded a write-off of $0.5 million related to an uncollectible receivable associated with CrossKnowledge.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

In the year ended April 30, 2025, upon the completion of the sale, we recognized a net gain of $4.1 million, primarily due to subsequent changes in the fair value less costs to sell, as well as changes in the carrying amount of the disposal group.

In the year ended April 30, 2024, in connection with the held-for-sale classification prior to the sale, we recognized cumulative impairment charges of $55.4 million on the remeasurement of the disposal group at the lower of carrying value or fair value less costs to sell.

University Services

On January 1, 2024, we completed the sale of University Services, which was included in our Held for Sale or Sold segment, and we recognized a net loss of $107.0 million in the year ended April 30, 2024.

On June 5, 2025, Wiley entered into an agreement with Metis Aggregator L.P. and Vistria AP Aggregator, LLC to sell the unsecured promissory note (University Services Seller Note), the contingent consideration in the form of an earnout (University Services Earnout) for fiscal year 2026, and the TVG Investment, and agreed with Education Services Upper Holdings Corp. (Upper Holdings) and Academic Partnerships LLC (Academic Partnerships) on the fiscal year 2025 University Services Earnout for total cash consideration of $119.5 million (Sale Agreement) which was fully paid in June 2025. As a result of this Sale Agreement, all amounts due to Wiley in accordance with the Membership Interest and Asset Purchase Agreement (University Services Agreement) with Academic Partnerships, and Upper Holdings have been settled.

In the year ended April 30, 2025, due to the process of selling these assets, as well as third-party customer consents, working capital adjustments, and changes in the costs to sell, we recognized an additional net loss on sale and impairments of assets of $12.6 million. In the year ended April 30, 2026, we recognized an additional pretax loss of $0.9 million as a result of selling these assets.

Wiley Edge

On May 31, 2024, we completed the sale of Wiley Edge, which was included in our Held for Sale or Sold segment, except for the India operations that sold on August 31, 2024.

In the year ended April 30, 2026, we recorded write-offs of $0.4 million related to uncollectible receivables for Wiley Edge.

In the year ended April 30, 2025, upon the completion of the sale, we recognized a net loss of $14.9 million primarily due to subsequent changes in the fair value less costs to sell, partially offset by the sale of the India operations. The selling price for Wiley Edge included additional contingent consideration in the form of an earnout with a fair value of $15.0 million at the time of sale, based on gross profit targets during each of the three fiscal years in the period beginning May 1, 2024 and ending April 30, 2027 (Wiley Edge Earnout). The fair value of the Wiley Edge Earnout was zero as of April 30, 2025, as the gross profit for the earnout periods was expected to be below the gross profit targets as defined in the stock and asset purchase agreement (Edge Agreement), resulting in no payment to Wiley. We estimate the fair value of the Wiley Edge Earnout to be zero as of April 30, 2026, as the gross profit forecast for each of the fiscal year 2026 and 2027 earnout periods is expected to be below the gross profit targets, which would result in no payments being made to Wiley in the respective periods.

In the year ended April 30, 2024, in connection with the held-for-sale classification, we recognized cumulative impairment charges of $19.4 million on the remeasurement of the disposal group at the lower of carrying value or fair value less costs to sell.

The selling price for Wiley Edge included an unsecured promissory note (Inspirit Seller Note). As of April 30, 2026 and 2025, the Inspirit Seller Note receivable inclusive of interest is $15.2 million and $14.4 million, respectively, and is reflected in Other non-current assets in our Consolidated Statements of Financial Position. The Inspirit Seller Note matures on May 31, 2028 and is prepayable at par plus accrued interest at any time and also if certain conditions are met. The original interest rate of the Inspirit Seller Note was 8% per annum commencing on May 31, 2024, increasing by 1% per annum each year on the anniversary of issuance.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

In November 2025, the Inspirit Seller Note was amended to provide that interest would cease to accrue prospectively effective January 5, 2026 (Interest End Date). As a result, no further interest accrues or is payable on the outstanding principal amount of the Inspirit Seller Note. Also in November 2025, we entered into an arrangement with Inspirit whereby we will receive a contingent payment equal to 120% of the foregone interest upon the future occurrence of certain sale or exit events if it exceeds a certain amount of proceeds. As of April 30, 2026, the likelihood and amount of any future payment was not determinable, and no amounts have been recognized related to this contingent arrangement.

Interest income from the note receivable was $0.9 million and $1.0 million for the years ended April 30, 2026 and 2025, respectively, and is included in Other (expense) income, net on the Consolidated Statements of Income (Loss).

**Note 5 – Reconciliation of Weighted Average Shares Outstanding**

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share further includes any common shares available to be issued upon the exercise of unvested, outstanding restricted stock units and other stock awards if such inclusions would be dilutive. The shares associated with performance-based stock awards (PSU) are considered contingently issuable shares and are included in the diluted weighted average number of common shares outstanding based on when they have met the performance conditions, and when their effect is dilutive. We determine the potentially dilutive common shares for all awards using the treasury stock method.

A reconciliation of the shares used in the computation of earnings (loss) per share follows (shares in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Weighted average shares outstanding | 52466 | 54054 | 54945 |
| **Shares used for basic earnings (loss) per share** | 52466 | 54054 | 54945 |
| Dilutive effect of unvested restricted stock units and other stock awards | 781 | 776 |  |
| **Shares used for diluted earnings (loss) per share** | 53247 | 54830 | 54945 |
| Antidilutive options to purchase Class A common shares, restricted shares, and contingently issuable restricted stock which are excluded from the table above | 683 | 509 | 1264 |

---

In calculating diluted net loss per common share for the year ended April 30, 2024, our diluted weighted average number of common shares outstanding excludes the effect of unvested restricted stock units and other stock awards as the effect was antidilutive. This occurs when a net loss is reported and the effect of using dilutive shares is antidilutive.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 6 – Accumulated Other Comprehensive Loss**

Changes in Accumulated other comprehensive loss by component, net of tax, for the years ended April 30, 2026, 2025, and 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Foreign**<br>**Currency**<br>**Translation** | **Unamortized**<br>**Retirement**<br>**Costs** | **Interest**<br>**Rate Swaps** | **Total**  |
| Balance at April 30, 2023 | $(326346) | $(206806) | $4250 | $(528902) |
| &nbsp;&nbsp;&nbsp;Other comprehensive (loss) income before reclassifications | (7481) | (37) | 11398 | 3880 |
| &nbsp;&nbsp;&nbsp;Amounts reclassified from Accumulated other comprehensive loss |  | 5921 | (9338) | (3417) |
| &nbsp;&nbsp;Total other comprehensive (loss) income | (7481) | 5884 | 2060 | 463 |
| Balance at April 30, 2024 | $(333827) | $(200922) | $6310 | $(528439) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 46052 | (14370) | (7912) | 23770 |
| &nbsp;&nbsp;&nbsp;Amounts reclassified from Accumulated other comprehensive loss | 23227 | 6102 | (3580) | 25749 |
| &nbsp;&nbsp;Total other comprehensive income (loss) | 69279 | (8268) | (11492) | 49519 |
| Balance at April 30, 2025 | $(264548) | $(209190) | $(5182) | $(478920) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income before reclassifications | 14827 | 11815 | 2637 | 29279 |
| &nbsp;&nbsp;Amounts reclassified from Accumulated other comprehensive loss | 1001 | 7049 | (627) | 7423 |
| &nbsp;&nbsp;Total other comprehensive income | 15828 | 18864 | 2010 | 36702 |
| Balance at April 30, 2026 | $(248720) | $(190326) | $(3172) | $(442218) |

---

In connection with the sale of Wiley Edge and CrossKnowledge, in the year ended April 30, 2025, we reclassified $23.2 million of cumulative translation adjustments out of Accumulated other comprehensive loss and included in the Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale in our Consolidated Statements of Income (Loss).

For the years ended April 30, 2026, 2025, and 2024, pretax actuarial losses included in Unamortized Retirement Costs of approximately $8.6 million, $8.1 million, and $7.9 million, respectively, were amortized from Accumulated other comprehensive loss and recognized as pension and postretirement benefit (expense) primarily in Operating and administrative expenses and Other (expense) income, net on our Consolidated Statements of Income (Loss).

Our policy for releasing the income tax effects from accumulated other comprehensive (loss) income is to release when the corresponding pretax accumulated other comprehensive (loss) income items are reclassified to earnings.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 7 – Restructuring and Related Charges**

***Global Restructuring Program***

The Company began a global restructuring program in fiscal year 2023, which aimed to enhance Wiley's position and drive profitability (Global Restructuring Program) which was expanded in fiscal year 2024. This program included severance related charges for the elimination of certain positions, the exit of certain leased office space, and the reduction of our occupancy at other facilities. Under this program, we reduced our real estate square footage occupancy by approximately 35%.

In the fourth quarter of fiscal year 2025, the program was further extended due to the completion of our divestitures with a focus on optimizing our cost structure, with particular emphasis on aligning our technology costs and other corporate expenses. As a result of these initiatives, this expanded program includes severance related charges, facility-related costs associated with certain properties, and other activities.

The following tables summarize the pretax restructuring charges related to the Global Restructuring Program:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **Total Charges<br>Incurred to Date** |
| | **2026** | **2025** | **2024** | **Total Charges<br>Incurred to Date** |
| Charges (Credits) by Segment: |  |  |  | **Total Charges<br>Incurred to Date** |
| &nbsp;&nbsp;Research | $1519 | $10047 | $7410 | $21389 |
| &nbsp;&nbsp;Learning | 2940 | 1515 | 11448 | 23707 |
| &nbsp;&nbsp;Held for Sale or Sold |  | (117) | 7326 | 12995 |
| &nbsp;&nbsp;Corporate Expenses | 14847 | 17902 | 35370 | 100998 |
| Total Restructuring and Related Charges | $19306 | $29347 | $61554 | $159089 |
| Charges by Activity: |  |  |  |  |
| &nbsp;&nbsp;Severance and termination benefits | $9179 | $20596 | $28556 | $84158 |
| &nbsp;&nbsp;Impairment of operating lease ROU assets and technology, property, and equipment |  | 656 | 10043 | 23395 |
| &nbsp;&nbsp;Acceleration of expense related to operating lease ROU assets, technology, property, and equipment, and intangible assets |  | 1786 | 4148 | 8074 |
| &nbsp;&nbsp;Facility related charges, net | 4368 | 4249 | 4254 | 17021 |
| &nbsp;&nbsp;Consulting costs | 5022 | 657 | 8967 | 16931 |
| &nbsp;&nbsp;Other activities | 737 | 1403 | 5586 | 9510 |
| Total Restructuring and Related Charges | $19306 | $29347 | $61554 | $159089 |

---

The severance related charges are for certain employees affected by the reduction in force under this program who are entitled to severance payments and certain termination benefits.

In the year ended April 30, 2024, the impairment charges include the impairment of operating lease ROU assets related to certain leases that will be subleased, and the related property and equipment described further below. In the year ended April 30, 2024, these charges were recorded in Corporate Expenses and the Research segment.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

Due to the actions taken above, we tested the operating lease ROU assets and the related property and equipment for those being subleased for recoverability. The undiscounted cash flows were below carrying values, indicating impairment. The resulting fair value was $8.7 million in the year ended April 30, 2024 determined using the present value of estimated cash flows, and was categorized as Level 3 within the fair value hierarchy under FASB ASC Topic 820, "Fair Value Measurements."

In addition, in the years ended April 30, 2025 and 2024, the impairment charges include the impairment of certain work-in-process capitalized software because it is no longer probable that the software being developed will be completed, and the work-in-process capitalized software was reported at the lower of its carrying amount or fair value which was zero. In the year ended April 30, 2025 these charges were recorded in the Research segment. In the year ended April 30, 2024, these charges were recorded in the Learning and Research segments, and in Corporate Expenses.

In the year ended April 30, 2024, the acceleration of expense includes the acceleration of rent expense associated with operating lease ROU assets related to certain leases that will be abandoned or terminated, and the related depreciation and amortization of property and equipment. In addition, in the years ended April 30, 2025 and 2024, the acceleration of expense includes the acceleration of amortization expense of certain capitalized software as a result of our decision to discontinue the use of those assets. We determined that a revision of the useful lives was warranted, and certain capitalized software was fully amortized over its revised remaining useful life. The acceleration of expense in the year ended April 30, 2025 also includes the acceleration of amortization expense of an intangible asset in our Research segment due to a revision of the useful life which resulted in the asset being fully amortized over its revised remaining useful life.

We incurred ongoing facility-related costs associated with certain properties, consulting costs, and costs for other activities, which includes relocation and other employee related costs.

The following table summarizes the activity for the Global Restructuring Program liability for the year ended April 30, 2026:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **April 30, 2025** | **Charges** | **Payments**  | **Foreign**<br>**Translation**<br>**& Other Adjustments** | **April 30, 2026** |
| Severance and termination benefits | $6622 | $9179 | $(12440) | $100 | $3461 |
| Consulting costs | 927 | 5022 | (5232) |  | 717 |
| Other activities | 289 | 737 | (32) | 4 | 998 |
| Total | $7838 | $14938 | $(17704) | $104 | $5176 |

---

Approximately $3.2 million of the restructuring liability for accrued severance and termination benefits is reflected in Accrued employment costs and approximately $0.3 million is reflected in Other long-term liabilities on our Consolidated Statements of Financial Position. The liability for consulting costs and other activities is reflected in Other accrued liabilities on our Consolidated Statements of Financial Position.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 8 – Inventories**

Inventories, net consisted of the following at April 30:

---

| | | |
|:---|:---|:---|
| | **2026** | **2025** |
| Finished goods | $23924 | $27581 |
| Work-in-process | 448 | 632 |
| Paper and other materials | 44 | 124 |
| Total inventories before estimated sales returns and LIFO reserve | 24416 | 28337 |
| Inventory value of estimated sales returns | 3085 | 4042 |
| LIFO reserve | (8236) | (9504) |
| Inventories, net | $19265 | $22875 |

---

<u>[See Note 2](#ib89f1fe374d74cbb9d0c7be7b6367e87_28579)</u>, "Summary of Significant Accounting Policies, Recently Issued and Recently Adopted Accounting Standards," under the caption "Sales Return Reserves," for a discussion of the Inventory value of estimated sales returns.

Finished goods are net of a reserve for inventory obsolescence of $8.7 million and $11.1 million as of April 30, 2026 and 2025, respectively.

**Note 9 – Product Development Assets**

Product development assets, net were included in Other non-current assets on the Consolidated Statements of Financial Position and consisted of the following at April 30:

---

| | | |
|:---|:---|:---|
| | **2026** | **2025** |
| Book composition costs | $246770 | $247442 |
| Software costs | 51795 | 50960 |
| Content development costs | 1360 | 1033 |
| Product development assets, gross | 299925 | 299435 |
| Accumulated amortization | (285430) | (283382) |
| Product development assets, net | $14495 | $16053 |

---

Product development assets include $2.7 million and $3.3 million of work-in-process as of April 30, 2026 and 2025, respectively, primarily for book composition costs.

The following table details our amortization expense for product development assets, net:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Amortization expense | $16058 | $16610 | $22835 |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 10 – Technology, Property, and Equipment**

Technology, property, and equipment, net consisted of the following at April 30:

---

| | | |
|:---|:---|:---|
| | **2026** | **2025** |
| Capitalized software | $687427 | $644900 |
| Computer hardware | 55511 | 54160 |
| Buildings and leasehold improvements | 69143 | 67589 |
| Furniture, fixtures, and warehouse equipment | 30303 | 31817 |
| Land and land improvements | 885 | 860 |
| Technology, property, and equipment, gross | 843269 | 799326 |
| Accumulated depreciation and amortization | (707009) | (637201) |
| Technology, property, and equipment, net | $136260 | $162125 |

---

The following table details our depreciation and amortization expense for technology, property, and equipment, net:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Capitalized software amortization expense | $61745 | $65348 | $83250 |
| Depreciation and amortization expense, excluding capitalized software | 12624 | 13346 | 14910 |
| Total depreciation and amortization expense for technology, property and equipment | $74369 | $78694 | $98160 |

---

In fiscal years 2025 and 2024, as a result of our decision to discontinue the use of certain capitalized software, we determined that a revision of the useful lives was warranted, and certain capitalized software was fully amortized over its revised remaining useful life. In addition, certain work-in-process capitalized software was impaired since it is no longer probable that the software being developed will be completed, and was reported at the lower of its carrying amount or fair value which was zero. The charges resulting from these actions are summarized below.

For the year ended April 30, 2025, the total amount was $1.5 million, which included $0.8 million of accelerated amortization expense and $0.7 million of impairment charges reflected in Restructuring and related charges on our Consolidated Statements of Income (Loss). These charges were recorded in the Research segment.

For the year ended April 2024, the total amount was $20.3 million, which included $15.9 million of accelerated amortization expense reflected in depreciation and amortization in Operating and administrative expenses and $4.4 million of impairment charges reflected in Restructuring and related charges on our Consolidated Statements of Income (Loss). These charges were recorded in the Research and Learning segments as well as Corporate Expenses.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 11 – Goodwill and Intangible Assets**

***Goodwill***

The following table summarizes the activity in goodwill by segment as of April 30:

---

| | | | |
|:---|:---|:---|:---|
| | **Research** | **Learning** | **Total** |
| Balance at April 30, 2024<sup>(1)</sup> | $607289 | $484079 | $1091368 |
| &nbsp;&nbsp;&nbsp;Acquisition<sup>(2)</sup>  |  | 1026 | 1026 |
| &nbsp;&nbsp;&nbsp;Foreign Translation Adjustment | 32145 | (3034) | 29111 |
| Balance at April 30, 2025 | $639434 | $482071 | $1121505 |
| &nbsp;&nbsp;&nbsp;Foreign Translation Adjustment | (67) | 10954 | 10887 |
| Balance at April 30, 2026 | $639367 | $493025 | $1132392 |

---

(1) As of April 30, 2024, the goodwill balance for the Held for Sale or Sold segment includes accumulated pretax noncash goodwill impairments of $318.2 million. These impairments reduced the goodwill for all reporting units within this segment to zero.

(2) Refer to <u>[Note 4](#i4999d179a1ee4db3afe68151d34a8db6_115)</u>, "Acquisition and Divestitures," for more information related to the acquisition that occurred in the year ended April 30, 2025.

*Annual Impairment Tests as of February 1, 2026 and 2025*

For our reporting units within the Research and Learning segments, we performed a qualitative assessment by reporting unit as of February 1, 2026 and 2025. This assessment included consideration of key factors including macroeconomic conditions, industry and market considerations, financial performance, weighted average cost of capital (WACC), market multiples of current and forward 12-month EBITDA, and other relevant entity and reporting unit-specific events. Based on our qualitative assessment, we determined it was not more likely than not that the fair value of any reporting unit was less than its carrying amount. As such, it was not necessary to perform a quantitative test. There have been no significant events or circumstances affecting the valuation of goodwill subsequent to the qualitative assessment performed as of February 1, 2026.

If the fair value of these reporting units decreases in future periods, we could potentially have an impairment. The future occurrence of a potential indicator of impairment, such as a decrease in expected net earnings, changes in assumptions, adverse equity market conditions, a decline in current market multiples, a decline in our common stock price, a significant adverse change in legal factors or business climates, an adverse action or assessment by a regulator, unanticipated competition, strategic decisions made in response to economic or competitive conditions, or a more-likely-than-not expectation that a reporting unit or a significant portion of a reporting unit will be sold or disposed of, could require an interim assessment for some or all of the reporting units before the next required annual assessment.

***Fiscal Year 2024***

We recorded a goodwill impairment of $108.4 million in the year ended April 30, 2024. These charges are reflected in Impairment of goodwill on our Consolidated Statements of Income (Loss).

*Change in Segment Reporting Structure and Goodwill Impairment* 

In the three months ended July 31, 2023, we reorganized our segments. Due to this realignment, we reallocated goodwill in the first quarter of fiscal year 2024 to our reporting units on a relative fair value basis.

As a result of this realignment, we were required to test goodwill for impairment immediately before and after the realignment. Since there were no changes to the Research reportable segment, no impairment test of the Research segment goodwill was required.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

We estimated the fair value of the reporting units using a weighting of fair values derived from an income and a market approach. Fair value computed by these methods is arrived at using a number of key assumptions including forecasted revenues and related growth rates, forecasted operating cash flows, the discount rate, and the selection of relevant market multiples of comparable publicly-traded companies with similar characteristics to the reporting unit. Under the income approach, we determined the fair value of a reporting unit based on the present value of estimated future cash flows. Cash flow projections are based on our best estimates of forecasted economic and market conditions over the period including growth rates and expected changes in operating cash flows. The discount rate used is based on a weighted average cost of capital adjusted for the relevant risk associated with the characteristics of the business and the projected cash flows. The market approach estimates fair value based on market multiples of current and forward 12-month revenue or EBITDA, as applicable, derived from comparable publicly traded companies with similar operating and investment characteristics as the reporting unit.

Prior to the realignment, the previous reporting units (Academic Publishing, Talent Development, which includes Wiley Edge, and Professional Learning) fair values were above their carrying values. Therefore, there was no indication of impairment. The carrying value of the University Services reporting unit was above its fair value, which resulted in a pretax noncash goodwill impairment of $11.4 million. Such impairment reduced the goodwill of the University Services reporting unit to zero. University Services was adversely impacted by market conditions and headwinds for online degree programs, which led to a decline in projected enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term which adversely impacted forecasted revenue growth and operating cash flows. We also evaluated the recoverability of long-lived assets of the University Services reporting unit and there was no impairment.

After the realignment, the new reporting units (Academic, Professional, and Wiley Edge) fair values were above their carrying values. Therefore, there was no indication of impairment. The carrying value of the CrossKnowledge reporting unit was above its fair value which resulted in a pretax noncash goodwill impairment of $15.3 million. Such impairment reduced the goodwill of the CrossKnowledge reporting unit to zero. CrossKnowledge was adversely impacted by a decline in the demand for its offerings, which resulted in lower sales and a decline in average contract value, that adversely impacted forecasted revenue growth and operating cash flows. We also evaluated the recoverability of long-lived assets of the CrossKnowledge reporting unit and there was no impairment.

*Wiley Edge Interim Impairment Test*

As a result of signing the Edge Agreement with Inspirit and the decrease in the fair value of the business, which was impacted by a decline in placements, in the third quarter of fiscal year 2024, we tested the goodwill of the Wiley Edge reporting unit for impairment. We concluded that the carrying value of the Wiley Edge reporting unit was above its fair value, which resulted in a pretax noncash goodwill impairment of approximately $81.7 million. Such impairment reduced the goodwill of the Wiley Edge reporting unit to zero. The impairment was due to subsequent changes in the fair value resulting from the continued progression of the selling process, indications of changes in the consideration for the business, and a decline in placements in the third quarter of fiscal year 2024, as well as changes in the carrying amounts of the disposal group. We also evaluated the recoverability of long-lived assets of the Wiley Edge reporting unit and there was no impairment.

Refer to <u>[Note 4](#i07300a4eeb7a47b3860e2ee1f39a3e3f_10911)</u>, "Acquisition and Divestitures," for more information.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Intangible Assets***

Intangible assets, net as of April 30 were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
| | **Cost** | **Accumulated<br>Amortization** | **Net** | **Cost** | **Accumulated<br>Amortization** | **Net** |
| <u>Intangible assets with definite lives, net</u><sup>(1)</sup>: |  |  |  |  |  |  |
| Content and publishing rights | $1119654 | $(705438) | $414216 | $1080115 | $(662133) | $417982 |
| Customer relationships | 131074 | (104683) | 26391 | 131037 | (95996) | 35041 |
| Developed technology<sup>(2)</sup> | 41243 | (34404) | 6839 | 41195 | (28789) | 12406 |
| Brands and trademarks | 30549 | (26211) | 4338 | 30538 | (25484) | 5054 |
| Covenants not to compete | 1157 | (1157) |  | 1157 | (1148) | 9 |
| Total intangible assets with definite lives, net | 1323677 | (871893) | 451784 | 1284042 | (813550) | 470492 |
| <u>Intangible assets with indefinite lives:</u> |  |  |  |  |  |  |
| Brands and trademarks<sup>(2)</sup> | 37000 |  | 37000 | 37000 |  | 37000 |
| Publishing rights | 90175 |  | 90175 | 87552 |  | 87552 |
| Total intangible assets with indefinite lives | 127175 |  | 127175 | 124552 |  | 124552 |
| Total intangible assets, net | $1450852 | $(871893) | $578959 | $1408594 | $(813550) | $595044 |

---

(1) Refer to <u>[Note 4](#i4999d179a1ee4db3afe68151d34a8db6_115)</u>, "Acquisition and Divestitures," for more information related to the acquisition that occurred in the year ended April 30, 2025.

(2) The developed technology balance as of April 30, 2026 and 2025 is presented net of accumulated impairments and write-offs of $2.8 million. The indefinite-lived brands and trademarks balance as of April 30, 2026 and 2025 is net of accumulated impairments of $93.1 million.

Based on the current amount of intangible assets subject to amortization and assuming current foreign exchange rates, the estimated amortization expense for the following years are as follows:

---

| | |
|:---|:---|
| **Fiscal Year** | **Amount** |
| 2027 | $50040 |
| 2028 | 44511 |
| 2029 | 39997 |
| 2030 | 36206 |
| 2031 | 33843 |
| Thereafter | 247187 |
| Total | $451784 |

---

*Annual Indefinite-lived Intangible Impairment Test as of February 1,* 2026 *and 2025*

We also review our indefinite-lived intangible assets for impairment annually, which consists of brands and trademarks and certain acquired publishing rights.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

For fiscal years 2026 and 2025, we performed a qualitative assessment for our annual indefinite-lived intangible assets impairment test. This assessment included consideration of key factors including macroeconomic conditions, industry and market considerations, financial performance, WACC, and other relevant entity and reporting unit-specific events. Based on our qualitative assessment, we determined it was not more likely than not that the fair value of any indefinite-lived intangible asset was less than its carrying amount. As such, it was not necessary to perform a quantitative test.

**Note 12 – Operating Leases**

We have operating leases with contractual obligations as a lessee with respect to offices, warehouses and distribution centers, automobiles, and office equipment.

For operating leases, the ROU assets and liabilities as of April 30 are presented in our Consolidated Statements of Financial Position as follows:

---

| | | |
|:---|:---|:---|
| | **2026** | **2025** |
| Operating lease ROU assets | $57128 | $66128 |
| Short-term portion of operating lease liabilities | 15954 | 18282 |
| Operating lease liabilities, non-current | $69544 | $81482 |

---

As a result of the Global Restructuring Program, which included the exit of certain leased office space, we recorded restructuring and related charges, which included impairment charges and the acceleration of expense associated with certain operating lease ROU assets. <u>[See Note 7](#i349fc9c6047d49dbbed2272840f209d9_6505)</u>, "Restructuring and Related Charges" for more information on this program and the charges incurred.

Our total net lease costs were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Operating lease cost | $14107 | $14613 | $14575 |
| Variable lease cost | 710 | 833 | 1096 |
| Short-term lease cost | 378 | 455 | 1059 |
| Sublease income | (367) | (560) | (847) |
| Total net lease cost <sup>(1)</sup> | $14828 | $15341 | $15883 |

---

(1) Total net lease cost does not include those costs and sublease income for operating leases identified as part of our restructuring programs, which are included in Restructuring and related charges on our Consolidated Statements of Income (Loss). See <u>[Note 7](#i4999d179a1ee4db3afe68151d34a8db6_124)</u>, "Restructuring and Related Charges" for more information on these programs.

Other supplemental information includes the following:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Weighted-average remaining contractual lease term (years) | 6 | 7 | 7 |
| Weighted-average discount rate | 6.23% | 6.16% | 6.05% |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |
| &nbsp;&nbsp;Operating cash flows from operating leases | $22704 | $22209 | $25852 |
| Operating lease liabilities arising from obtaining ROU assets | $1642 | $1646 | $2199 |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The table below reconciles the undiscounted cash flows for the first five years and total of the remaining years to the operating lease liabilities recorded in the Consolidated Statement of Financial Position as of April 30, 2026:

---

| | |
|:---|:---|
| **Fiscal Year** | **Operating Lease<br>Liabilities** |
| 2027 | $20180 |
| 2028 | 16545 |
| 2029 | 15199 |
| 2030 | 14706 |
| 2031 | 14457 |
| Thereafter | 21635 |
| Total future undiscounted minimum lease payments | 102722 |
| &nbsp;&nbsp;Less: Imputed interest | 17224 |
| Present value of minimum lease payments | 85498 |
| &nbsp;&nbsp;Less: Current portion | 15954 |
| Noncurrent portion | $69544 |

---

**Note 13 – Income Taxes**

The (benefit) provision for income taxes were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Current provision |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;US – Federal | $4445 | $5497 | $2152 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 62254 | 50300 | 49357 |
| &nbsp;&nbsp;&nbsp;&nbsp;State and local | 1454 | 1981 | (337) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current provision | $68153 | $57778 | $51172 |
| Deferred (benefit) provision |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;US – Federal | $(53217) | $3394 | $(25026) |
| &nbsp;&nbsp;&nbsp;&nbsp;International | (10993) | 1696 | (4772) |
| &nbsp;&nbsp;&nbsp;&nbsp;State and local | (10474) | (4151) | (8102) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total deferred (benefit) provision | $(74684) | $939 | $(37900) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total (benefit) provision | $(6531) | $58717 | $13272 |

---

International and United States pretax income (loss) were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| International | $192809 | $189781 | $109616 |
| United States | 22277 | (46903) | (296663) |
| Total | $215086 | $142878 | $(187047) |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

In accordance with our adoption of ASU 2023-09 on a prospective basis, the reconciliation of our US federal statutory tax rate to our effective income tax rate, presented as both a rate and dollar amount, is as follows:

---

| | | |
|:---|:---|:---|
| | **For the Year Ended April 30, 2026** | **For the Year Ended April 30, 2026** |
| US federal statutory rate | $45168 | 21.0% |
| State and local income tax, net of federal (national) income tax effect<sup>(1)</sup> | (9478) | (4.4)% |
| Foreign tax effects |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;United Kingdom | 5773 | 2.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Germany |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Statutory tax rate difference | (4630) | (2.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in future corporate income tax rate | (4286) | (2.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade tax | 12225 | 5.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 905 | 0.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Hong Kong |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pillar II top-up tax | 2611 | 1.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax exemption | (2873) | (1.3)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | (782) | (0.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Brazil |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Withholding tax | 2686 | 1.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 59 | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Australia | 2164 | 1.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other foreign jurisdictions | 599 | 0.3% |
| Effect of changes in tax laws or rates enacted in the current period |  | —% |
| Effect of cross-border tax laws |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net controlled foreign corporation tested income | 3942 | 1.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign-derived deduction eligible income | (5049) | (2.3)% |
| Tax credits | (1737) | (0.8)% |
| Changes in valuation allowances | (57019) | (26.4)% |
| Nontaxable or nondeductible items | 3482 | 1.6% |
| Worldwide changes in unrecognized tax benefits | 333 | 0.2% |
| Other adjustments | (624) | (0.3)% |
| Effective income tax rate | $(6531) | (3.0)% |

---

(1) State taxes in California, New Jersey, Illinois, Pennsylvania, Massachusetts, Maryland, and New York made up the majority (greater than 50 percent) of the tax effect in this category

The Company's effective tax rate for the fiscal year ended April 30, 2026, was primarily driven by the impact of the US valuation allowance, the enactment of tax rate reductions in Germany, the rates of tax imposed on income earned in foreign jurisdictions, and state taxes.

Prior to the adoption of ASU 2023-09, our effective income tax rate as a percentage of pretax income differed from the US federal statutory rate as shown below:

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | | |
|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2025** | **2024** |
| US federal statutory rate | 21.0% | 21.0% |
| Impact of foreign operations | 8.8% | (11.7)% |
| Change in valuation allowance | 14.4% | (14.0)% |
| State income taxes, net of US federal tax benefit | (1.5)% | 4.6% |
| Tax credits and related net benefits | (2.7)% | 1.8% |
| Impairment of goodwill | —% | (10.9)% |
| Return to provision | (1.9)% | 6.1% |
| Other | 3.0% | (4.0)% |
| Effective income tax rate | 41.1% | (7.1)% |

---

Cash paid for income taxes, net of refunds received, by jurisdiction is as follows:

---

| | |
|:---|:---|
| | **For the Year Ended April 30, 2026** |
| Federal | $410 |
| State and local | 1789 |
| International |  |
| &nbsp;&nbsp;&nbsp;&nbsp;UK | 21317 |
| &nbsp;&nbsp;&nbsp;&nbsp;Germany | 20910 |
| &nbsp;&nbsp;&nbsp;&nbsp;Australia | 8377 |
| Other | 5621 |
| Cash paid for income taxes, net of refunds received | $58424 |

---

<u>Accounting for Uncertainty in Income Taxes:</u> 

As of April 30, 2026 and 2025, the total amount of unrecognized tax benefits was $10.2 million and $9.8 million, respectively, of which $0.6 million and $0.4 million represented accruals for interest and penalties recorded as additional tax expense in accordance with our accounting policy. As of April 30, 2026 and 2025, the total interest and penalties was $1.0 million and $0.8 million, respectively. We recorded net interest expense on reserves for unrecognized and recognized tax benefits of $0.2 million in each of the years ended April 30, 2026, 2025, and 2024. As of April 30, 2026 and 2025, the total amounts of unrecognized tax benefits that would reduce our income tax provision, if recognized, were approximately $10.2 million and $9.8 million, respectively.

A reconciliation of the unrecognized tax benefits included within the Other long-term liabilities on the Consolidated Statements of Financial Position is as follows:

---

| | | |
|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** |
| Balance at May 1 | $9797 | $9151 |
| Additions for current year tax positions | 1428 | 1423 |
| Reductions for prior year tax positions | (119) | (337) |
| Reductions for lapse of statute of limitations | (887) | (440) |
| Balance April 30 | $10219 | $9797 |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

<u>Tax Audits:</u>

We file income tax returns in the US and various states and non-US tax jurisdictions. Our major taxing jurisdictions are the United States, the United Kingdom, Germany, and Australia. We are no longer subject to income tax examinations for years prior to fiscal year 2014 in the major jurisdictions in which we are subject to tax.

<u>Deferred Taxes:</u>

Deferred taxes result from temporary differences in the recognition of revenue and expense for tax and financial reporting purposes.

The significant components of deferred tax assets and liabilities as of April 30 were as follows:

---

| | | |
|:---|:---|:---|
| | **2026** | **2025** |
| Net operating losses | $7437 | $11360 |
| Capital losses | 2948 |  |
| Reserve for sales returns and doubtful accounts | 2988 | 2095 |
| Accrued employee compensation | 20946 | 24967 |
| Foreign and federal credits | 23891 | 28835 |
| Other accrued expenses | 1039 | 1009 |
| Retirement and post-employment benefits | 5491 | 8282 |
| Operating lease liabilities | 16685 | 18308 |
| Interest expense disallowance | 6689 | 14919 |
| Impairment |  | 9543 |
| Other | 517 | 415 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total gross deferred tax assets | $88631 | $119733 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less valuation allowance | (7282) | (77309) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax assets | $81349 | $42424 |
| Prepaid expenses and other assets | $(813) | $(861) |
| Unremitted foreign earnings | (2220) | (2220) |
| Intangible and fixed assets | (108088) | (130077) |
| Right-of-use assets | (10289) | (10848) |
| Total deferred tax liabilities | $(121410) | $(144006) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net deferred tax liabilities | $(40061) | $(101582) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Reported As** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax assets | $58911 | $3563 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax liabilities | (98972) | (105145) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net deferred tax liabilities | $(40061) | $(101582) |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The change in net deferred taxes during fiscal year 2026 was primarily attributable to the release of approximately $70.0 million of valuation allowance previously recorded against US federal and state deferred tax assets. The valuation allowance release was driven by management's conclusion that it is more likely than not that substantially all US federal and state deferred tax assets will be realized based on all available positive and negative evidence, primarily related to the elimination of losses associated with businesses that have been divested and demonstrated sustained US pretax income adjusted for other comprehensive income and permanent differences as of April 30, 2026. This information is both objective and verifiable and represents positive evidence that when considered alongside the other positive and negative factors, as well as the anticipated future earnings, supports management's conclusion as to the realizability of substantially all of the US federal and state deferred tax assets. The release of the valuation allowance on US net deferred tax assets resulted in the recognition of deferred tax assets and income tax benefit in the current period.

We have provided a $7.3 million valuation allowance as of April 30, 2026 for deferred tax assets related to capital losses that are not realizable as of the current period due to lack of capital gains, and state NOLs and credits that we expect will expire unutilized.

As of April 30, 2026, we have apportioned state net operating loss carryforwards totaling approximately $134.4 million, with a tax effected value of $6.7 million net of federal benefits. We have foreign net operating loss carryforwards totaling approximately $0.3 million, and federal net operating loss carryforwards totaling $1.9 million, with a tax effected value of $0.4 million. We also have US capital loss carryforwards total approximately $12.1 million, with a tax effected value of $2.9 million. Our state, foreign, and federal NOLs and credits, to the extent they expire, expire in various amounts from 1 year to indefinite.

We intend to repatriate earnings from our non-US subsidiaries, and to the extent we repatriate these funds to the US, we may be required to pay taxes in various US state and local jurisdictions and withholding or similar taxes in applicable non-US jurisdictions in the periods in which such repatriation occurs. As of April 30, 2026, we have recorded a $2.2 million liability related to the estimated taxes that would be incurred upon repatriating certain non-US earnings to the US.

***Enactment of the "One Big Beautiful Bill Act" (OBBBA)***

On July 4, 2025, President Trump signed into law the OBBBA. Key corporate tax provisions of the OBBBA include a handful of elective tax measures such as restoration of 100% bonus depreciation, the introduction of new Section 174A permitting immediate expending of domestic research and experimental (R&E) expenditures. Other tax measures include modifications to Section 163(j) interest expense limitations, updates to the rules governing global intangible low-taxed income (GILTI) and foreign-derived intangible income (FDII), amendments to energy credit provisions, and the expansion of Section 162(m) aggregation requirements.

Under US GAAP, the effects of changes in tax laws are recognized in the period in which the new law is enacted. Upon assessment of the OBBBA, we determined the impact of these to be insignificant and reflected these in our financial statements using management's best estimate for fiscal year 2026. We are continuing to evaluate the impact of the OBBBA on future periods.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 14 – Debt and Available Credit Facilities**

Our total debt outstanding as of April 30 consisted of the amounts set forth in the following table:

---

| | | |
|:---|:---|:---|
| | **2026** | **2025** |
| Short-term portion of long-term debt<sup>(1)</sup> | $12500 | $10000 |
| Term loan A - Amended and Restated CA<sup>(2)</sup> | 162243 | 174581 |
| Revolving credit facility - Amended and Restated CA | 508654 | 614854 |
| Total long-term debt, less current portion | 670897 | 789435 |
| Total debt | $683397 | $799435 |

---

(1) Relates to our term loan A under the Amended and Restated CA.

(2) Amounts are shown net of unamortized issuance costs of $0.3 million as of April 30, 2026 and $0.4 million as of April 30, 2025.

The following table summarizes the scheduled annual maturities for the next two years of our long-term debt, including the short-term portion of long-term debt. This schedule represents the principal portion amount of debt outstanding and therefore excludes unamortized issuance costs.

---

| | |
|:---|:---|
| **Fiscal Year** | **Amount** |
| 2027 | $12500 |
| 2028 | 671154 |
| Total | $683654 |

---

***Amended and Restated CA***

On November 30, 2022, we entered into the second amendment to the Third Amended and Restated Credit Agreement (collectively, the Amended and Restated CA). The Amended and Restated CA as of November 30, 2022 provided for senior unsecured credit facilities comprised of the following (i) a five-year revolving credit facility in an aggregate principal amount up to $1.115 billion which matures November 2027, (ii) a five-year term loan A facility consisting of $200 million which matures November 2027, and (iii) $185 million aggregate principal amount revolving credit facility which matured in May 2024.

Under the terms of the Amended and Restated CA, which can be drawn in multiple currencies, we have the option of borrowing at the following floating interest rates depending on the currency borrowed: (i) at a rate based on the US Secured Overnight Financing Rate (SOFR), the Sterling Overnight Index Average Rate (SONIA) or a EURIBOR-based rate, each rate plus an applicable margin ranging from 0.98% to 1.50%, depending on our consolidated net leverage ratio, as defined, or (ii) at the lender's base rate plus an applicable margin ranging from zero to 0.50%, depending on our consolidated net leverage ratio. With respect to SOFR loans, there is a SOFR adjustment of between 0.10% and 0.25% depending on the duration of the loan. The lender's base rate is defined as the highest of (i) the US federal funds effective rate plus a 0.50% margin, (ii) the Daily SOFR rate, as defined, plus a 1.00% margin, or (iii) the Bank of America prime lending rate. In addition, we pay a facility fee for the Amended and Restated CA ranging from 0.15% to 0.25% depending on our consolidated net leverage ratio. We also may request an increase in the aggregate commitments provided that the total credit exposures of all lenders shall at no time exceed $2 billion, and any such request shall be in minimum increments of $50 million, subject to the approval of the lenders. On May 15, 2026, we entered into the third amendment to the Third Amended and Restated Credit Agreement for the establishment of incremental term commitments in an aggregate principal amount of $300.0 million, increasing the total available lines of credit to $1,590.5 million.

The Amended and Restated CA contains certain customary affirmative and negative covenants, including a financial covenant in the form of a consolidated net leverage ratio and consolidated interest coverage ratio, which we were in compliance with as of April 30, 2026.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The amortization expense of the costs incurred related to the Amended and Restated CA related to the lender and non-lender fees is recognized over a five-year term for credit commitments that mature in November 2027 and an 18-month term for credit commitments that matured in May 2024. Total amortization expense included in Interest expense on our Consolidated Statements of Income (Loss) is as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Amortization expense | $1137 | $1145 | $1246 |

---

***Lines of Credit***

We have other lines of credit aggregating $1.0 million at various interest rates. There were no outstanding borrowings under these credit lines at April 30, 2026 and 2025.

Our total available lines of credit as of April 30, 2026 were approximately $1,290.5 million which includes the Amended and Restated CA, of which approximately $606.9 million was unused. We had letters of credit of $0.5 million outstanding under the Amended and Restated CA, and the aggregate stated amount outstanding of these letters of credit reduces the total borrowing base available under the Amended and Restated CA.

The weighted average interest rates on total debt outstanding during the years ended April 30, 2026 and 2025 were 5.63% and 6.10%, respectively. As of April 30, 2026 and 2025, the weighted average interest rates for total debt were 5.48% and 5.57%, respectively.

Based on estimates of interest rates currently available to us for loans with similar terms and maturities, the fair value of our debt approximates its carrying value.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 15– Derivative Instruments and Hedging Activities**

***Interest Rate Contracts***

As of April 30, 2026, we had total debt outstanding of $683.4 million, net of unamortized issuance costs of $0.3 million. The $683.7 million of debt outstanding are variable rate loans under the Amended and Restated CA. The carrying value of the debt approximates fair value.

As of April 30, 2026 and 2025, the interest rate swap agreements we maintained were designated as fully effective cash flow hedges as defined under ASC Topic 815. As a result, the impact on our Consolidated Statements of Income (Loss) from changes in the fair value of the interest rate swaps was fully offset by changes in the interest expense on the underlying variable rate debt instruments. It is management's intention that the notional amount of interest rate swaps be less than the variable rate loans outstanding during the life of the derivatives.

As of April 30, 2026 and 2025, we had interest rate swaps outstanding with a combined notional amount of $300.0 million and $500.0 million, respectively, that were designated as cash flow hedges.

We record the fair value of our interest rate swaps on a recurring basis using Level 2 inputs of quoted prices for similar assets or liabilities in active markets. The fair value of our interest rate swaps designated as cash flow hedges as of April 30 are reflected in our Consolidated Statements of Financial Position as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Asset (Liability)** | **Balance Sheet Location** | **2026** | **2025** |
| Current asset portion | Prepaid expenses and other current assets | $— | $197 |
| Current liability portion | Other accrued liabilities | (156) | (118) |
| Non-current liability portion | Other long-term liabilities | (716) | (3438) |
| Total cash flow hedges |  | $(872) | $(3358) |

---

The effect of our interest rate swaps on the Consolidated Statements of Comprehensive Income (Loss) and the Consolidated Statements of Income (Loss) are as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Amount of pretax gains (losses) recognized in Other comprehensive income | $3453 | $(8186) | $15164 |
| Amount of pretax gains reclassified from Accumulated other comprehensive loss into Interest expense | $829 | $4755 | $12420 |

---

Based on the amount in Accumulated other comprehensive loss at April 30, 2026, approximately $(0.6) million, net of tax, would be reclassified into Net income in the next twelve months.

***Foreign Currency Contracts***

We may enter into foreign currency forward contracts to manage our exposure on certain foreign currency denominated assets and liabilities. The foreign currency forward exchange contracts are marked to market through Net foreign exchange transaction losses on our Consolidated Statements of Income (Loss) and carried at fair value on our Consolidated Statements of Financial Position. Foreign currency denominated assets and liabilities are remeasured at spot rates in effect on the balance sheet date, with the effects of changes in spot rates reported in Net foreign exchange transaction losses on our Consolidated Statements of Income (Loss).

As of April 30, 2026 and 2025, we did not maintain any open foreign currency forward contracts. In addition, we did not maintain any open foreign currency forward contracts during the years ended April 30, 2026, 2025, and 2024.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 16 – Commitment and Contingencies**

***Legal Proceedings***

We are involved in routine litigation in the ordinary course of our business. A provision for litigation is accrued when information available to us indicates that it is probable a liability has been incurred and the amount of loss can be reasonably estimated. Significant judgment may be required to determine both the probability and estimates of loss. When the amount of the loss can only be estimated within a range, the most likely outcome within that range is accrued. If no amount within the range is a better estimate than any other amount, the minimum amount within the range is accrued. When uncertainties exist related to the probable outcome of litigation and/or the amount or range of loss, we do not record a liability, but disclose facts related to the nature of the contingency and possible losses if management considers the information to be material. Reserves for legal defense costs are recognized when incurred. The accruals for loss contingencies and legal costs are reviewed regularly and may be adjusted to reflect updated information on the status of litigation and advice of legal counsel. In the opinion of management, the ultimate resolution of all pending litigation as of April 30, 2026, will not have a material effect upon our consolidated financial condition or results of operations.

***Anthropic Class-Action Lawsuit***

In August 2024, certain authors filed a class-action lawsuit against Anthropic in the US District Court for the Northern District of California. They alleged that Anthropic used their copyrighted content, obtained through piracy, to train its AI models. In August 2025, a settlement was reached pursuant to which Anthropic will pay $1.5 billion into a settlement fund, which will be used to make cash payments to class members and cover certain costs in the case. The court preliminarily approved the settlement on September 25, 2025. We are aware that our content is included in the pirated copyrighted content and we have submitted claims for such works with the settlement administrator. The Company's portion of the settlement has not yet been determined.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 17 – Retirement Plans**

We have retirement plans that cover substantially all employees. The plans generally provide for employee retirement between the ages 60 and 65, and benefits based on length of service and compensation, as defined.

***Defined Benefit Plans***

Our Board of Directors approved plan amendments that froze the following retirement plans:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Retirement Plan for the Employees of John Wiley & Sons, Canada was frozen effective December 31, 2015;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Retirement Plan for the Employees of John Wiley & Sons, Ltd., a UK plan was frozen effective April 30, 2015 and;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• US Employees' Retirement Plan, Supplemental Benefit Plan, and Supplemental Executive Retirement Plan, were frozen effective June 30, 2013.

We maintain the Supplemental Executive Retirement Plan for certain officers and senior management which provides for the payment of supplemental retirement benefits after the termination of employment for 10 years, or in a lifetime annuity. Under certain circumstances, including a change of control as defined, the payment of such amounts could be accelerated on a present value basis. Future accrued benefits to this plan have been discontinued as noted above.

The components of net pension expense for the defined benefit plans and the weighted average assumptions were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2026** | **2025** | **2025** | **2024** | **2024** |
| | **US** | **Non-US** | **US** | **Non-US** | **US** | **Non-US** |
| Service cost | $— | $499 | $— | $560 | $— | $532 |
| Interest cost | 11850 | 17479 | 12133 | 16603 | 11654 | 16069 |
| Expected return on plan assets | (9641) | (18371) | (9610) | (18449) | (10372) | (19443) |
| Amortization of prior service cost | (154) | 60 | (154) | 66 | (154) | 60 |
| Amortization of net actuarial loss | 2293 | 6532 | 2314 | 6058 | 2446 | 5656 |
| Curtailment/settlement (credit) |  |  |  | (181) |  |  |
| Net pension expense | $4348 | $6199 | $4683 | $4657 | $3574 | $2874 |
| Discount rate | 5.7% | 5.5% | 5.8% | 5.1% | 5.1% | 4.8% |
| Rate of compensation increase | N/A | 3.0% | N/A | 3.0% | N/A | 3.0% |
| Expected return on plan assets | 5.8% | 6.2% | 5.8% | 6.2% | 5.8% | 6.4% |

---

In the year ended April 30, 2025, due to the sale of the CrossKnowledge business, there was a curtailment and a settlement credit due to the divestment of the CrossKnowledge Pension Plan of $(0.2) million which is primarily reflected in Other (expense) income, net on our Consolidated Statements of Income (Loss).

The service cost component of net pension expense is reflected in Operating and administrative expenses on our Consolidated Statements of Income (Loss). The other components of net pension expense are reported separately from the service cost component and below Operating income. Such amounts are reflected in Other (expense) income, net on our Consolidated Statements of Income (Loss).

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The recognized net actuarial loss for each fiscal year is calculated using the "corridor method," which reflects the amortization of the net loss at the beginning of the fiscal year in excess of 10% of the greater of the market value of plan assets or the projected benefit obligation. The amortization period is based on the average expected life of plan participants for plans with all or almost all inactive participants and frozen plans, and on the average remaining working lifetime of active plan participants for all other plans.

The vested benefit obligation for our defined benefit postretirement plans is the actuarial present value of the vested benefits to which the employee is currently entitled but based on the employee's expected date of separation of retirement.

We recognize the overfunded or underfunded status of defined benefit postretirement plans, measured as the difference between the fair value of plan assets and the projected benefit obligation, on the Consolidated Statements of Financial Position. The change in the funded status of the plan is recognized in Accumulated other comprehensive loss on the Consolidated Statements of Financial Position. Plan assets and obligations are measured at fair value as of our Consolidated Statements of Financial Position date.

The following table sets forth the changes in, and the status of, our defined benefit plans' assets and benefit obligations:

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2026** | **2026** | **2025** | **2025** |
| | **US** | **Non-US** | **US** | **Non-US** |
| **CHANGE IN PLAN ASSETS** |  |  |  |  |
| Fair value of plan assets, beginning of year | $174170 | $302532 | $173569 | $293168 |
| Actual return on plan assets | 17429 | 13376 | 13312 | (7426) |
| Employer contributions | 2961 | 1887 | 3198 | 13526 |
| Employee contributions |  |  |  |  |
| Settlements |  |  |  | (729) |
| Benefits paid | (15677) | (14548) | (15909) | (14560) |
| Foreign currency rate changes |  | 3870 |  | 18553 |
| Fair value, end of year | $178883 | $307117 | $174170 | $302532 |
| **CHANGE IN PROJECTED BENEFIT OBLIGATION** |  |  |  |  |
| Benefit obligation, beginning of year | $(216547) | $(323332) | $(215563) | $(324362) |
| Service cost |  | (499) |  | (560) |
| Interest cost | (11850) | (17479) | (12133) | (16603) |
| Actuarial gains (losses) | 1282 | 14725 | (4760) | 22520 |
| Benefits paid | 15677 | 14548 | 15909 | 14560 |
| Foreign currency rate changes |  | (4572) |  | (19984) |
| Settlements and other |  |  |  | 1097 |
| Benefit obligation, end of year | $(211438) | $(316609) | $(216547) | $(323332) |
| Underfunded status, end of year | $(32555) | $(9492) | $(42377) | $(20800) |
| **AMOUNTS RECOGNIZED ON THE STATEMENT OF FINANCIAL POSITION** |  |  |  |  |
| Noncurrent assets |  | 21769 |  | 12885 |
| Current pension liability | (2884) | (1405) | (2881) | (1282) |
| Noncurrent pension liability | (29671) | (29856) | (39496) | (32403) |
| Net amount recognized in statement of financial position | $(32555) | $(9492) | $(42377) | $(20800) |
| **AMOUNTS RECOGNIZED IN ACCUMULATED OTHER COMPREHENSIVE LOSS (BEFORE TAX) CONSIST OF** |  |  |  |  |
| Net actuarial losses | $(64405) | $(193249) | $(75768) | $(206945) |
| Prior service cost gains (losses) | 1330 | (947) | 1484 | (992) |
| Total accumulated other comprehensive loss | $(63075) | $(194196) | $(74284) | $(207937) |
| Change in accumulated other comprehensive loss | $11209 | $13741 | $1103 | $(10008) |
| **INFORMATION FOR PENSION PLANS WITH AN ACCUMULATED BENEFIT OBLIGATION IN EXCESS OF PLAN ASSETS** |  |  |  |  |
| Accumulated benefit obligation | $211438 | $31783 | $216547 | $34189 |
| Fair value of plan assets | $178883 | $527 | $174170 | $511 |
| **INFORMATION FOR PENSION PLANS WITH A PROJECTED BENEFIT OBLIGATION IN EXCESS OF PLAN ASSETS** |  |  |  |  |
| Projected benefit obligation | $211438 | $31789 | $216547 | $34198 |
| Fair value of plan assets | $178883 | $527 | $174170 | $511 |
| **WEIGHTED AVERAGE ASSUMPTIONS USED IN DETERMINING ASSETS AND LIABILITIES** |  |  |  |  |
| Discount rate | 5.8% | 6.0% | 5.7% | 5.5% |
| Rate of compensation increase | N/A | 3.0% | N/A | 3.0% |
| Accumulated benefit obligations | $(211438) | $(308934) | $(216547) | $(315748) |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

Actuarial gains in the US plans resulting in a decrease to our projected benefit obligation for the year ended April 30, 2026, were primarily due to a change in the discount rate. Actuarial gains for the non-US plans, resulting in a decrease to our projected benefit obligation for the year ended April 30, 2026, were primarily due to changes in the discount rates, offset by losses from demographic experience and a change in the mortality assumption for the UK Plan.

Actuarial losses in the US plans resulting in an increase to our projected benefit obligation for the year ended April 30, 2025, were primarily due to a change in the discount rate and losses from actual demographic experience being different than expected. Actuarial gains for the non-US plans, resulting in a decrease to our projected benefit obligation for the year ended April 30, 2025, were primarily due to a change in the discount rates.

Pension plan assets/investments:

The investment guidelines for the defined benefit pension plans are established based upon an evaluation of market conditions, plan liabilities, cash requirements for benefit payments, and tolerance for risk. Investment guidelines include the use of actively and passively managed securities. The investment objective is to ensure that funds are available to meet the plans' benefit obligations when they are due. The investment strategy is to invest in high quality and diversified equity and debt securities to achieve our long-term expectation. The plans' risk management practices provide guidance to the investment managers, including guidelines for asset concentration, credit rating, and liquidity. Asset allocation favors a balanced portfolio, with a global aggregated target allocation of approximately 15% equity securities and 85% fixed income securities and cash. Due to volatility in the market, the target allocation is not always desirable and asset allocations will fluctuate between acceptable ranges of plus or minus 5%. We regularly review the investment allocations and periodically rebalance investments to the target allocations. We categorize our pension assets into three levels based upon the assumptions (inputs) used to price the assets. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1: Unadjusted quoted prices in active markets for identical assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets in active markets or quoted prices for identical assets in inactive markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3: Unobservable inputs reflecting assumptions about the inputs used in pricing the asset.

We did not maintain any level 3 assets during the years ended April 30, 2026 and 2025.

Certain of our pension assets are invested in common collective trusts managed and valued by the fund administrator. The fair value of the funds is based on the Net Asset Value (NAV) of the underlying investments owned by the fund less its liabilities based on published daily rate. Certain investments that are measured at fair value using the NAV per share (or its equivalent) practical expedient do not have to be classified in the fair value hierarchy. The fair value amounts presented in the following tables are intended to permit reconciliation of the fair value hierarchy to the amounts presented for the total pension benefit plan assets. For those plan assets measured at NAV, a redemption request can be executed within a 7-day notice. There are no unfunded commitments or redemption restrictions for these funds.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The following tables set forth, by level within the fair value hierarchy, pension plan assets at their fair value as of April 30:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2026** | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** | **2025** |
| | **Level 1** | **Level 2** | **NAV** | **Total** | **Level 1** | **Level 2** | **NAV** | **Total** |
| **US Plan Assets** |  |  |  |  |  |  |  |  |
| Global equity securities: Limited Partnership |  | $4740 | $49912 | $54652 |  | $4904 | $51727 | $56631 |
| Fixed income securities: Commingled trust funds |  |  | 124231 | 124231 |  |  | 117539 | 117539 |
| Total US plan assets |  | $4740 | $174143 | $178883 |  | $4904 | $169266 | $174170 |
| **Non-US Plan Assets** |  |  |  |  |  |  |  |  |
| Equity securities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;US equities | $— | $11922 |  | $11922 | $— | $25110 |  | $25110 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-US equities |  | 5412 |  | 5412 |  | 9530 |  | 9530 |
| Balanced managed funds |  | 49171 |  | 49171 |  | 71629 |  | 71629 |
| Fixed income securities: Commingled funds |  | 145632 |  | 145632 |  | 100740 |  | 100740 |
| Other: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate/other |  | 526 |  | 526 |  | 511 |  | 511 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 11057 | 83397 |  | 94454 | 12503 | 82509 |  | 95012 |
| Total Non-US plan assets | $11057 | $296060 | $— | $307117 | $12503 | $290029 | $— | $302532 |
| Total plan assets | $11057 | $300800 | $174143 | $486000 | $12503 | $294933 | $169266 | $476702 |

---

Expected employer contributions to the defined benefit pension plans in the year ended April 30, 2027 will be approximately $6.0 million, including $2.0 million of minimum amounts required for our non-US plans. From time to time, we may elect to make voluntary contributions to our defined benefit plans to improve their funded status.

Benefit payments to retirees from all defined benefit plans are expected to be the following in the fiscal year indicated:

---

| | | | |
|:---|:---|:---|:---|
| **Fiscal Year** | **US** | **Non-US** | **Total** |
| 2027 | $16120 | $14921 | $31041 |
| 2028 | 16100 | 15000 | 31100 |
| 2029 | 16117 | 16233 | 32350 |
| 2030 | 15796 | 17207 | 33003 |
| 2031 | 15623 | 17998 | 33621 |
| 2032–2036 | 77619 | 103865 | 181484 |
| Total | $157375 | $185224 | $342599 |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Retiree Health Benefits***

We provide contributory life insurance and health care benefits, subject to certain dollar limitations, for substantially all of our eligible retired US employees. The retiree health benefit is no longer available for any employee who retires after December 31, 2017. The cost of such benefits is expensed over the years the employee renders service and is not funded in advance. The accumulated postretirement benefit obligation recognized on the Consolidated Statements of Financial Position as of April 30, 2026 and 2025 was $0.3 million and $0.6 million, respectively. Annual credits for these plans were $(0.3) million, $(0.1) million, and $(0.1) million for the years ended April 30, 2026, 2025, and 2024, respectively, and are reflected in Operating and administrative expenses on our Consolidated Statements of Income (Loss).

***Defined Contribution Savings Plans***

We have defined contribution savings plans. Our contribution is based on employee contributions and the level of our match. We may make discretionary contributions to all employees as a group. The expense recorded for these plans was approximately $21.5 million, $22.8 million, and $27.0 million in the years ended April 30, 2026, 2025, and 2024, respectively, and is reflected in Operating and administrative expenses on our Consolidated Statements of Income (Loss).

**Note 18– Stock-Based Compensation**

The Company provides stock-based compensation to its employees and non-employee directors, which may include restricted stock units (RSU), PSU, and stock options (collectively, stock-based awards). All equity compensation plans have been approved by shareholders. On September 29, 2022, the Company's shareholders approved the John Wiley & Sons, Inc. 2022 Omnibus Stock and Long-Term Incentive Plan (the 2022 Plan), which replaced, with respect to new award grants, our 2014 Key Employee Stock Plan and 2018 Director Stock Plan (the Prior Plans) that were previously in effect. Following the approval of the 2022 Plan, no further awards were available to be issued under the Prior Plans, but awards outstanding under the Prior Plans as of that date remain outstanding in accordance with their terms. A total number of 6.2 million shares of our Class A stock was authorized under the 2022 Plan. In addition, any outstanding awards cancelled from the Prior Plans are added to the shares available under the 2022 Plan. As of April 30, 2026, there were approximately 4.7 million securities remaining that are available for future issuance under the 2022 Plan. We issue treasury shares to fund awards issued under the 2022 Plan.

***Performance-Based and Other Restricted Stock Activity***

Under the terms of our long-term incentive plans, PSU are payable in restricted shares of our Class A Common Stock upon the achievement of certain three-year or less financial performance-based targets. During each three-year period or less, we adjust compensation expense based upon our best estimate of expected performance. PSU vest 100% on June 30 following the end of the three-year performance cycle.

We may also grant individual RSU payable in shares of our Class A Common Stock to key employees in connection with their employment. RSU generally vest ratably 25% per year.

Under certain circumstances relating to a change of control or termination, as defined, the restrictions would lapse and shares would vest earlier.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

Activity for performance-based and other restricted stock awards during the years ended April 30, was as follows (shares in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2026** | **2026** | **2025** | **2024** |
| | **Restricted<br>Shares** | **Weighted<br>Average<br>Grant Date<br>Value** | **Restricted<br>Shares** | **Restricted<br>Shares** |
| Nonvested shares at beginning of year | 1216 | $38.51 | 1203 | 1073 |
| Granted | 599 | $42.77 | 735 | 1089 |
| Change in shares due to performance | 33 | $28.67 | 71 | 54 |
| Vested and issued | (492) | $40.57 | (448) | (660) |
| Forfeited | (147) | $40.87 | (345) | (353) |
| Nonvested shares at end of year | 1209 | $39.22 | 1216 | 1203 |

---

We recognized stock-based compensation expense (including stock options) primarily in Operating and administrative expenses on the Consolidated Statements of Income (Loss), on a pretax basis, as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Stock-based compensation expense | $20608 | $22222 | $24982 |

---

As of April 30, 2026, there was $28.5 million of unrecognized share-based compensation cost related to performance-based and other restricted stock awards, which is expected to be recognized over a period up to 4.0 years, or 2.2 years on a weighted average basis.

Compensation expense for restricted stock awards is measured using the closing market price of our Class A Common Stock at the date of grant. The total grant date value of shares vested during the years ended April 30 was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **2026** | **2025** | **2024** |
| Grant date value of shares vested | $19966 | $18504 | $29874 |

---

***Stock Option Activity***

Under the terms of our stock option plan, the exercise price of stock options granted may not be less than 100% of the fair market value of the stock at the date of grant. Options are exercisable over a maximum period of ten years from the date of grant. There were no options granted in the years ended April 30, 2026 and 2025, respectively. For the options granted in the year ended April 30, 2024, such options generally vest 10%, 20%, 30%, and 40% on April 30, or on each anniversary date after the award is granted.

The following table provides the estimated weighted average fair value for options granted during the year ended April 30, 2024 using the Black-Scholes option-pricing model, and the significant weighted average assumptions used in their determination:

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | |
|:---|:---|
| Weighted average fair value of options on grant date | $6.47 |
| <u>Weighted average assumptions:</u> |  |
| Expected life of options (years) | 6.3 |
| Risk-free interest rate | 4.6% |
| Expected volatility | 34.0% |
| Expected dividend yield | 4.6% |
| Fair value of common stock on grant date | $30.37 |
| Exercise price of stock option grant | $34.86 |

---

As of April 30, 2026, there was $0.3 million of unrecognized share-based compensation cost related to options, which is expected to be recognized over a period up to 2.0 years, or 1.0 year on a weighted average basis.

The following table summarizes the activity and status of our stock option plans during the year ended April 30, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Number<br>of Options<br>(in 000's)** | **Weighted<br>Average<br>Exercise<br>Price** | **Weighted<br>Average<br>Remaining<br>Term<br>(in years)** | **Aggregate<br>Intrinsic<br>Value <br>(in millions)** |
| Outstanding at beginning of year | 250 | $46.87 |  |  |
| Granted |  | $— |  |  |
| Exercised | (3) | $32.68 |  |  |
| Expired or forfeited | (3) | $55.99 |  |  |
| Outstanding at end of year | 244 | $46.93 | 6.5 | $0.8 |
| Exercisable at end of year | 181 | $50.90 | 6.2 | $0.4 |
| Vested and expected to vest in the future at April 30 | 243 | $46.98 | 6.5 | $0.8 |

---

The intrinsic value is the difference between our common stock price and the option grant price. The total intrinsic value of options exercised during the years ended April 30, 2026 and 2025 was less than $0.1 million and $0.1 million, respectively. There were no options exercised during the year ended April 30, 2024.

The total grant date fair value of stock options vested during the years ended April 30, 2026, 2025, and 2024 was $0.2 million, $0.6 million, and $0.9 million, respectively.

***Director Stock Awards***

Under the terms of the 2022 Plan, each nonemployee director is eligible to receive an annual award of restricted shares of our Class A Common Stock equal in value to 100% of the annual director stock retainer fee, based on the stock price at the close of the New York Stock Exchange on the date of grant. Such restricted shares will vest on the earliest of (i) the day before the next annual meeting of stockholders following the grant, (ii) the nonemployee director's death or disability (as determined by the Governance Committee of the Board of Directors (Governance Committee)), or (iii) a change in control (as defined in the 2022 Plan). The granted shares may not be sold or transferred during the time the nonemployee director remains a director.

There were 26,980, 23,940, and 25,744 restricted shares awarded under the 2022 Plan for the years ended April 30, 2026, 2025, and 2024, respectively. In addition, pursuant to the John Wiley & Sons, Inc. Deferred Compensation Plan for Directors' 2005 & After Compensation, as amended through September 20, 2022 (Deferred Compensation Plan), each nonemployee director has the option of receiving all or part of the annual cash retainer in the form of deferred stock and receive dividends in the form of deferred stock. The annual cash retainers deferred as stock and the dividends received in the form of deferred stock, all pursuant to the Deferred Compensation Plan, are nominal for the years ended April 30, 2026, 2025, and 2024.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 19 – Capital Stock and Changes in Capital Accounts**

Wiley has two classes of common stock, Class A and Class B. Each share of our Class B Common Stock is convertible into one share of Class A Common Stock. The holders of Class A stock are entitled to elect 30% of the entire Board of Directors and the holders of Class B stock are entitled to elect the remainder. On all other matters, each share of Class A stock is entitled to one tenth of one vote, and each share of Class B stock is entitled to one vote.

***Share Repurchases***

In fiscal year 2020, our Board of Directors authorized a share repurchase program of up to $200 million of Class A or B Common Stock, which was fully utilized as of April 30, 2026. In the first quarter of fiscal year 2026, our Board of Directors authorized an additional share repurchase program of up to $250 million of Class A or B Common Stock. As of April 30, 2026, $207.4 million of share repurchase authority remained under this authorization.

The following table summarizes the share repurchases during the years ended April 30 (shares in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **2026** | **2025** | **2024** |
| Shares repurchased - Class A | 2843 | 1186 | 1294 |
| Shares repurchased - Class B | 7 | 173 | 3 |
| Average price - Class A and Class B | $35.08 | $44.16 | $34.71 |

---

The average price per share excludes excise taxes payable on share repurchases and may differ from the share repurchases reflected in Purchases of treasury shares in our Consolidated Statements of Cash Flows. As of April 30, 2026, total shares repurchased include unsettled purchases.

***Dividends***

We declared and paid quarterly cash dividends on our Class A and Class B Common Stock for a total of $74.4 million, $76.1 million, and $77.0 million during the years ended April 30, 2026, 2025, and 2024, respectively.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

***Changes in Common Stock***

The following is a summary of changes during the years ended April 30, in shares of our common stock and common stock in treasury (shares in thousands).

---

| | | | |
|:---|:---|:---|:---|
| **Changes in Class A Common Stock:** | **2026** | **2025** | **2024** |
| **Number of shares, beginning of year** | 70312 | 70259 | 70231 |
| Common stock class conversions | 2 | 53 | 28 |
| **Number of shares issued, end of year** | 70314 | 70312 | 70259 |
| **Changes in Class A Common Stock in treasury:** |  |  |  |
| **Number of shares held, beginning of year** | 25687 | 24828 | 23983 |
| Restricted shares issued under stock-based compensation plans | (492) | (448) | (662) |
| Impact of tax withholding on stock-based compensation and other | 181 | 121 | 213 |
| Purchases of treasury shares | 2843 | 1186 | 1294 |
| **Number of shares held, end of year** | 28219 | 25687 | 24828 |
| **Number of Class A Common Stock outstanding, end of year** | 42095 | 44625 | 45431 |
| **Changes in Class B Common Stock:** | **2026** | **2025** | **2024** |
| **Number of shares, beginning of year** | 12870 | 12923 | 12951 |
| Common stock class conversions | (2) | (53) | (28) |
| **Number of shares issued, end of year** | 12868 | 12870 | 12923 |
| **Changes in Class B Common Stock in treasury:** |  |  |  |
| **Number of shares held, beginning of year** | 4101 | 3928 | 3925 |
| Purchases of treasury shares | 7 | 173 | 3 |
| **Number of shares held, end of year** | 4108 | 4101 | 3928 |
| **Number of Class B Common Stock outstanding, end of year** | 8760 | 8769 | 8995 |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 20 – Segment Information**

We report our segment information in accordance with the provisions of FASB ASC Topic 280, "Segment Reporting." We determine our operating and reportable segments based on how our CODM evaluates our business performance, manages the operations, makes operating decisions, and allocates resources.

Our segment reporting structure consists of three operating and reportable segments, which are listed below, as well as a Corporate expense category, which includes certain costs that are not allocated to the reportable segments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Research

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Learning

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Held for Sale or Sold

Our President and Chief Executive Officer is the Company's CODM. The performance metric used by our CODM to evaluate performance of our reportable segments is Adjusted Operating Income. The CODM uses Adjusted Operating Income during the annual budgeting process and evaluates budget and forecast-to-actual variances on a monthly basis to make decisions about the allocation of resources to our segments.

Our significant expense categories that are included within Adjusted Operating Income include cost of sales, direct expenses, allocated expenses from our Corporate expense category, and amortization of intangible assets. The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.

The following tables present a summary of our Adjusted Operating Income (Loss) by segment, and the reconciliation to Income (loss) before taxes:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended April 30, 2026** | **For the Year Ended April 30, 2026** | **For the Year Ended April 30, 2026** |
| | **Research** | **Learning** | **Total** |
| Revenue | $1129942 | $546586 | $1676528 |
| Cost of sales | 303702 | 127807 | 431509 |
| Direct expenses | 331192 | 136301 | 467493 |
| Allocated Corporate expenses | 167578 | 107909 | 275487 |
| Amortization of intangible assets | 44866 | 8184 | 53050 |
| **Adjusted Operating Income by segment**<sup>(1)</sup> | $282604 | $166385 | $448989 |
| Reconciliation of Adjusted Operating Income by segment to Income before taxes |  |  |  |
| &nbsp;&nbsp;Adjusted unallocated Corporate expenses<sup>(2)</sup> |  |  | (152819) |
| &nbsp;&nbsp;Restructuring and related charges<sup>(3)</sup> |  |  | (19203) |
| &nbsp;&nbsp;Interest expense |  |  | (43848) |
| &nbsp;&nbsp;Net foreign exchange transaction losses |  |  | (6564) |
| &nbsp;&nbsp;Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale |  |  | (4828) |
| &nbsp;&nbsp;Other expense, net |  |  | (6533) |
| &nbsp;&nbsp;Legal settlement<sup>(4)</sup> |  |  | (108) |
| **Income before taxes** |  |  | $215086 |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Year Ended April 30, 2025** | **For the Year Ended April 30, 2025** | **For the Year Ended April 30, 2025** | **For the Year Ended April 30, 2025** |
| | **Research** | **Learning** | **Held for Sale or Sold** | **Total** |
| Revenue | $1075459 | $584768 | $17382 | $1677609 |
| Cost of sales | 278867 | 144758 | 7755 | 431380 |
| Direct expenses | 336484 | 142204 | 10365 | 489053 |
| Allocated Corporate expenses | 160959 | 114703 | 2840 | 278502 |
| Amortization of intangible assets | 43569 | 8253 |  | 51822 |
| **Adjusted Operating Income (Loss) by segment** | $255580 | $174850 | $(3578) | $426852 |
| Reconciliation of Adjusted Operating Income by segment to Income before taxes |  |  |  |  |
| &nbsp;&nbsp;Adjusted unallocated Corporate expenses<sup>(2)</sup> |  |  |  | (179882) |
| &nbsp;&nbsp;Restructuring and related charges<sup>(3)</sup> |  |  |  | (25561) |
| &nbsp;&nbsp;Interest expense |  |  |  | (52547) |
| &nbsp;&nbsp;Net foreign exchange transaction losses |  |  |  | (8142) |
| &nbsp;&nbsp;Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale |  |  |  | (23340) |
| &nbsp;&nbsp;Other income, net |  |  |  | 5498 |
| **Income before taxes** |  |  |  | $142878 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Year Ended April 30, 2024** | **For the Year Ended April 30, 2024** | **For the Year Ended April 30, 2024** | **For the Year Ended April 30, 2024** |
| | **Research** | **Learning** | **Held for Sale or Sold** | **Total** |
| Revenue | $1042705 | $574739 | $255543 | $1872987 |
| Cost of sales | 281109 | 145054 | 153559 | 579722 |
| Direct expenses | 323392 | 145514 | 48127 | 517033 |
| Allocated Corporate expenses | 155495 | 132394 | 23142 | 311031 |
| Amortization of intangible assets | 44946 | 9044 | 2004 | 55994 |
| **Adjusted Operating Income by segment** | $237763 | $142733 | $28711 | $409207 |
| Reconciliation of Adjusted Operating Income by segment to Income before taxes |  |  |  |  |
| &nbsp;&nbsp;Adjusted unallocated Corporate expenses<sup>(2)</sup> |  |  |  | (185456) |
| &nbsp;&nbsp;Impairment of goodwill<sup>(3)</sup> |  |  |  | (108449) |
| &nbsp;&nbsp;Restructuring and related charges<sup>(3)</sup> |  |  |  | (63041) |
| &nbsp;&nbsp;Interest expense |  |  |  | (49003) |
| &nbsp;&nbsp;Net foreign exchange transaction losses |  |  |  | (2959) |
| &nbsp;&nbsp;Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale |  |  |  | (183389) |
| &nbsp;&nbsp;Other expense, net |  |  |  | (3957) |
| **Loss before taxes** |  |  |  | $(187047) |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

(1) Our Held for Sale or Sold segment is excluded from the segment results as all businesses within this segment were sold prior to the start of the reporting period presented. See <u>[Note](#i4999d179a1ee4db3afe68151d34a8db6_115) [4](#i4999d179a1ee4db3afe68151d34a8db6_115)</u>, "Acquisition and Divestitures" for more details on the divestitures.

(2) Corporate expenses include certain costs that are not allocated to the reportable segments.

(3) See <u>[Note 7](#i349fc9c6047d49dbbed2272840f209d9_6505)</u>, "Restructuring and Related Charges" and <u>[Note 11](#i4999d179a1ee4db3afe68151d34a8db6_136)</u>, "Goodwill and Intangible Assets" for more information of these charges by segment.

(4) In the year ended April 30, 2026, we settled a litigation matter related to consideration for a previous acquisition for $0.1 million which is included in Corporate Operating and administrative expenses.

<u>[See Note 3](#i07367b72690a4395824ae69fddb9e9fe_18015)</u>, "Revenue Recognition, Contracts with Customers," for revenue from contracts with customers disaggregated by segment and product type for the years ended April 30, 2026, 2025, and 2024.

Depreciation and amortization expense were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| Research | $92472 | $89302 | $93422 |
| Learning | 41148 | 43900 | 57696 |
| Held for Sale or Sold |  |  | 3437 |
| Total depreciation and amortization | $133620 | $133202 | $154555 |
| Corporate depreciation and amortization | 9857 | 13924 | 22434 |
| Total depreciation and amortization | $143477 | $147126 | $176989 |

---

Revenue by geographical area is attributed based on the location of the legal entity that recognized the revenue. Previously, revenue was attributed based on the location of the customer. We believe the change to revenue attributed based upon legal entity better reflects the geographical profile of our revenue and how we manage our operations. Prior period information has been recast to reflect this change.

Revenue from external customers by geographical area was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Years Ended April 30,** | **For the Years Ended April 30,** | **For the Years Ended April 30,** |
| | **2026** | **2025** | **2024** |
| United States | $854540 | $848575 | $988129 |
| United Kingdom | 490431 | 498934 | 520418 |
| Germany | 192291 | 183044 | 172855 |
| Other countries | 139266 | 147056 | 191585 |
| Total | $1676528 | $1677609 | $1872987 |

---

Total long-lived assets, consisting of technology, property and equipment, net and operating lease ROU assets by geographical area as of April 30 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **2026** | **2025** | **2024** |
| United States | $157172 | $185610 | $213192 |
| United Kingdom | 21187 | 25315 | 27584 |
| Other countries | 15029 | 17328 | 20736 |
| Total | $193388 | $228253 | $261512 |

---

Our CODM reviews our financial position at a consolidated level and does not review assets by segment to evaluate segment performance or allocate resources. As such, assets by segment are not disclosed.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Note 21 – Subsequent Event**

On June 1, 2026, John Wiley & Sons Ltd. (Buyer), a private limited company incorporated in England and Wales and an indirect wholly-owned subsidiary of the Company, entered into an Equity Purchase Agreement (Purchase Agreement) with CIG Emerald Midco LLC, a Delaware limited liability company (Seller), and CIG Emerald Holding LLC, a Delaware limited liability company (Emerald Holding), pursuant to which Buyer acquired from the Seller all of the issued and outstanding equity securities of Emerald Holding (Transaction) in exchange for £337.5 million (approximately $452 million based on the exchange rate on June 1, 2026), subject to customary purchase price adjustments.

The acquisition was made to extend Wiley's scale in its Research business and to strengthen its proprietary content advantage in AI. Emerald Holding, through its subsidiaries, operates Emerald Publishing, a research publisher headquartered in Leeds, England, with a portfolio of over 480 peer-reviewed journals, 8,000 books, and 3,000 business cases across disciplines with particular emphasis on economics, business, finance, engineering, and the social sciences. The purchase price was funded with available cash and proceeds from the Company's revolving credit facility under the Amended and Restated CA. For its year ended December 31, 2025, Emerald Holding had total revenue of approximately $82.7 million.

The initial accounting for the acquisition, including the final purchase price and purchase price allocation, is not yet complete. As such, we are not able to disclose certain information relating to the acquisition, including the preliminary fair value of assets acquired and liabilities assumed. We estimate the purchase price allocation is primarily related to goodwill, along with identified intangible assets that may consist of content, customer relationships, and brands and trademarks. We do not expect to acquire a material amount of tangible assets, and the liabilities assumed primarily relate to contract liabilities. We expect to complete the purchase price allocation within the measurement period, which will not exceed one year from the acquisition date.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure**

None

**Item 9A. Controls and Procedures**

*Disclosure Controls and Procedures:* The Company's Chief Executive Officer and Chief Financial Officer, together with the Chief Accounting Officer and other members of the Company's management, have conducted an evaluation of the Company's disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the Exchange Act) as of the end of the period covered by this report. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports filed or submitted under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission's rules and forms, and (ii) accumulated and communicated to the Company's management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

*Changes in Internal Control over Financial Reporting:* There were no changes in our internal control over financial reporting in the fourth quarter of fiscal year 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

*Management's Report on Internal Control over Financial Reporting:* Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) of the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, management conducted an evaluation of the effectiveness of our internal control over financial reporting based upon the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on their evaluation, our management concluded that our internal control over financial reporting was effective as of April 30, 2026.

The effectiveness of our internal control over financial reporting as of April 30, 2026 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which is included herein.

**Item 9B. Other Information**

During the fiscal quarter ended April 30, 2026, none of our directors or officers adopted, modified or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement" as such terms are defined under Item 408 of Regulation S-K.

**Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections**

Not applicable.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**PART III**

**Item 10. Directors, Executive Officers and Corporate Governance**

Set forth below is information about the Company's current executive officers and directors.

**<u>Information About Our Executive Officers</u>**

---

| | | |
|:---|:---|:---|
| **Name, Current and Former Positions** | **Age** | **First Elected to<br>Current Position** |
| **Matthew Kissner** | 72 | October 2023 |
| President and Chief Executive Officer and Director |  |  |
| July 2024 – Former Interim President and Chief Executive Officer, Wiley |  |  |
| May 2017 – Former Interim CEO, Group Executive and Board Chair, Wiley |  |  |
| June 1999-Present – Vice Chair, Regional Plan Association |  |  |
| **Craig Albright** | 56 | June 2025 |
| Executive Vice President and Chief Financial Officer |  |  |
| February 2024 – Independent Consultant |  |  |
| February 2020 – CFO, Americas & Global Cash Center Lead, Xerox |  |  |
| **Christopher Caridi** | 60 | June 2025 |
| Senior Vice President, Chief Accounting Officer and Finance Transformation Leader |  |  |
| September 2024 – Senior Vice President, Chief Accounting Officer and Interim Chief Financial Officer |  |  |
| October 2020 – SVP, Global Corporate Controller and Chief Accounting Officer, Wiley |  |  |
| June 2020 – SVP, Chief Accounting Officer and Controller, Teladoc Health, Inc. |  |  |
| March 2017 – SVP, Chief Accounting Officer and Controller, Wiley |  |  |
| **Jessica Kowalski** | 45 | May 2026 |
| Executive Vice President and General Manager, Research |  |  |
| January 2022 – General Manager of Consulting and Customer Success, Microsoft |  |  |
| August 2018 – General Manager Accenture/AWS Business Group, AWS |  |  |
| **Danielle McMahan** | 51 | November 2019 |
| Executive Vice President and Chief People Officer |  |  |
| September 2017 – Chief Human Resources Officer, York Risk Services |  |  |
| June 2020-Present – Board Member, All In Together |  |  |
| **Kevin Monaco** | 62 | October 2018 |
| Senior Vice President, Treasurer and Tax |  |  |
| October 2009 – SVP, Finance, Treasurer, and Investor Relations, Coty Inc. |  |  |
| 2019-Present – Treasurer, The Wiley Foundation |  |  |
| **Deirdre Silver** | 58 | February 2020 |
| Executive Vice President and General Counsel |  |  |
| August 2015 – Associate General Counsel, SVP of Legal, Research, Wiley |  |  |
| November 2018-Present – Director, Copyright Clearance Center |  |  |
| **Andrew Weber** | 58 | November 2024 |
| Executive Vice President, Technology & Operations |  |  |
| November 2023 – SVP, Operations, Wiley |  |  |
| July 2021 – SVP, Business Management & Operations, Wiley |  |  |
| September 2020 – Global Chief Operating Officer, Macmillan Publishers |  |  |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**<u>Information About Our Non-Employee Directors</u>**

---

| | |
|:---|:---|
| **Jesse C. Wiley**<br>*Chair of the Board*<br>Director Since: 2012 | **Mr. Wiley, 55,** is a 7th generation member of the Wiley family and brings to the Board deep knowledge and a passion for the contributions Wiley makes to research, learning and knowledge. His alignment with shareholder and stakeholder interests makes Mr. Wiley an important part of the Board's governance processes, along with a majority of independent directors. Mr. Wiley has broad and deep experience in Wiley's industries with partners and customers in the markets Wiley serves. He also brings in-depth knowledge of numerous businesses, functions and initiatives within Wiley, including in digital publishing and platforms and new product and business development, partnerships and global business and M&A. Mr. Wiley was elected Chair of the Board of Directors of Wiley in 2019, having served as a director since 2012. Prior to being elected as Chair, Mr. Wiley was an employee since 2003. Before becoming Chair, Mr. Wiley worked in Wiley's Research division on business development including building partnerships with academic and professional societies, and in China. Previously he worked in corporate M&A and strategy development, on international business development, digital and new business initiatives, and product development. Prior to that, he worked as a marketer and editor of professional books and products. |
| **Katya D. Andresen**<br>*EVP and Chief Data, Digital & AI Officer, The Cigna Group*<br>Director Since: 2025 | **Ms. Andresen, 58,** brings over 25 years of experience driving digital transformation and technology innovation across diverse industries. She is a recognized expert in artificial intelligence, data monetization, and enterprise-wide digital strategy, having held senior executive positions in Fortune 100 companies focused on leveraging technology to create new business models and drive customer experience innovation. Since 2021, she has served in various roles at The Cigna Group, most recently as EVP and Chief Data, Digital & AI Officer at The Cigna Group, where she leads digital transformation initiatives across the $247 billion global health services company. Her expertise spans building AI-powered solutions, transforming traditional businesses into digital-first organizations, and scaling technology capabilities across large, complex enterprises. She actively contributes to the venture capital ecosystem, academic communities, and mission driven organizations in various capacities, including as a Wiley published author and thought leader on digital innovation. Ms. Andresen currently serves on the boards of Forsyth Health and the Morrison Center for Marketing and Analytics at the UCLA Anderson School of Management and is a sought-after AI advisor to venture capital firms. |
| **Mari J. Baker**<br>*Former Chief Executive Officer, PlayFirst, Inc.*<br>Director Since: 2011 | **Ms. Baker, 61,** has over 30 years of board service in public, private and non-profit environments. She is an experienced general manager and business leader, and has held a number of executive officer positions in public and private companies primarily in technology fields, including roles as Chief Executive Officer of PlayFirst, Inc. and Navigenics, Inc., Chief Operating Officer of Velti, plc (Nasdaq: VELT), President of BabyCenter, Inc., a Johnson and Johnson company (NYSE: JNJ), and SVP/General Manager at Intuit, Inc. (Nasdaq: INTU). She has also been involved in venture capital, higher education, and executive leadership communities, in various capacities, including serving on the Board of Trustees of Stanford University. Ms. Baker also currently serves on the board of Blue Shield of California (BSC), where she currently chairs the Compensation Committee, serves on the Finance and Investment Committee, and previously chaired the Audit Committee. She also serves on the Board of Ascendiun, Inc., BSC's parent company, where she is also a member of the Executive Committee and the Technology Committee. |
| **David C. Dobson**<br>*Chief Executive Officer, Epiq Global*<br>Director Since: 2017 | **Mr. Dobson, 63,** has over 30 years of experience in transforming and building global technology and service organizations, as well as extensive experience in senior leadership positions. Mr. Dobson has been Chairman and Chief Executive Officer of Epiq, a global provider of legal and business services, since 2026, and Chief Executive Officer since 2019, and also serves on its board of directors. Previously, Mr. Dobson was the Chief Executive Officer of Digital River from 2013 to 2018 and served as Vice Chairman of the Digital River's board of directors until 2019. From 2010 to 2012, Mr. Dobson served as Executive Vice President and Group Executive, Global Lines of Business, at CA Technologies. From 2009 to 2010, Mr. Dobson served as President of Pitney Bowes Management Services, Inc., a wholly owned subsidiary of Pitney Bowes, Inc. |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | |
|:---|:---|
| **Brian O. Hemphill, Ph.D.**<br>*President of Old Dominion University (ODU)*<br>Director Since: 2022 | **Dr. Hemphill, 56,** has extensive executive leadership experience in academia, bringing insight into the needs and practices of the academic community critical for developing and innovating new business models in our key businesses. Dr. Hemphill has served as Old Dominion University's (ODU) ninth president since 2021 and previously served as Radford University's seventh president from 2016 to 2021. Dr. Hemphill has also held senior roles at various educational institutions earlier in his career, including the University of Arkansas-Fayetteville, Northern Illinois University, and West Virginia State University. In his role as President of ODU, Dr. Hemphill serves on various boards and commissions, including the boards of Jefferson Science Associates, LLC and Preston Hollow Community Capital. He brings deep experience in Mergers and Acquisitions (M&A) and is actively engaged in driving innovation through Forward Focused Digital Transformation (FFDT) initiatives across academic and institutional models. |
| **Karen N. Madden, Ph.D.**<br>*Senior Vice President and Chief Technology Officer, MilliporeSigma*<br>Director Since: 2025 | **Dr. Madden, 57,** has extensive executive leadership experience in life science technology and innovation, bringing strategic vision to research and development in the pharmaceutical and biotech industries. Dr. Madden has served as Senior Vice President and Chief Technology Officer at MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany since 2022. Previously, Dr. Madden served as Senior Vice President and Chief Innovation Officer at PerkinElmer from 2016 to 2022, and as their General Manager of Informatics from 2014 to 2016. In her role at MilliporeSigma, Dr. Madden shapes the Technology Roadmap and long-term R&D strategy, leads the Life Science Innovation Board, and serves as a member of the Life Science Executive Team responsible for the overall leadership and governance of the more than $9 billion Life Science Business. She also serves as the U.S. Country Speaker for Merck KGaA, Darmstadt, Germany, and sits on the boards of the Analytical, Life Science, and Diagnostics Association, and the New England Council. |
| **Raymond W. McDaniel, Jr.**<br>*Former Non-Executive Chairman, President and Chief Executive Officer, of the Moody's Corporation*<br>Director Since: 2005 | **Mr. McDaniel, 68,** is a seasoned non-executive director, having served as the non-executive chairman of the board of directors of Moody's Corporation from 2005 to 2012 and again from 2021 to 2023 and a member of the board from 2003 to 2023. Mr. McDaniel is also a global leader with extensive strategic and operational knowledge in a highly regulated financial services environment and experienced in implementing international business expansion, including the launch of new products. He previously served as the Chief Executive Officer of Moody's Corporation for over 15 years from 2005 through 2020, as well as held additional roles in senior leadership including as President and Chief Operating Officer of Moody's Corporation. Mr. McDaniel serves on the board of directors of Raymond James Financial (NYSE: RJF) and as a Trustee on the Muhlenberg College Board. |
| **William J. Pesce**<br>*Retired President and Chief Executive Officer, John Wiley & Sons, Inc.*<br>Director Since: 1998 | **Mr. Pesce, 75,** has extensive experience with leading a global public company, strategic planning, financial planning and analysis, acquisitions and partnerships, and investor relations. In addition, through his active engagement in the academic community and investing in early-stage companies, he has exposure to innovative, technology-enabled business models. He has served as Wiley's 10th President and Chief Executive Officer for 13 years from 1998 to 2011, when he retired after nearly 22 years. Mr. Pesce is a member of the Board of Trustees of William Paterson University. Mr. Pesce is also a benefactor and advisor to the Pesce Family Mentoring Institute at William Paterson University. He served on the Board of Overseers of New York University's Stern School of Business for 17 years until 2005. Mr. Pesce also launched Pesce Family Ventures, LLC in 2015 with the aim to invest in early-stage companies, particularly entities that leverage enabling technology to serve customers. |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | |
|:---|:---|
| **Inder M. Singh**<br>*Chief Financial Officer and Chief Operating Officer of IonQ*<br>Director Since: 2021 | **Mr. Singh, 67,** has extensive finance and corporate management experience, as well as knowledge in the technology and infrastructure sectors in both developed and emerging markets, serving as CFO and COO of IonQ Quantum, (NYSE: IONQ) where he previously served as Lead Independent Director and Chair of its Audit Committee until September 2025, when he took on his current operating role. Mr. Singh previously served as Executive Vice President and Chief Financial Officer of Arm Limited from 2019 to 2022. From 2016 to 2019, Mr. Singh served as Senior Vice President and Chief Financial Officer, and in 2016, as Chief Strategy and Marketing Officer, of Unisys Corp. Prior to that, Mr. Singh was a Managing Director at SunTrust Bank's equities unit from 2013 to 2016, and a Senior Vice President in finance at Comcast Corporation from 2012 to 2013. Mr. Singh is currently a member of the Board of Directors of Axelera AI, Switch Data Centers and the advisory board of Resonance. <br>In addition to his role as Chair of the Audit Committee at Wiley, he also serves as Audit Committee chair at Switch Data Centers and Axelera AI. He has advised startups as a member of Columbia University's Entrepreneurship Advisory Board and Engineering Development Council. He has also participated as a project advisor for the U.S. Department of Homeland Security and other agencies on national security and critical infrastructure matters. |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

The following information will be included in the Company's Proxy Statement for our 2026 Annual Meeting of Shareholders to be filed within 120 days of the Company's fiscal year end of April 30, 2026 (2026 Proxy Statement) and is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Additional information about our directors who are standing for reelection and any persons nominated to become directors of the Company is contained under the caption "Election of Director Nominees".

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Information regarding compliance with Section 16(a) of the Securities Exchange Act of 1934 is incorporated herein by reference to the information set forth under the caption "Delinquent Section 16(a) Reports".

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Information concerning the Company's committees of the Board of Directors, including the audit committee and designated financial experts is contained under the captions "Report of the Audit Committee" and "Committees of the Board of Directors."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Information concerning the Company's code of business conduct and ethics for directors, officers and employees, also known as the "Business Conduct and Ethics Policy" and the Company's "Corporate Governance Principles" are described under "Corporate Governance — Key Corporate Governance Documents." All of these documents are publicly available on the Company's Corporate Governance website at *https://www.wiley.com/en-us/corporategovernance.*

**Item 11. Executive Compensation**

The information required by this item will be included in the 2026 Proxy Statement under the headers "Directors' Compensation," "Compensation Committee Interlocks and Insider Participation," and "Executive Compensation," respectively, and is incorporated herein by reference.

**Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters**

The following information required in this item will be included under the "Ownership of Common Stock" section in the Company's 2026 Proxy Statement and is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Information on the beneficial ownership reporting for the directors and executive officers is contained under the caption "Stock Ownership of Officers and Directors."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Information on the beneficial ownership reporting for all other shareholders that own 5% or more of the Company's Class A or Class B Common Stock is contained under the caption "Stock Ownership of Certain Beneficial Owners."

The following table summarizes the Company's equity compensation plan information as of April 30, 2026:

---

| | | | |
|:---|:---|:---|:---|
| **Plan Category** | **Number of**<br>**Securities to Be**<br>**Issued Upon Exercise**<br>**of Outstanding Options,**<br>**Warrants and Rights** <sup>(1)</sup> | **Weighted Average<br>Exercise Price of<br>Outstanding Options,<br>Warrants and Rights** | **Number of**<br>**Securities Remaining**<br>**Available for Future**<br>**Issuance Under Equity**<br>**Compensation Plans** <sup>(2)</sup> |
| Equity compensation plans approved by shareholders | 1453427 | $46.93 | 4719727 |

---

(1)This amount includes the following awards issued under the 2022 Plan and Prior Plans:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 244,000 shares issuable upon the exercise of outstanding stock options with a weighted average exercise price of $46.93.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 1,209,427 non-vested performance-based and other restricted stock awards. Since these awards have no exercise price, they are not included in the weighted average exercise price calculation.

(2)Per the terms of the 2022 Plan, a total of 6,200,000 shares shall be authorized for awards granted under the 2022 Plan, less one (1) share for every one (1) share that was subject to an award granted under a Prior Plan after July 13, 2022 and prior to the approval of the 2022 Plan on September 29, 2022 (Effective Date). In addition, after July 13, 2022, if any shares subject to an award under any Prior Plans are forfeited or an award under any Prior Plans expires or is settled for cash, then in each such case the shares subject to such award or award under any Prior Plan shall be added to the shares available for awards under the Plan, on a one-for-one-basis. After the Effective Date of the 2022 Plan, no awards may be granted under any Prior Plan.

All of the Company's equity compensation plans are approved by shareholders.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Item 13. Certain Relationships and Related Transactions, and Director Independence**

Information on related party transactions and the policies and procedures for reviewing and approving related party transactions will be contained under the caption "Transactions with Related Persons" within the "Corporate Governance" section of the 2026 Proxy Statement and are incorporated herein by reference.

Information on director independence will be contained under the caption "Director Independence" within the "Corporate Governance" section of the 2026 Proxy Statement and is incorporated herein by reference.

**Item 14. Principal Accountant Fees and Services**

Our independent registered public accounting firm is PricewaterhouseCoopers LLP, New York, NY, Auditor ID: 238

Information required by this item will be contained in the 2026 Proxy Statement under the captions "Audit Committee Matters" and "Audit Committee Report" and is incorporated herein by reference.

**PART IV**

**Item 15. Exhibits and Financial Statement Schedules**

**(a) Documents filed as a part of this Annual Report on Form 10-K:**

(1) Financial Statements

See Index to Consolidated Financial Statements and Schedule of this Annual Report on Form 10-K in Part II Item 8.

(2) Financial Statement Schedule

See Schedule II - Valuation and Qualifying Accounts and Reserves - Years Ended April 30, 2026, 2025, and 2024 of this Annual Report on Form 10-K. The other schedules are omitted as they are not applicable, or the amounts involved are not material.

(3) Exhibits

---

| | |
|:---|:---|
| **Articles of Incorporation and By-Laws** | **Articles of Incorporation and By-Laws** |
| **3.1** | <u>[Restated Certificate of Incorporation of John Wiley & Sons, Inc. February 26, 2025](https://www.sec.gov/Archives/edgar/data/107140/000010714025000081/exhibit31-restatedcertif.htm)[(incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2025).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000081/exhibit31-restatedcertif.htm)</u> |
| **3.2** | <u>[Amended and Restated By-Laws effective December 13, 2023 (incorporated by reference to Form 8-K dated December 19, 2023)](https://www.sec.gov/Archives/edgar/data/107140/000010714023000248/wiley-bylawsclean121323f.htm)</u>. |
| **Instruments Defining the Rights of Security Holders, Including Indentures** | **Instruments Defining the Rights of Security Holders, Including Indentures** |
| **4.1** | <u>[Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended (incorporated by reference to the Company's Annual Report on Form 10-K/A (Amendment No. 1) for the year ended April 30, 2020).](https://www.sec.gov/Archives/edgar/data/107140/000010714020000052/exhibit4_1.htm)</u> |
| **Material Contracts** | **Material Contracts** |
| **10.1** | <u>[Form of the Fiscal Year 202](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit104-fy26eaipfinal.htm)[6](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit104-fy26eaipfinal.htm)[Executive Annual Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 202](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit104-fy26eaipfinal.htm)[5](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit104-fy26eaipfinal.htm)[).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit104-fy26eaipfinal.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit104-fy26eaipfinal.htm)</u> |
| **10.2** | <u>[Form of the Fiscal Year 2026 Executive Long Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 2025).●](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit103-fy26eltipfina.htm)</u> |
| **10.3** | <u>[Form of the Fiscal Year 2025 Executive Long Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 2024).●](https://www.sec.gov/Archives/edgar/data/107140/000010714024000189/exhibit105-fy25executive.htm)</u> |
| **10.4** | <u>[Form of the Fiscal Year 2024 Executive Long Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended October 31, 2023).●](https://www.sec.gov/Archives/edgar/data/107140/000010714023000239/exhibit102formofthefiscaly.htm)</u> |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | |
|:---|:---|
| **10.5** | <u>[Restricted Share Unit Grant Agreement Under the Executive Long-Term Incentive Plan, Under the Business Officer Equity Program Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 202](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit101-fy26restricte.htm)[5](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit101-fy26restricte.htm)[).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit101-fy26restricte.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit101-fy26restricte.htm)</u> |
| **10.6** | <u>[Restricted Share Unit Grant Agreement Under the Executive Long-Term Incentive Plan, Under the Business Officer Equity Program Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 2024).](https://www.sec.gov/Archives/edgar/data/107140/000010714024000189/exhibit102-fy25restricte.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714024000189/exhibit102-fy25restricte.htm)</u> |
| **10.7** | <u>[Restricted Share Unit Grant Agreement for Matthew Kissner Under the Executive Long-Term Incentive Plan, Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 2024).](https://www.sec.gov/Archives/edgar/data/107140/000010714024000189/exhibit106-fy25restricte.htm)</u>● |
| **10.8** | <u>[Restricted Share Unit Grant Agreement Under the Executive Long-Term Incentive Plan, Under the Business Officer Equity Program Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 2023).](https://www.sec.gov/Archives/edgar/data/107140/000010714023000168/exhibit103fy24restrictedsh.htm)</u>● |
| **10.9** | <u>[Restricted Share Unit Grant Agreement for Matthew Kissner Under the Executive Long-Term Incentive Plan, Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended October 31, 2023).](https://www.sec.gov/Archives/edgar/data/107140/000010714023000239/exhibit103fy24restrictedsh.htm)</u>● |
| **10.10** | <u>[Restricted Share Unit Grant Agreement Under the Executive Long-Term Incentive Plan, Under the Business Officer Equity Program Pursuant to the 2014 Key Employee Stock Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 2022).](https://www.sec.gov/Archives/edgar/data/107140/000010714022000038/exhibit10_3.htm)</u>● |
| **10.11** | <u>[Performance Share Unit Grant Agreement Under the Executive Long-Term Incentive Plan, Under the Business Officer Equity Program Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 202](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit102-fy26performan.htm)[5](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit102-fy26performan.htm)[).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit102-fy26performan.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit102-fy26performan.htm)</u> |
| **10.12** | <u>[Performance Share Unit Grant Agreement Under the Executive Long-Term Incentive Plan, Under the Business Officer Equity Program Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended July 31, 2024).](https://www.sec.gov/Archives/edgar/data/107140/000010714024000189/exhibit103-fy25performan.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714024000189/exhibit103-fy25performan.htm)</u> |
| **10.13** | <u>[Performance Share Unit Grant Agreement Under the Executive Long-Term Incentive Plan, Under the Business Officer Equity Program Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended October 31, 2023).](https://www.sec.gov/Archives/edgar/data/107140/000010714023000239/exhibit105fy24performances.htm)</u>● |
| **10.14** | <u>[Form of the Fiscal Year 2024 Non-Qualified Premium Stock Option Grant Agreement Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarterly period ended October 31, 2023).](https://www.sec.gov/Archives/edgar/data/107140/000010714023000239/exhibit104fy24premiumstock.htm)</u>● |
| **10.15** | <u>[John Wiley & Sons, Inc. 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q](https://www.sec.gov/Archives/edgar/data/107140/000010714022000098/exhibit101-johnwileysonsin.htm)[for the quarterly period ended October 31, 2022](https://www.sec.gov/Archives/edgar/data/107140/000010714021000032/exhibit10_5.htm)</u>)<u>[.](https://www.sec.gov/Archives/edgar/data/107140/000010714022000098/exhibit101-johnwileysonsin.htm)</u>● |
| **10.16** | <u>[John Wiley & Sons, Inc. Director Restricted Share Unit Grant Agreement pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended October 31, 202](https://www.sec.gov/Archives/edgar/data/107140/000010714025000198/exhibit101-2025directorr.htm)[5](https://www.sec.gov/Archives/edgar/data/107140/000010714025000198/exhibit101-2025directorr.htm)[.](https://www.sec.gov/Archives/edgar/data/107140/000010714025000198/exhibit101-2025directorr.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714025000198/exhibit101-2025directorr.htm)</u> |
| **10.17** | <u>[John Wiley & Sons, Inc. Deferred Compensation Plan for Directors' 2005 & After Compensation Amended and Restated as of September 29, 2022 (incorporated by reference to the Company's Report on Form 10-Q](https://www.sec.gov/Archives/edgar/data/107140/000010714022000098/exhibit103-johnwileysonsin.htm)[for the quarterly period ended October 31, 2022).](https://www.sec.gov/Archives/edgar/data/107140/000010714021000032/exhibit10_5.htm)</u>● |
| **10.18** | <u>[Second Amendment to the Third Amended and Restated Credit Agreement, dated as of November 30, 2022, among John Wiley & Sons, Inc., John Wiley & Sons Limited, J Wiley Limited, Wiley Europe Investment Holdings Limited, and Wiley-VCH GmbH, as borrowers, Bank of America, N.A., as Administrative Agent, L/C Issuer and Swing Line Lender, and the other Lenders party thereto, which amends the Third Amended and Restated Credit Agreement dated as of May 30, 2019 (incorporated by reference to the Company's Report on Form 8-K dated as of December 6, 2022).](https://www.sec.gov/Archives/edgar/data/107140/000010714022000088/exhibit101bofa_johnwileyxs.htm)</u> |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | |
|:---|:---|
| **10.19** | <u>[Third Amended and Restated Credit Agreement, among John Wiley & Sons, Inc., John Wiley & Sons Limited, J Wiley Limited, Wiley Europe Investment Holdings Limited, and Wiley-VCH GmbH , as borrowers, Bank of America, N.A., as Administrative Agent, L/C Issuer and Swing Line Lender, and the other Lenders party thereto, which amends the Third Amended and Restated Credit Agreement dated as of May 30, 2019 (incorporated by reference to the Company's Report on Form 8-K dated as December 6, 2022).](https://www.sec.gov/Archives/edgar/data/107140/000010714022000088/exhibit102exhibita_restate.htm)</u> |
| **<u>[10.20\*](exhibit1020-bofaxwileyxt.htm)</u>** | Third Amendment to Third Amended and Restated Credit Agreement dated as of May 15, 2026 among John Wiley & Sons, Inc., John Wiley & Sons Limited, Wiley-VCH GmbH, J Wiley Limited, Wiley Europe Investment Holdings Limited, as borrowers, Bank of America, N.A., as Administrative Agent, and each other Lenders party hereto, which amends the Third Amended and Restated Credit Agreement dated as of May 30, 2019 (as amended, supplemented, extended, restated or otherwise modified from time to time, including pursuant to that certain First Amendment thereto, dated as of December 15, 2021, and pursuant to that certain Second Amendment thereto, dated as of November 30, 2022. |
| **10.21** | <u>[Agreement of the Lease dated as of July 14, 2014 between Hub Properties Trust as Landlord, an independent third party, and John Wiley & Sons, Inc as Tenant (incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarterly period ended July 31, 2014).](https://www.sec.gov/Archives/edgar/data/107140/000010714014000032/exhibit32_3.htm)</u> |
| **10.22** | <u>[Executive Severance Plan ("ESP"), with an effective date of June 20, 2016, as amended September 22, 2023 (incorporated by reference to the Company's Report on Form 10-Q for the quarterly period ended October 31, 2023).](https://www.sec.gov/Archives/edgar/data/107140/000010714023000239/exhibit106esp92023final.htm)</u>● |
| **10.23** | <u>[Employment Letter dated July 7, 2024 between Matthew Kissner, President and Chief Executive Officer, and the Company (incorporated by reference to the Company's Report on Form 8-K dated July 8, 2024).](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000107140/000010714024000150/jwa-20240708.htm)</u> ● |
| **10.24** | <u>[Employment Letter dated](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[June 18,](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[2025](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[between](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[Craig](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[Albright](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[, Executive Vice President](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[and Ch](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[ief Financia](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[l Officer](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[and th](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[e Company (incorporated by reference to the Company's](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[Report on](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[Form 8-K](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[date](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[d as](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[June 23, 2025](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714025000073/exhibit101-employmentagree.htm)</u> |
| **10.25** | <u>[Employment](https://www.sec.gov/Archives/edgar/data/107140/000010714025000081/exhibit1028-christopherc.htm)[Letter](https://www.sec.gov/Archives/edgar/data/107140/000010714025000081/exhibit1028-christopherc.htm)[dated September 24, 2020 between Christopher F. Caridi and the Company (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2025).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000081/exhibit1028-christopherc.htm)</u> ● |
| **10.26** | <u>[Employment Letter dated September 28, 2021 between James Flynn, Executive Vice President and General Manager, Research, and the Company.](https://www.sec.gov/Archives/edgar/data/107140/000010714024000114/exhibit1025-flynnjayoffe.htm)[(incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2024).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_27.htm)</u> ● |
| **<u>[10.27](exhibit1027-employmentle.htm)[\*](exhibit1027-employmentle.htm)</u>** | Employment Letter dated October 4, 2019 between Danielle McMahan, Executive Vice President and Chief Human Resources Officer and the Company.● |
| **10.28** | <u>[Employment Letter dated](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[July 28, 2020](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[between](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[Dei](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[r](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[d](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[re Si](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[l](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[v](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[er](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[,](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[Executive Vice President](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[,](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[General](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[Cou](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[n](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[s](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[el](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[and t](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[he Company](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[(incorporated by reference to the Company's](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[Quarterl](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[y](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[Report on Form 10-](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[Q](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[for the](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[period](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[ended](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[July 31,](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[2025](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714025000155/exhibit105-deirdresilver.htm)</u> |
| **10.29** | <u>[Amendment to John Wiley & Sons, Inc. Supplemental Benefit Plan effective as of December 20, 2024](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit104-amendmenttosu.htm)[(](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit104-amendmenttosu.htm)[incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2025)](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit104-amendmenttosu.htm)[.](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit104-amendmenttosu.htm)</u>● |
| **10.30** | <u>[John Wiley & Sons, Inc. Supplemental Benefit Plan Amended and Restated as of January 1, 2014 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_28.htm)</u>● |
| **10.31** | <u>[Deferred Compensation Plan of John Wiley & Sons, Inc. as Amended and Restated Effective as of January 1, 2016 including amendments through December 31, 2016 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_29.htm)</u>● |
| **10.32** | <u>[Amendment to John Wiley & Sons, Inc. Deferred Compensation Plan effective as of December 20, 2024](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[(incorporated by reference to the Company's](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[Quarterly](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[Report on Form 10-](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[Q](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[for the](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[quarterly perio](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[d](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[ended](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[January 31, 2025](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[)](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[.](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit101-amendmenttode.htm)</u> |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | |
|:---|:---|
| **10.33** | <u>[Amendment to the Deferred Compensation Plan of John Wiley & Sons, Inc. effective January 1, 2020 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_30.htm)</u>● |
| **10.34** | <u>[Amendment to the Deferred Compensation Plan of John Wiley & Sons, Inc. effective January 1, 2022 (incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2022).](https://www.sec.gov/Archives/edgar/data/107140/000010714022000007/exhibit10_2.htm)</u>● |
| **10.35** | <u>[Amendment to the Deferred Compensation Plan of John Wiley & Sons, Inc. effective January 1, 2024 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2024).](https://www.sec.gov/Archives/edgar/data/107140/000010714024000114/exhibit1035-wileyamended.htm)</u> ● |
| **10.36** | <u>[Amendment to Employees' Retirement Plan of John Wiley & Sons, Inc. effective as of December 20, 2024](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit102-amendmenttoem.htm)[(](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit102-amendmenttoem.htm)[incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2025](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit102-amendmenttoem.htm)[).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit102-amendmenttoem.htm)[●](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit102-amendmenttoem.htm)</u> |
| **10.37** | <u>[Amendment to John Wiley & Sons, Inc. Supplemental Executive Retirement Plan effective as of December 20, 2024](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit105-amendmenttosu.htm)[(incorporated by reference to th](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit105-amendmenttosu.htm)[e Company's Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2025).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit105-amendmenttosu.htm)</u>● |
| **10.38** | <u>[Amendment to the Employees' Retirement Plan of John Wiley & Sons, Inc. effective October 1, 2016 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_32.htm)</u>● |
| **10.39** | <u>[Amendment to the Employees' Retirement Plan of John Wiley & Sons, Inc. (IRS model 436 provisions) (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_33.htm)</u>● |
| **10.40** | <u>[Summary Plan Description for John Wiley & Sons, Inc. Employees' Savings Plan Effective as of January 1, 2024, Amended as of December 20, 2024](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit103-summaryplande.htm)[(incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2025).](https://www.sec.gov/Archives/edgar/data/107140/000010714025000018/exhibit103-summaryplande.htm)</u>● |
| **10.41** | <u>[John Wiley & Sons, Inc. Employees' Savings Plan Amended and Restated Effective July 1, 2013 including amendments through January 1, 2014 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_34.htm)</u>● |
| **10.42** | <u>[Amendment to the John Wiley & Sons, Inc. Employees' Savings Plan approved December 19, 2018 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_35.htm)</u>● |
| **10.43** | <u>[Amendment to the John Wiley & Sons, Inc. Employees' Savings Plan approved September 26, 2019 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_36.htm)</u>● |
| **10.44** | <u>[Amendment to the John Wiley & Sons, inc. Employees' Savings Plan effective January 1, 2020 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_37.htm)</u>● |
| **10.45** | <u>[Amendment to the John Wiley & Sons, Inc. Employees' Savings Plan effective September 1, 2020 and January 1, 2021 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2021).](https://www.sec.gov/Archives/edgar/data/107140/000114036121023449/exhibit10_38.htm)</u>● |
| **10.46** | <u>[Amendment to the John Wiley & Sons, Inc. Employees' Savings Plan effective January 1, 2022 (incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2022).](https://www.sec.gov/Archives/edgar/data/107140/000010714022000007/exhibit10_3.htm)</u>● |
| **10.47** | <u>[Equity Purchase Agreement, dated as of June 1, 2026, by and among John Wiley & Sons Ltd., CIG Emerald Holding LLC and CIG Emerald Midco LLC](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000107140/000010714026000034/jwa-20260601.htm)[(incorporated by reference to the Company's Report on Form 8-K dated as](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000107140/000010714026000034/jwa-20260601.htm)[June 2,](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000107140/000010714026000034/jwa-20260601.htm)[2026](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000107140/000010714026000034/jwa-20260601.htm)[).](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000107140/000010714026000034/jwa-20260601.htm)</u> |
| **Insider trading policies and procedures.** | **Insider trading policies and procedures.** |
| **19** | <u>[John Wiley & Sons, Inc. Insider Trading Policy dated March 21, 2025](https://www.sec.gov/Archives/edgar/data/107140/000010714025000081/exhibit19-johnwileysonsi.htm)[(incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 202](https://www.sec.gov/Archives/edgar/data/107140/000010714025000081/exhibit19-johnwileysonsi.htm)[5](https://www.sec.gov/Archives/edgar/data/107140/000010714025000081/exhibit19-johnwileysonsi.htm)[)](https://www.sec.gov/Archives/edgar/data/107140/000010714025000081/exhibit19-johnwileysonsi.htm)</u> |

---

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

---

| | |
|:---|:---|
| **Subsidiaries** | **Subsidiaries** |
| **<u>[21\*](exhibit21.htm)</u>** | List of Subsidiaries of the Company. |
| **Consent of Independent Registered Public Accounting Firm** | **Consent of Independent Registered Public Accounting Firm** |
| **<u>[23.1\*](exhibit231consentfy26.htm)</u>** | Consent of PricewaterhouseCoopers LLP. |
| **Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** | **Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** |
| **<u>[31.1\*](exhibit311.htm)</u>** | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| **<u>[31.2\*](exhibit312.htm)</u>** | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| **Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002** | **Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002** |
| **<u>[32.1\*\*](exhibit321.htm)</u>** | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| **<u>[32.2\*\*](exhibit322.htm)</u>** | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| **Clawback Policy** | **Clawback Policy** |
| **97.1** | <u>[John Wiley & Sons, Inc. Clawback Policy effective November 27, 2023 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended April 30, 2024).](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000107140/000010714024000114/jwa-20240430.htm)</u> |
| **Inline XBRL** | **Inline XBRL** |
| **101.INS\*** | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
| **101.SCH\*** | Inline XBRL Taxonomy Extension Schema Document. |
| **101.CAL\*** | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| **101.DEF\*** | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| **101.LAB\*** | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| **101.PRE\*** | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| **104** | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |

---

\*Filed herewith

\*\*&nbsp;&nbsp;&nbsp;&nbsp;Furnished herewith

● &nbsp;&nbsp;&nbsp;&nbsp;Indicates management compensatory plan, contract, or arrangement

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**Item 16. Form 10-K Summary**

Not applicable.

(2) Financial Statement Schedule

**Schedule II**

**JOHN WILEY & SONS, INC. AND SUBSIDIARIES**

**VALUATION AND QUALIFYING ACCOUNTS**

**FOR THE YEARS ENDED APRIL 30, 2026, 2025, AND 2024**

**(Dollars in thousands)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Balance at<br>Beginning<br>of Period** | **Charged to<br>Expenses** | **Deductions**<br>**From Reserves**<br>**and Other**<sup>(1)</sup> | **Balance at<br>End of Period** |
| Year Ended April 30, 2026 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Allowance for sales returns<sup>(3)</sup> | $8984 | $14197 | $16102 | $7079 |
| &nbsp;&nbsp;&nbsp;Allowance for doubtful accounts | $13172 | $2478 | $1880 | $13770 |
| &nbsp;&nbsp;&nbsp;Allowance for inventory obsolescence | $11122 | $5663 | $8120 | $8665 |
| &nbsp;&nbsp;&nbsp;Valuation allowance on deferred tax assets<sup>(2)</sup> | $77309 | $(70027) | $— | $7282 |
| Year Ended April 30, 2025 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Allowance for sales returns<sup>(3)</sup> | $14448 | $12529 | $17993 | $8984 |
| &nbsp;&nbsp;&nbsp;Allowance for doubtful accounts | $17297 | $839 | $4964 | $13172 |
| &nbsp;&nbsp;&nbsp;Allowance for inventory obsolescence | $11919 | $4705 | $5502 | $11122 |
| &nbsp;&nbsp;&nbsp;Valuation allowance on deferred tax assets<sup>(2)</sup> | $53498 | $20816 | $(2995) | $77309 |
| Year Ended April 30, 2024 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Allowance for sales returns<sup>(3)</sup> | $14419 | $21158 | $21129 | $14448 |
| &nbsp;&nbsp;&nbsp;Allowance for doubtful accounts | $18662 | $3844 | $5209 | $17297 |
| &nbsp;&nbsp;&nbsp;Allowance for inventory obsolescence | $12990 | $5906 | $6977 | $11919 |
| &nbsp;&nbsp;&nbsp;Valuation allowance on deferred tax assets<sup>(2)</sup> | $27448 | $24620 | $(1430) | $53498 |

---

(1) Deductions From Reserves and Other for the years ended April 30, 2026, 2025, and 2024 include foreign exchange translation adjustments. Included in Allowance for doubtful accounts are accounts written off, less recoveries as well as amounts reclassified as held-for-sale or sold as of April 30, 2024. Included in Allowance for inventory obsolescence are items removed from inventory.

(2) In fiscal year 2024, due to losses in the US resulting from impairments, restructuring, and acceleration of amortization expense on capitalized software, we concluded it was more-likely-than-not that a portion of our deferred tax asset would not be realized. As a result, we established a valuation allowance of $53.5 million. During fiscal year 2025, we increased this valuation allowance to $77.3 million, because of an increase in the US deferred tax assets attributable primarily to interest expense disallowance and intangible and fixed assets. During fiscal year 2026, we released approximately $70.0 million of valuation allowance previously recorded against US deferred tax assets. The valuation allowance release was driven by management's conclusion that it is more likely than not that substantially all US federal and state deferred tax assets will be realized based on the weight of available positive and negative evidence.

(3) Allowance for sales returns represents anticipated returns net of a recovery of inventory and royalty costs. The provision is reported as a reduction of gross sales to arrive at revenue and the reserve balance is reported as an increase in Contract liabilities with a corresponding increase in Inventories, net and a reduction in Accrued royalties for the years ended April 30, 2026, 2025, and 2024.

------

<u>[Index](#i4999d179a1ee4db3afe68151d34a8db6_7)</u> 

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | JOHN WILEY & SONS, INC. |
| | | (Company) |
| Dated: June 24, 2026 | By: | /s/ Matthew S. Kissner |
|  |  | Matthew S. Kissner |
|  |  | President and Chief Executive Officer |

---

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signatures** | **Titles** | **Dated** |
| /s/ Matthew S. Kissner | President and Chief Executive Officer and Director | June 24, 2026 |
| Matthew S. Kissner | President and Chief Executive Officer and Director |  |
| /s/ Craig Albright | Executive Vice President and Chief Financial Officer | June 24, 2026 |
| Craig Albright | Executive Vice President and Chief Financial Officer |  |
| /s/ Christopher F. Caridi | Senior Vice President, Chief Accounting Officer and Finance Transformation Leader | June 24, 2026 |
| Christopher F. Caridi |  |  |
| /s/ Jesse C. Wiley | Chairman of the Board | June 24, 2026 |
| Jesse C. Wiley |  |  |
| /s/ Katya D. Andresen | Director | June 24, 2026 |
| Katya D. Andresen |  |  |
| /s/ Mari J. Baker | Director | June 24, 2026 |
| Mari J. Baker |  |  |
| /s/ David C. Dobson | Director | June 24, 2026 |
| David C. Dobson |  |  |
| /s/ Brian O. Hemphill | Director | June 24, 2026 |
| Brian O. Hemphill |  |  |
| /s/ Karen N. Madden | Director | June 24, 2026 |
| Karen N. Madden |  |  |
| /s/ Raymond W. McDaniel, Jr. | Director | June 24, 2026 |
| Raymond W. McDaniel, Jr. |  |  |
| /s/ William J. Pesce | Director | June 24, 2026 |
| William J. Pesce |  |  |
| /s/ Inder Singh | Director | June 24, 2026 |
| Inder Singh |  |  |

---

## Exhibit 10.20

![](exhibit1020-bofaxwileyxt001.jpg)

Execution Version [John Wiley & Sons] Third Amendment #5364448936 THIRD AMENDMENT TO THIRD AMENDED AND RESTATED CREDIT AGREEMENT This THIRD AMENDMENT TO THIRD AMENDED AND RESTATED CREDIT AGREEMENT, dated as of May 15, 2026 (this "Amendment"), is by and among JOHN WILEY & SONS, INC., a New York corporation (the "Company"), JOHN WILEY & SONS LIMITED, a private limited company incorporated under the laws of England and Wales ("Wiley UK"), WILEY-VCH GmbH, a limited liability company organized under the laws of Germany ("Wiley-VCH"), J WILEY LIMITED, a private limited company incorporated under the laws of England and Wales ("J.Wiley UK"), WILEY EUROPE INVESTMENT HOLDINGS LIMITED, a private limited company incorporated under the laws of England and Wales ("WEIHL" and, together with Wiley UK and J.Wiley UK, collectively, the "UK Borrowers" and, together with Wiley-VCH and the Company, the "Borrowers" and each a "Borrower"), the other Loan Parties party hereto, each of the financial institutions with an Incremental Term Commitment (as defined below) party hereto (the "Incremental Lenders" and each an "Incremental Lender"), each other Lenders party hereto, and BANK OF AMERICA, N.A., as administrative agent (in such capacity, the "Administrative Agent"). Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed thereto in the Credit Agreement (as defined below). W I T N E S S E T H WHEREAS, the Company, the other Loan Parties party thereto, the Lenders and the Administrative Agent are parties to that certain Third Amended and Restated Credit Agreement, dated as of May 30, 2019 (as amended, supplemented, extended, restated or otherwise modified from time to time, including pursuant to that certain First Amendment thereto, dated as of December 15, 2021, and pursuant to that certain Second Amendment thereto, dated as of November 30, 2022, the "Credit Agreement"); WHEREAS, the Company has requested (i) the establishment of Incremental Term Commitments in an aggregate principal amount of $300,000,000 pursuant to Section 2.15 of the Credit Agreement (the "Incremental Term Commitment"), and (ii) certain other amendments to the Credit Agreement; and WHEREAS, (i) each Incremental Lender has agreed to provide the Incremental Term Commitment, and (ii) the Administrative Agent and the Required Lenders agree to the other amendments to the Credit Agreement, in each case on the terms and conditions set forth herein. NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: Article 1 AGREEMENTS 1.1 Incremental Commitments. The parties hereto agree as follows: (a) Subject to the terms and conditions set forth herein, each Incremental Lender agrees, severally and not jointly, to make a Term Loan in U.S. Dollars to the Company on the Amendment Effective Date in an aggregate principal amount equal to its Incremental Term Commitment as set forth opposite such Incremental Lender's name on Schedule 2.01 of the Credit Agreement (as amended hereby) (the "Incremental Term Loans"). Amounts paid or prepaid in respect of the Incremental Term Loans may not be reborrowed. The funding of the Incremental Term Loans on the Amendment Effective Date shall be made in the manner contemplated by Sections 2.02 and 2.15 of the Credit Agreement; provided that it is acknowledged and agreed that

------

![](exhibit1020-bofaxwileyxt002.jpg)

------

![](exhibit1020-bofaxwileyxt003.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;3 [John Wiley & Sons] Third Amendment #5364448936 Article 2 CONDITIONS TO EFFECTIVENESS This Amendment shall become effective as of the date hereof upon satisfaction of the following conditions (in each case, in form and substance reasonably acceptable to the Administrative Agent) (the "Amendment Effective Date"): 2.1 Executed Amendment. The Administrative Agent shall have received a copy of this Amendment duly executed by the Loan Parties, each of the Incremental Lenders, the Required Lenders, and the Administrative Agent. 2.2 Executed Term Notes. To the extent requested by any Incremental Lender, each such Incremental Lender shall have received a Term Note, in respect of its Incremental Term Loans, duly executed by the Company. 2.3 Officer's Certificate. The Administrative Agent shall have received (i) certificates executed by a secretary, assistant secretary or equivalent of each Loan Party, which certify and attach true and complete copies of the Organization Documents of each Loan Party, resolutions of its board of directors or equivalent governing body and incumbency of signatories (or equivalents) to the Loan Documents and (ii) such customary documents and certifications as the Administrative Agent may reasonably require to evidence that each Loan Party is duly organized, incorporated or formed (as applicable), and that each Loan Party is validly existing and in good standing and is qualified to engage in business in each jurisdiction where its ownership, lease or operation of properties or the conduct of its business requires such qualification, except to the extent that failure to be so qualified could not reasonably be expected to have a Material Adverse Effect. 2.4 Legal Opinions of Counsel. The Administrative Agent shall have received a favorable opinion or opinions of counsel for the Loan Parties, dated the Amendment Effective Date and addressed to the Administrative Agent and the Lenders, in form and substance reasonably acceptable to the Administrative Agent. 2.5 Default. Both before and after giving effect to this Amendment and the making of the Incremental Term Loans, no Default shall exist. 2.6 Request for Credit Extension. The Administrative Agent shall have received a Request for Credit Extension with respect to any Loans (including the Incremental Term Loans) to be made on the Amendment Effective Date. 2.7 Anti-Money Laundering; Beneficial Ownership. (a) Upon the reasonable request of any Lender made at least ten (10) days prior to the Amendment Effective Date, each Loan Party shall have provided to such Lender, and such Lender shall be reasonably satisfied with, the Patriot Act Disclosures so requested, and (b) at least five (5) days prior to the Amendment Effective Date, any Loan Party that qualifies as a "legal entity customer" under the Beneficial Ownership Regulation shall deliver, to each Lender that so requests, a Beneficial Ownership Certification in relation to such Loan Party. 2.8 Closing Certificate. The Administrative Agent shall have received a certificate signed by a Responsible Officer of the Company (i) certifying that (A) with respect to the Company and its Subsidiaries, there has been no event or circumstance since the date of the Audited Financial Statements that has had or could be reasonably expected to have, either individually or in the aggregate, a Material Adverse Effect, and (B) there is no action, suit, investigation or proceeding pending or, to the knowledge

------

![](exhibit1020-bofaxwileyxt004.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;4 [John Wiley & Sons] Third Amendment #5364448936 of the Company, threatened in any court or before any arbitrator or Governmental Authority that could reasonably be expected to have a Material Adverse Effect, and (ii) either (A) attaching copies of all consents, licenses and approvals required in connection with the execution, delivery and performance by each Loan Party and the validity against each Loan Party of this Amendment, if any, and certifying that such consents, licenses and approvals are in full force and effect, or (B) stating that no such consents, licenses or approvals are so required. 2.9 Fees, Costs and Expenses. The Administrative Agent shall have received from the Company such fees and expenses that are payable in connection with the consummation of the transactions contemplated hereby and Holland & Knight LLP, counsel to the Administrative Agent, shall have received from the Company payment of all outstanding fees and expenses previously incurred and all fees and expenses incurred in connection with this Amendment, in each case, to the extent required to be paid by the Company pursuant to Section 10.04 of the Credit Agreement and invoiced prior to or on the Amendment Effective Date. Article 3 MISCELLANEOUS 3.1 Amended Terms. On and after the Amendment Effective Date, all references to the Credit Agreement in each of the Loan Documents shall hereafter mean the Credit Agreement as amended by this Amendment. Except as specifically amended hereby or otherwise agreed, the Credit Agreement is hereby ratified and confirmed and shall remain in full force and effect according to its terms. 3.2 Representations and Warranties of Loan Parties. Each Loan Party represents and warrants as follows: (a) It has taken all necessary action to authorize the execution, delivery and performance of this Amendment. (b) This Amendment has been duly executed and delivered by such Loan Party and constitutes such Loan Party's legal, valid and binding obligation, enforceable in accordance with its terms, except as such enforceability may be subject to (i) bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting creditors' rights generally and (ii) general principles of equity (regardless of whether such enforceability is considered in a proceeding at law or in equity). (c) No consent, approval, authorization or order of, or filing, registration or qualification with, any court or governmental authority or third party is required in connection with the execution, delivery or performance by such Loan Party of this Amendment. (d) The representations and warranties of such Loan Party in Article V of the Credit Agreement or any other Loan Document, or which are contained in any document furnished at any time under or in connection therewith, are true and correct in all material respects on and as of the Amendment Effective Date, except that (i) such representations and warranties that specifically refer to an earlier date shall be true and correct in all material respects as of such earlier date, (ii) such representations and warranties shall be true and correct in all respects to the extent they are qualified by a materiality standard and (iii) the representations and warranties contained in clauses (a) and (b) of Section 5.05 of the Credit Agreement shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of Section 6.01 of the Credit Agreement.

------

![](exhibit1020-bofaxwileyxt005.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;5 [John Wiley & Sons] Third Amendment #5364448936 (e) As of the Amendment Effective Date, no event has occurred and is continuing which constitutes a Default or an Event of Default. (f) The Obligations are not reduced or modified by this Amendment and are not subject to any offsets, defenses or counterclaims. 3.3 Reaffirmation of Obligations. Each Loan Party hereby ratifies the Credit Agreement and each other Loan Document to which each such Loan Party is a party, and acknowledges and reaffirms that it is (a) bound by all terms of the Credit Agreement and each such Loan Document applicable to it and (b) responsible for the observance and full performance of its respective Obligations. 3.4 Reaffirmation of Guaranties. Each Guarantor reaffirms its guarantee of the Guaranteed Obligations under the terms and conditions of the applicable Guaranty and agrees that such Guaranty remains in full force and effect and is hereby ratified, reaffirmed and confirmed. Each Guarantor hereby confirms that it consents to the terms of this Amendment, including, without limitation, the extension in whole or in part of the Loans under the Credit Agreement, all of which constitute "Guaranteed Obligations" of such Guarantor under the Guaranty. Each Guarantor hereby (i) confirms that each Loan Document to which it is a party or is otherwise bound will continue to guarantee, to the fullest extent possible in accordance with the Loan Documents, the payment and performance of the Guaranteed Obligations, including without limitation the payment and performance of all such applicable Guaranteed Obligations that are joint and several obligations of each such Guarantor now or hereafter existing; (ii) acknowledges and agrees that its Guaranty and each of the Loan Documents to which it is a party or otherwise bound shall continue in full force and effect and that all of its obligations thereunder shall be valid and enforceable and shall not be impaired or limited by the execution or effectiveness of this Amendment; and (iii) acknowledges, agrees and warrants for the benefit of the Administrative Agent and each Guaranteed Party that there are no rights of set-off or counterclaim, nor any defenses of any kind, whether legal, equitable or otherwise, that would enable such Guarantor to avoid or delay timely performance of its obligations under the Loan Documents. 3.5 Loan Document. This Amendment shall constitute a Loan Document under the terms of the Credit Agreement. 3.6 Expenses. Each Loan Party agrees to pay all reasonable and documented out-of-pocket costs and expenses incurred by the Administrative Agent in connection with the preparation, execution and delivery of this Amendment, in each case to the extent required to be paid pursuant to Section 10.04 of the Credit Agreement. 3.7 Further Assurances. Each Loan Party agrees to promptly take such action, upon the request of the Administrative Agent, as is necessary to carry out the intent of this Amendment. 3.8 Entirety. This Amendment and the other Loan Documents embody the entire agreement among the parties hereto and supersede all prior agreements and understandings, oral or written, if any, relating to the subject matter hereof. 3.9 Counterparts; Delivery. This Amendment may be in the form of an Electronic Record and may be executed using Electronic Signatures (including, without limitation, facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record. This Amendment may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts are one and the same Amendment. For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or

------

![](exhibit1020-bofaxwileyxt006.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;6 [John Wiley & Sons] Third Amendment #5364448936 acceptance by the Administrative Agent of a manually signed paper Communication which has been converted into electronic form (such as scanned into PDF format), or an electronically signed Communication converted into another format, for transmission, delivery and/or retention. Notwithstanding anything contained herein to the contrary, the Administrative Agent is under no obligation to accept an Electronic Signature in any form or in any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved by it; provided that, without limiting the foregoing, (a) to the extent the Administrative Agent has agreed to accept such Electronic Signature, the Administrative Agent shall be entitled to rely on any such Electronic Signature without further verification and (b) upon the request of the Administrative Agent any Electronic Signature shall be promptly followed by a manually executed, original counterpart. 3.10 No Actions, Claims, Etc. As of the date hereof, the Company, on behalf of itself and each other Loan Party, hereby acknowledges and confirms that it has no knowledge of any actions, causes of action, claims, demands, damages and liabilities of whatever kind or nature, in law or in equity, against the Administrative Agent, the Lenders, or the Administrative Agent's or the Lenders' respective officers, employees, representatives, agents, counsel or directors arising from any action by such Persons, or failure of such Persons to act under the Credit Agreement on or prior to the date hereof. 3.11 GOVERNING LAW. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK, INCLUDING FOR SUCH PURPOSES SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK. 3.12 Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. 3.13 Consent to Jurisdiction; Service of Process; Waiver of Jury Trial. The jurisdiction, service of process and waiver of jury trial provisions set forth in Sections 10.14 and 10.15 of the Credit Agreement are hereby incorporated by reference, mutatis mutandis. [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

------

![](exhibit1020-bofaxwileyxt007.jpg)

John Wiley & Sons, Inc. Third Amendment to Credit Agreement IN WITNESS WHEREOF the parties hereto have caused this Amendment to be duly executed on the date first above written. JOHN WILEY & SONS, INC. By: /s/ Kevin Monaco Name: Kevin Monaco Title: Senior Vice President, Treasurer and Tax JOHN WILEY & SONS LIMITED By: /s/ Ben Wardleworth Name: Ben Wardleworth Title: Director J WILEY LIMITED By: /s/ Ben Wardleworth Name: Ben Wardleworth Title: Director WILEY EUROPE INVESTMENT HOLDINGS LIMITED By: /s/ Ben Wardleworth Name: Ben Wardleworth Title: Director WILEY-VCH GMBH By: /s/ Guido Hermann Name: Guido Herrmann Title: Managing Director

------

![](exhibit1020-bofaxwileyxt008.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement WILEY PERIODICALS, LLC By: /s/ Kevin Monaco Name: Kevin Monaco Title: Treasurer WWL LLC By: : /s/ Kevin Monaco Name: Kevin Monaco Title: Treasurer INSCAPE PUBLISHING, LLC By: : /s/ Kevin Monaco Name: Kevin Monaco Title: Treasurer ATYPON SYSTEMS, LLC By: : /s/ Kevin Monaco Name: Kevin Monaco Title: Treasurer WILEY INTERNATIONAL, LLC By: : /s/ Kevin Monaco Name: Kevin Monaco Title: Treasurer

------

![](exhibit1020-bofaxwileyxt009.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement JOHN WILEY & SONS (HK) LIMITED By: /s/ Karl Schliesing Name: Karl Schliesing Title: Director WILEY HK2 LIMITED By: /s/ Karl Schliesing Name: Karl Schliesing Title: Director WILEY EUROPE LIMITED By: /s/ Ben Wardleworth Name: Ben Wardleworth Title: Director WILEY HEYDEN LIMITED By: /s/ Ben Wardleworth Name: Ben Wardleworth Title: Director

------

![](exhibit1020-bofaxwileyxt010.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement ADMINISTRATIVE AGENT: BANK OF AMERICA, N.A., as Administrative Agent By: /s/ Felicia Brinson______________________ Name: Felicia Brinson Title: Assistant Vice President

------

![](exhibit1020-bofaxwileyxt011.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement BANK OF AMERICA, N.A., In its capacity as a Lender, including by reference as an Incremental Lender By: /s/ Jana L. Baker Name: Jana L. Baker Title: Senior Vice President

------

![](exhibit1020-bofaxwileyxt012.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement PNC BANK, NATIONAL ASSOCIATION, In its capacity as a Lender (including by reference as an Incremental Lender) By: /s/ Blaise Schultheis Name: Blaise Schultheis Title: Managing Director

------

![](exhibit1020-bofaxwileyxt013.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement JPMORGAN CHASE BANK, N.A., in its capacity as a Lender (including by reference as an Incremental Lender) By: /s/ Christopher Beery Name: Christopher Beery Title: Vice President

------

![](exhibit1020-bofaxwileyxt014.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement U.S. BANK, NATIONAL ASSOCIATION, as a Lender (including by reference as an Incremental Lender) By: /s/ Steven J. Correll Name: Steven J. Correll Title: Senior Vice President

------

![](exhibit1020-bofaxwileyxt015.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement HSBC BANK USA, NATIONAL ASSOCIATION, in its capacity as a Lender (By: /s/ Jillian Clemons Name: Jillian Clemons Title: Senior Vice Preident

------

![](exhibit1020-bofaxwileyxt016.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement THE HUNTINGTON NATIONAL BANK, in its capacity as a Lender (including by reference as an Incremental Lender) By: /s/ Martin H. McGinty Name: Martin H. McGinty Title: Director

------

![](exhibit1020-bofaxwileyxt017.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons, Inc. Third Amendment to Credit Agreement FLAGSTAR BANK, N.A., in its capacity as a Lender (including by reference as an Incremental Lender) By: /s/ Mike Maher Name: Mike Maher Title: Vice President

------

![](exhibit1020-bofaxwileyxt018.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;Exhibit A to Third Amendment Exhibit A Amended Credit Agreement [Attached]

------

![](exhibit1020-bofaxwileyxt019.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;Exhibit B to Third Amendment Exhibit B Commitments and Applicable Percentages Lenders Revolving Commitment Revolving Commitment Applicable Percentage Third Amendment Incremental Term Commitment Term Commitments as of Second Amendment Effective Date Term Facility Applicable Percentage as of the Third Amendment Effective Date Total Commitments Applicable Percentage as of the Third Amendment Effective Date Bank of America, N.A. $207,500,000.00 18.609865471% $50,000,000.00 $42,500,000.00 18.355263158% 18.533805031% PNC Bank, National Association $152,500,000.00 13.677130045% $87,500,000.00 $27,500,000.00 23.486842105% 16.607704403% JPMorgan Chase Bank, N.A. $152,500,000.00 13.677130045% $50,000,000.00 $27,500,000.00 15.592105263% 14.249213836% TD Bank, N.A. $166,666,666.67 14.947683109% --- $33,333,333.33 6.140350878% 12.316561845% Truist Bank $152,500,000.00 13.677130045% --- $27,500,000.00 5.065789474% 11.104559748% U.S. Bank National Association $75,000,000.00 6.726457399% $50,000,000.00 --- 10.526315789% 7.861635220% HSBC Bank USA, National Association $62,500,000.00 5.605381166% $18,750,000.00 $12,500,000.00 6.250000000% 5.797955975% The Huntington National Bank $62,500,000.00 5.605381166% $18,750,000.00 $12,500,000.00 6.250000000% 5.797955975% Citizens Bank, N.A. $62,500,000.00 5.605381166% --- $12,500,000.00 2.302631579% 4.618710692% Flagstar Bank, N.A. $20,833,333.33 1.868460388% $25,000,000.00 $4,166,666.67 6.030701754% 3.111897274% Total: $1,115,000,000.00 100.000000% $300,000,000 $200,000,000.00 100% 100%

------

## Exhibit 10.27

![](exhibit1027-employmentle001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;111 River Street, Hoboken, NJ 07030-5774, U.S. T +1 201 748 6000 F +1 201 748 6088 www.wiley.com October 4, 2019 Ms. Danielle McMahan Dear Danielle: I am pleased to confirm our offer and your acceptance of employment with John Wiley & Sons, Inc. as Executive Vice President and Chief Human Resources Officer. Your employment date will be November 11, 2019. Your base salary will be $400,000, paid on a semi-monthly basis. You will be eligible to participate in the Executive Annual Incentive Plan ("EAIP"), with an annualized target incentive is equal to 75% of your base salary, or $300,000. For FY20, which began May 1, 2019, you are eligible for prorated participation. Payout will be based on achievement of enterprise financial goals, and strategic milestones. All payouts under the EAIP are in accordance with plan provisions. Beginning with the FY20-22 performance cycle, you will be eligible to receive annual grants under the Company's Executive Long-Term Incentive Program ("ELTIP"). Your targeted long- term incentive is $450,000. For FY20, your equity grant will not be prorated. The ELTIP delivers sixty percent of the long-term value in the form of target performance share units which vest 100% after the end of the cycle, and forty percent in restricted share units that vest 25% per year over a four-year period. All payouts under the ELTIP are subject to and in accordance with plan provisions. All compensation is subject to withholding and payroll taxes to the extent required by applicable law. You will be eligible for our Executive Perquisites Program, including annual reimbursement for financial counseling and tax preparation services up to $15,755, club memberships up to $3,000, and commutation and/or parking in our Hoboken facility (if needed), up to $3,900. You will be eligible to participate in all of Wiley's benefits plans in which any Wiley senior executive is eligible to participate. While we look forward to a mutually beneficial relationship, your employment is "at-will." This offer letter does not guarantee any employment duration, terms, or conditions. Should your

------

![](exhibit1027-employmentle002.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;111 River Street, Hoboken, NJ 07030-5774, U.S. T +1 201 748 6000 F +1 201 748 6088 www.wiley.com employment be involuntarily terminated without Cause or due to Constructive Discharge, you will receive as severance (in addition to any unpaid base salary earned at the date of termination, and prorated annual incentive paid at the regular time based on actual performance if active for nine months or more of the fiscal year): • Absent a Change in Control: One month of base salary for each year of employment, subject to a minimum of 12 months and a maximum of 18 months. Continued health insurance for the number of months of the cash severance period. • Within Twenty-Four Months of a Change in Control: Eighteen months of base salary and eighteen months of "target" annual incentive to be paid in a lump sum, full acceleration of all unvested equity awards (with performance share units vested at "target") and Benefit Continuation for eighteen months. All severance is payable under the Executive Severance Plan and is subject to your signing a release and waiver of claims and compliance with the restrictive covenants included in the attached document, which apply as material terms of your employment in any event. For the avoidance of doubt, you will be entitled to any applicable benefits under the Executive Severance Plan, the relevant equity plan or grant agreement to the extent not covered in or greater than the benefits set forth in this letter. Danielle, I know that you will contribute significantly to the success of the Company. I am sure you will find this position challenging and rewarding, and I look forward to working with you. Please sign and return this letter, and the Agreements and Restrictive Covenants document, to me prior to your employment date. Sincerely, Acknowledged and Agreed: Suzanne Hyland _______________________ VP, Global Rewards Danielle McMahan Date /s/ Danielle McMahan

------

![](exhibit1027-employmentle003.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;111 River Street, Hoboken, NJ 07030-5774, U.S. T +1 201 748 6000 F +1 201 748 6088 www.wiley.com Agreements and Restrictive Covenants Definitions For purposes of the attached letter, the following definitions shall apply: "Cause" means (A) your refusal or willful and continued failure to substantially perform your material duties to the best of your ability under this letter (for reasons other than death or disability), in any such case after written notice thereof; (B) your gross negligence in the performance of your material duties under this letter; (C) any act of fraud, misappropriation, material dishonesty, embezzlement, willful misconduct or similar conduct; (D) your conviction of or plea of guilty or nolo contendere to a felony or any crime involving moral turpitude; or (E) your material and willful violation of any of the Company's reasonable rules, regulations, policies, directions and restrictions. The Company will provide you with written notice which describes the circumstances it relies on for termination of employment for any of the foregoing reasons. If the alleged reason for termination is based on sections (A), (B), or (E), you shall have 60 days to remedy the situation. "Constructive Discharge" means: (A) any material failure by the Company to fulfill its obligations under this letter (including, without limitation, any reduction of base salary, as the same may be increased during your employment, or other material element of compensation); (B) a material and adverse change to, or a material reduction of, your duties and responsibilities to the Company; or (C) the relocation of your primary office to any location more than fifty (50) miles from the Company's principal executive offices, resulting in a materially longer commute for you. You will provide the Company a written notice which describes the circumstances being relied upon for all terminations of employment by you resulting from any circumstances claimed to be a constructive discharge within thirty (30) days after the event giving rise to the notice. The Company will have thirty (30) days after receipt of such notice to remedy the situation prior to your termination of employment due to a constructive discharge, and you must resign no later than thirty (30) days after the end of such 30-day period. Business Expenses The Company will reimburse you for all reasonable travel and other expenses incurred by you in connection with the performance of your duties and obligations under this letter, including attendance at industry and other relevant conferences. You will comply with such limitations and reporting requirements with respect to expenses as may be established by Company from time to time and will promptly provide all appropriate and requested documentation in

------

![](exhibit1027-employmentle004.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;111 River Street, Hoboken, NJ 07030-5774, U.S. T +1 201 748 6000 F +1 201 748 6088 www.wiley.com connection with such expenses. Indemnification The Company will indemnify you to the fullest extent permitted by the laws of the state of the Company's incorporation in effect at that time, or the certificate of incorporation and by-laws of the Company, whichever affords you the greater protection. Intellectual Property Rights You hereby confirm that inventions, trade secrets and other work product produced by you or with your participation during the term of your employment with Wiley, in any form (collectively the "Work Product") shall be deemed work for hire on behalf of Wiley and you agree that Wiley shall be the sole owner of the Work Product, and all underlying rights therein, in all media now known or hereinafter devised, throughout the universe and in perpetuity without any further obligations to you. If the Prior Work Product, the Work Product, or any portion thereof, is deemed not to be Work for Hire, you hereby irrevocably convey, transfer and assign to Wiley, all rights, in all media now known or hereinafter devised, throughout the universe and in perpetuity, in and to the Prior Work Product and Work Product, including without limitation, all of your right, title and interest in the copyrights and patents thereto, free and clear of all liens and other encumbrances. You shall make such applications, sign such papers (including without limitation assignments), take all rightful oaths, and perform all acts as may be reasonably requested, during or after the term of your employment, with respect to evidencing ownership of the Prior Work Product and Work Product. You shall assist Wiley to obtain any registrations covering Prior Work Product and Work Product assigned hereunder to Wiley and you hereby irrevocably designate and appoint Wiley and its duly authorized officers and agents as your attorney in fact, to act for and in your behalf and stead, to execute and further the prosecution and issuance of registrations thereon with the same legal force and effect as if executed by you. Protection of Confidential Information You acknowledge that during the course of employment with Wiley, you may be privy to certain confidential information which may be communicated to you verbally or in writing, relating to Wiley, its businesses, its customers, trade secrets, know-how, inventions, techniques, processes, algorithms, software programs, hardware designs, schematics, designs, contracts, customer lists, financial information, sales and marketing plans, business plans and information, products, current and potential business partners, customers or other third parties (collectively, "Third Parties"), or other information which is not known to the public, and which may include material developed by you. You acknowledge that all such information is and shall be deemed

------

![](exhibit1027-employmentle005.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;111 River Street, Hoboken, NJ 07030-5774, U.S. T +1 201 748 6000 F +1 201 748 6088 www.wiley.com to be "Confidential Information" belonging to Wiley or Third Parties. You agree to protect such Confidential Information from disclosure with the same degree of care that you normally use to protect your own confidential information, but not less than reasonable care, shall not divulge any such Confidential Information to anyone and shall not make use of the same without prior written consent of Wiley. All Confidential Information is and shall remain the property of Wiley (or the applicable Third Party), and you shall not acquire any rights therein. At the conclusion of your employment by Wiley, you shall promptly return all Wiley materials, including Confidential Information, in your possession and shall not retain any copies of any such material. In addition, both parties agree that this agreement is confidential and that neither of us shall disclose its contents to others without the other's prior approval. Business Opportunities Should your role with Wiley expose you to business opportunities that might be attractive to Wiley as well as to others (including yourself), you agree to give Wiley consideration of any opportunity before you allow others to consider the opportunity. Non-Compete, Non-Solicitation During your employment with Wiley, you have and shall become familiar with Wiley's trade secrets, information related to the operations, products and services of the Wiley, and with other Confidential Information concerning Wiley, its affiliates and companies acquired by Wiley. Therefore, during your employment period and for a period of one year thereafter, you agree that you shall not directly or indirectly own any interest in, manage, control, participate in, consult with, or render services for any (i) publishing or information services company or (ii) individual if either competes with Wiley in the publishing or information services industries. During your employment and for a period of one year thereafter, you agree that you shall not directly, or indirectly through another entity, (i) induce or attempt to induce any employee of Wiley or any affiliate to leave the employ of Wiley or such affiliate, or in any way interfere with the relationship between Wiley or any affiliate and any employee thereof, (ii) hire any person who was an employee of Wiley or any affiliate at any time during your employment with Wiley or (iii) induce or attempt to induce any customer, supplier, licensee, licensor, franchisee or other business relation of Wiley or any affiliate to cease doing business with Wiley or such affiliate, or in any way interfere with the relationship between any such customer, supplier, licensee, licensor, franchisee or business relation and Wiley or any affiliate (including, without limitation, making any negative statements or communications about Wiley or its affiliates). You agree that during the term of your employment with Wiley, you will devote full time to the business of Wiley and will not engage in any activity that conflicts with your obligations to Wiley.

------

![](exhibit1027-employmentle006.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;111 River Street, Hoboken, NJ 07030-5774, U.S. T +1 201 748 6000 F +1 201 748 6088 www.wiley.com Representations You hereby represent and warrant that: (a) you have the right to enter into this Agreement, to grant the rights granted in this Agreement and to perform fully all their obligations under this Agreement. No consent of any other person or entity is necessary for you to enter into and fully perform this Agreement and you have not done and shall not do any act and have not made and shall not make any grant, assignment or agreement which shall or would likely conflict or interfere with the complete enjoyment of all of Wiley's rights under this Agreement; (b) the material contributed by you, including without limitation, any Work Product, (i) shall not violate or infringe in any way upon the rights of others, including, without limitation, any copyright, patent, trademark or other proprietary right or the right of privacy or publicity, (ii) shall not contain any libelous, obscene or other unlawful matter, and (iii) shall not violate any applicable law. Modification It is the intention of the parties to make these restrictive covenants and agreements binding to the fullest extent permitted under existing applicable laws. In the event that any part of any of these restrictive covenants and agreements is determined by a court of law of competent jurisdiction to be overly broad or too long in duration or otherwise objectionable, thereby making the covenants unenforceable, the parties hereto agree, and it is their desire, that such a court shall substitute a reasonable judicial enforceable limitation in place of the offensive part of the covenant, and that as so modified the covenant shall be as fully enforceable as if set forth herein by the parties themselves in the modified form. Miscellaneous This Offer Letter and any and all related issues – including but not limited to interpretation, enforcement, and performance – shall be governed by the laws of the State of New York, without reference to the conflicts of law provisions thereof. General This document, those documents expressly referred to herein and other documents of even date herewith embody the complete agreement and understanding among the parties and supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may have related to the subject matter hereof in any way. This document may be signed in one or more counterparts, each of which once signed shall be deemed to be an original. All such counterparts together shall constitute one and the same instrument.

------

![](exhibit1027-employmentle007.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;111 River Street, Hoboken, NJ 07030-5774, U.S. T +1 201 748 6000 F +1 201 748 6088 www.wiley.com For Wiley By: __ _____ ______________ Suzanne Hyland Date Danielle McMahan Date VP, Global Rewards

------

## Ex-21

**Exhibit 21**

---

| | |
|:---|:---|
| **SUBSIDIARIES OF JOHN WILEY & SONS, INC. (1)** | **SUBSIDIARIES OF JOHN WILEY & SONS, INC. (1)** |
| **As of April 30, 2026** | **As of April 30, 2026** |
| | **Jurisdiction of Formation** |
| Atypon Systems, LLC | Delaware |
| Inscape Publishing, LLC | Delaware |
| John Wiley & Sons Canada Limited | Canada |
| Wiley Periodicals LLC | Delaware |
| Personality Profile Solutions, LLC | Delaware |
| PIIEU Ltd | United Kingdom |
| &nbsp;&nbsp;&nbsp;&nbsp;Wiley Heyden Ltd | United Kingdom |
| Zyante Inc. | Delaware |
| Wiley Publishing LLC | Delaware |
| &nbsp;&nbsp;&nbsp;&nbsp;Wiley India Private Ltd | India |
| Wiley APAC Services LLP | India |
| WWL LLC | Delaware |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wiley International LLC | Delaware |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons (HK) Limited | Hong Kong |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wiley HK2 Limited | Hong Kong |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wiley Europe Investment Holdings, Ltd. | United Kingdom |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wiley Europe Ltd | United Kingdom |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wiley Heyden Ltd | United Kingdom |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; John Wiley & Sons Ltd | United Kingdom |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;J Wiley Ltd | United Kingdom |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Atypon Systems Ltd | United Kingdom |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons Singapore Pte. Ltd. | Singapore |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons Commercial Service (Beijing) Co Ltd | China |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wiley Information & Technology (Shanghai) Co Ltd | China |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Madgex Holdings Ltd | United Kingdom |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Blackwell Science (Overseas Holdings) Ltd | United Kingdom |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;John Wiley & Sons AS | Denmark |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wiley-VCH GmbH  | Germany |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ernst & Sohn GmbH | Germany |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wiley-VHCA AG | Switzerland |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wiley Publishing Japan KK | Japan |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wiley Publishing Australia Pty Ltd. | Australia |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;John Wiley and Sons Australia Ltd. | Australia |

---

(1) The names of other subsidiaries that would not constitute a significant subsidiary in the aggregate have been omitted.

## Exhibit 23.1

**Exhibit 23.1**

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-267661) of John Wiley & Sons, Inc. of our report dated June 24, 2026 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

New York, New York

June 24, 2026

## Exhibit 31.1

**Exhibit 31.1**

**<u>CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</u>**

I, Matthew S. Kissner, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this annual report on Form 10-K of John Wiley & Sons, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclose controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| By: | /s/ Matthew S. Kissner |
|  | Matthew S. Kissner |
|  | President and Chief Executive Officer |
|  | Dated: June 24, 2026 |

---

## Exhibit 31.2

**Exhibit 31.2**

**<u>CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</u>**

I, Craig Albright, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this annual report on Form 10-K of John Wiley & Sons, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| By: | /s/ Craig Albright |
|  | Craig Albright |
|  | Executive Vice President and Chief Financial Officer |
|  | Dated: June 24, 2026 |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of John Wiley & Sons, Inc. (the "Company") on Form 10-K for the year ended April 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Matthew S. Kissner, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| By: | /s/ Matthew S. Kissner |
|  | Matthew S. Kissner |
|  | President and Chief Executive Officer |
|  | Dated: June 24, 2026 |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of John Wiley & Sons, Inc. (the "Company") on Form 10-K for the year ended April 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Craig Albright, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| By: | /s/ Craig Albright |
|  | Craig Albright |
|  | Executive Vice President and Chief Financial Officer |
|  | Dated: June 24, 2026 |

---

<br>